Ryman Healthcare Limited – Annual Report 2022
Ryman Healthcare
ANNUAL REPORT 2022
RYMAN HEALTHCARE
As a vertically-integrated retirement village and
aged-care operator, our purpose-driven care model
is woven into every stage of a Ryman village. From
the construction site to welcoming residents in to
their beautiful new homes, care is what drives us
every step of the way.
ANNUAL REPORT 2022
About this report
This is our fifth annual report prepared according to the guiding principles of the
International Integrated Reporting <IR> Framework. The <IR> Framework encourages
businesses to report against issues most material to their stakeholders, as well as
providing insight into how their business creates value and how this value contributes
to sustainable returns for stakeholders over the long term.
Pictured on the front cover is Joyce, a 92-year-old resident at our Logan Campbell Village
in Auckland. Joyce is well known in the village for enjoying daily walks around the beautiful
gardens, often seeking out the support of Caregiver Ramon Martir.
On the inside front cover are Fit-out Site Manager Jason Q Zhao and Site Administrator
Matakeu Timms at our Miriam Corban Village in Auckland. Once complete, the village
will provide residents with exceptional independent and serviced apartment living, plus
resthome, hospital and specialist dementia care.
2
RYMAN HEALTHCARE
04
85
151
182
190
Building for the future
04 At a glance
06 Chair and Group Chief Executive report
16 Our story
19 Who we are and how we create value
27 Listening and responding to our stakeholders
31 Providing sustainable returns to our shareholders
39 An unwavering commitment to care
47 Raising the bar on our resident experience
55 Building a solid platform to grow
65 Caring for our environment
75 Investing in our people
Our financials
87 6-year summary
90 Consolidated financial statements
95 Notes to the consolidated financial statements
146 Independent auditor’s report
Corporate governance
152 Our directors
154 Our senior executives
156 Statement of corporate governance
Thank you to our team of Rymanians
Village locations and directory
ANNUAL REPORT 2022
3
45 operational
villages
16
sites under construction
$783.0m
invested in new villages
6,700+
team members
96.0%
care occupancy
$1.40bn
cash receipts from
residents
1.4%
of total units available
for resale
43.0%
debt to debt-plus-equity
gearing
4,239
care beds
8,538
retirement village units
22.4c
dividend per share
interim 8.8c
final 13.6c
13,200+
residents
$255.0m
underlying profit*
reported
profit
$692.9m
63.8%
13.6%
18.7%
$10.97bn
total assets
19.6%
At a glance
* Refer to page 87 for a definition of underlying profit.
RYMAN HEALTHCARE
4
961
unit refurbishments
completed
$455.9m
new sales
Commenced construction
on 4 new sites
$500,000+
donated to charitable
partnerships
4 new sites
added to the land bank
$623.9m
resales
$1.87bn
resale bank of
future earnings
3
new villages opened
$1.42bn
work in progress
8.99 million care
hours provided
8x voted
Reader’s Digest
Most Trusted Brand
ANNUAL REPORT 2022
5
Chair and
Group Chief Executive report
Image: Greg and Richard inside a new apartment at our Kevin Hickman Village in Christchurch.
RYMAN HEALTHCARE
6
Our success as a
business is what
enables us to take our
exceptional Ryman
model to more and
more people, and
that’s a good thing.”
Richard Umbers, Group Chief Executive
“
7
ANNUAL REPORT 2022
We are pleased to report a strong result delivered during this period
of considerable disruption. The resilience, commitment and
professionalism of our Ryman team played a key role in helping us
adapt quickly and respond decisively to the changing circumstances.
Quite simply, their efforts have been magnificent.
Our vertically-integrated business model proved particularly
advantageous in maintaining the momentum of the business, allowing
us to reallocate resources to the areas of most need. As a result,
we have been able to keep our residents and team safe as well as
build for the future, acquiring land, constructing new villages, selling
completed and refurbished units and setting new benchmarks in
clinical care.
These outcomes have served to enhance our reputation in the market
and cement our position as a market leader in the retirement sector.
We remain committed to maintaining our leadership position, as well
as generating increased returns to our shareholders and positioning
Ryman for further growth in the years ahead.
Providing care that in the words of our co-founder has got to be
“good enough for Mum or Dad” is key to us achieving this. This ethos
captures something truly unique in the spirit of Ryman and is what
motivates our people every day.
Our low resale stock, combined with mature care occupancy of
96 percent, demonstrates that our villages continue to be in
strong demand.
In a year when we faced increased operating costs and could not
trade or build for a significant amount of time, we are pleased with
what the team has achieved.
Kia ora koutou
As a business that cares
for older people, the last
2 years have certainly
presented us with
challenges, testing all
aspects of our operation
as never before.
RYMAN HEALTHCARE
8
A strong result in a tough year
Strong demand for our continuum of care model,
which delivers both peace of mind and security,
helped to underpin our strong result this year.
The 63.8 percent increase in our reported
IFRS profit to $692.9 million was also driven by
movements in the wider property market and
the payback on our investment in higher-value
locations over recent years.
Underlying profit for the year rose 13.6 percent
to $255.0 million. This included $20.9 million
of COVID-incurred costs related to resident
welfare, staffing, security and personal
protective equipment.
The full-year dividend of 22.4 cents per share
was in line with the prior year and reflects a
payout ratio of 43.9 percent. This is within the
new flexible dividend policy range adopted by
the board of 30 to 50 percent of underlying profit.
Total booked sales rose 8.1 percent to a
record 1,543 units for the year and was a great
achievement given the restrictions in our two
biggest markets, Victoria and Auckland, during
2021 followed by the arrival of Omicron later
that year.
In Victoria, the sales uptick in the wake of the
Omicron peak has been strong. The number of
transacted sales in the last quarter of our financial
year were double what we achieved in the first half.
This is an outstanding turnaround off the back
of a pandemic and further highlights the strong
demand for what we do.
Across New Zealand and Australia, this saw us
end the year with only 120 units or 1.4 percent of
our retirement village portfolio available for resale.
Strengthening the resilience of our
balance sheet
We have continued to diversify our debt and have
executed four separate debt capital market
transactions since December 2020. This has
resulted in $1.13 billion of diversification across
three
geographies, including the NZ$290.0 million
United States Private Placement (USPP), which
closed in April 2022.
We ended the year with total facilities of $3.36 billion
and $737.0 million of headroom. This positions
us well to continue to invest wisely in the
business to meet the demands of our rapidly
ageing population.
Over the year, our debt to debt-plus-equity gearing
has improved to 43 percent reflecting the benefit
of our investment in higher-value villages. The
benefit of this is also evident in the value of our
new sales, the resale bank we have accumulated
and the strong lift in our cash receipts and total
assets during the year.
The value of our new sales lifted 15.4 percent
to $455.9 million. The embedded value of our
portfolio, which includes the resale bank of
$1.87 billion, accrued management fees and
resident loans, is now $2.45 billion. The realisation
of this embedded value, and potential after-tax
earnings, over the next 6 to7 years will support
our growth aspirations as the baby-boomer
generation start entering our villages.
Despite the challenging conditions, cash receipts
from residents rose 18.7 percent to $1.40 billion for
the year. Total assets lifted to $10.97 billion, and
we invested $783.0 million in the portfolio.
“
We’ve kept our residents and teams safe as well as
building for the future.”
Greg Campbell, Chair
ANNUAL REPORT 2022
9
An unwavering commitment to care
A highlight of the year was the recognition we received for our
COVID response. In Victoria, we were recognised for the many
ways we used innovation and industry-leading initiatives to
encourage COVID-safe practices. Our team was also named
Team of the Year at the 2021 Excellence in Age Services Awards.
Our overall COVID response has been a marathon effort, and
we are incredibly proud of the extraordinary dedication
demonstrated by the Ryman team. A particular highlight was
our vaccination programme, which reached over 13,000 residents
and 6,700 team members throughout the course of the year.
Our commitment to providing exceptional care never wavered.
This was evident in the results of our certification audits where the
number of New Zealand villages to achieve 4-year certification
(the 'gold standard' in care) increased to 91 percent. In Australia,
our villages continue to achieve excellent results and meet the
Aged Care Quality Standards.
We will continue to advocate strongly for improved residential
care resourcing for the sector. However, our emphasis remains on
business improvement and innovation to strengthen care earnings
and ensure the ongoing quality of our care offering. Looking
forward, we expect the rapidly developing critical shortage of care
beds to drive decision making about retirement options. In that
context, Ryman’s investment in our continuum of care means future
residents can choose our villages with confidence.
Demand for our continuum of care model continues to increase,
and we remain focused on exceeding the ever-changing expectations
of our residents.
of our New Zealand villages
have 4-year certification,
the ‘gold standard’ in care
91%
RYMAN HEALTHCARE
10
Enhancing our resident experience
year on year
As a care business, we are steadfast in enhancing
our resident experience. It’s one of the reasons
why we have been named Reader’s Digest
Most Trusted Brand in the aged care and retirement
village sector in New Zealand for the eighth time.
During lockdowns, we adapted our activity and
entertainment line-up into a digital format,
ensuring
that our residents could remain connected
. We
created a speaker series featuring various
celebrities as well as wellness workshops on
sleep, meditation, exercise and movement to
name just a few.
We’re constantly trialling new events and
activities, the highlight this year being our
Olympics@RYMAN tournament. The use of
advanced technology enabled residents at all
of our villages in New Zealand and Australia to
compete against one another for prized gold
medals. The tournament created the perfect
opportunity for connection, camaraderie and fun.
It also encouraged residents to venture out again
after numerous lockdowns and to incorporate
physical activity back into their daily routines.
In the face of challenges, we kept
momentum going
Our growth opportunity is driven by a rapidly
ageing population. Although COVID halted or
slowed construction across several of our villages
for periods of time during the year, we were still
able to welcome residents into their new homes
at three new villages – Raelene Boyle in Melbourne,
Kevin Hickman in Christchurch and Keith Park
in Auckland.
We also commenced construction on four new
villages – Highett and Ringwood East in Melbourne,
Takapuna in Auckland, and Northwood in
Christchurch. These villages will be home to more
than 1,000 residents when completed.
Within our growth plan, we have included a
stronger focus on building more energy-efficient
homes and reducing the embodied carbon in our
villages. We are already seeing this focus come to
life at our Kevin Hickman Village in Christchurch.
Here, we are replacing some structural elements
previously made from steel and concrete with
cross-laminated timber. In doing so, we will be able
to significantly reduce the embodied carbon of
the structure.
ANNUAL REPORT 2022
11
Making great strides in our high-value expansion plans
Our focus on acquiring and developing sites for new communities
in
premium locations has made great strides this year with the
purchase
of four new sites. The sites at Rolleston in Canterbury and
Mulgrave and Kealba in Melbourne are well suited to townhouse-style
developments. The fourth site in Coburg North, Melbourne, will be
an apartment-style village.
We also purchased additional land adjacent to our fast-selling
Deborah Cheetham Village in Ocean Grove as well as a small
retirement village next to our Essendon site in Melbourne.
The value creation that will come from what we are currently building
and what we are primed to build with our land bank is significant.
“
Our persistent
drive for
improvement
would not be
possible without
the commitment
and dedication
of our teams.”
We’re well prepared for the challenges to come
The supply-chain constraints, material availability and construction
cost inflation challenges facing the construction sector over the
last 12 months are likely to linger for some time after the clinical
emergency of COVID has abated.
We have been very focused on how we face in to these challenges.
We enjoy strong partnerships with our supplier base, many of
whom have grown alongside us over the years. As one of the largest
builders in our sector, we have strong purchasing power, and our
ability to purchase cross-Tasman helps to offset shortages or
delays in either market.
Richard Umbers,
Group Chief Executive
RYMAN HEALTHCARE
12
Our people: our inspiration, our most
precious resource
We continue to invest in growing and developing
our team of committed Rymanians who safeguard
our culture of kindness and excellence but also
deliver strong commercial outcomes.
Our persistent drive for improvement would
not be possible without the commitment and
dedication of our teams. It’s our people who are
the inspiration and driving force behind every
improvement we make.
That’s why investing in the training and
development of our people is paramount. We will
continue to make Ryman a fulfilling place to work,
recognising talent that can be further developed
and encouraging our people to grow their careers
with us.
Leadership that will inspire generations
of Rymanians
In May 2022, Dr David Kerr let us know that he
was stepping down as a director of Ryman. David
has served on Ryman’s board since 1994 and held
the position of chair from 1999 until January 2022.
He participated in Ryman’s listing on the NZX
in 1999 and has been instrumental in Ryman’s
subsequent growth.
David’s legacy as chair is defined by his unwavering
dedication to care, clinical excellence and
outstanding commercial leadership through many
years of extraordinary growth. David has also
formed deep connections with many residents
and has been a sounding board for leaders
across Ryman.
This includes former Group Chief Executive
Gordon MacLeod who we farewelled in October 2021
after 15 years of dedicated service to Ryman.
David’s wisdom will not be lost entirely. We are
delighted that he has agreed to take up a role as
an advisor to our Clinical Governance Committee.
On behalf of everyone, we offer both David and
Gordon a sincere vote of thanks for everything
they have done.
ANNUAL REPORT 2022
13
A strong focus on the future
Our vertically-integrated model and continuum of care offering have
proven to be robust through the global pandemic and will underpin
our success as we continue to face in to the challenges ahead.
We are committed to achieving our corporate ambition of 15 percent
per annum per share growth in underlying profit.
The work our development and construction teams undertake
ensures that we have a good blend of village styles in our land bank
and a strong pipeline of consented sites.
“
To our Ryman
teams, your
actions personify
what it means
to be a Rymanian,
and we extend
our sincere
thanks to each
and every one
of you.”
A heroic team performance
As chair and group chief executive, we are immensely proud of our
team’s performance over the last year, and we are excited about
Ryman’s journey ahead.
To our Ryman teams, your incredible efforts have kept residents
safe, connected, entertained, informed, cherished and loved. The
flow-on effects of these actions have been felt well beyond the
boundary of our village gates. Your actions personify what it means
to be a Rymanian, and we extend our sincere thanks to each and
every one of you.
Greg Campbell
CHAIR,
RYMAN HEALTHCARE
Richard Umbers
GROUP CHIEF EXECUTIVE,
RYMAN HEALTHCARE
Greg Campbell,
Chair
RYMAN HEALTHCARE
14
Greg Campbell joined the board as director in March 2021 and was
appointed deputy chair in July the same year. Greg’s transition into
the role as chair from January 2022 has been a smooth one, and he
feels very fortunate to be surrounded by the depth of experience
within our board and within the management team.
Greg brings a wealth of experience to the table through his many
years as chief executive and board director across a number of
leading organisations. Greg is a firm believer in striking a balance
between care and commerciality and is passionate that success in
both can be achieved simultaneously and in a sustainable way.
Richard Umbers is an internationally experienced chief executive
with a background leading large organisations in many industry
sectors. He joined us as group chief executive in October 2021
and lives in Christchurch. Richard is a strong believer in fostering a
strong sense of purpose within the team and investing in people to
drive a culture of high performance.
What Richard admires most about Ryman is the unique culture
of genuine care that exists within the business, and his strong
commercial background makes him a natural fit to lead us through
this next period of growth.
Image: Greg and Richard at the construction site at our Kevin Hickman Village
in Christchurch.
ANNUAL REPORT 2022
15
Our story
Bringing their purpose-driven business to life
They soon found a block of 14 two-bedroom flats, which they would
convert into their first resthome.
They renamed the resthome Riverside, the cash flow started to
come in and they were soon in the market for a second property.
With that, Ryman – formed from combining Ryder and Hickman
– was born.
The pair were on the look-out for a business opportunity.
“The perfect business,” Kevin says, “had to combine residential
property – because it’s a good long-term investment and the
banks always like to lend on property – and a strong cash flow.’’
In 1983, when investigating a fire-damaged resthome, Kevin didn’t
like the standard of care he saw. With multiple people to a room and
shared toilets, preserving the dignity of residents didn’t appear to
be a priority.
That experience got Kevin thinking about what the standard should
be. “I thought, what would I want for Mum? I’d want a private room
for a start.”
Kevin had discovered the missing piece to the pair’s perfect
business opportunity – a genuine purpose anchored in care.
It would be a business that would improve the way older people lived
and how they were cared for. A business they could feel good about,
believe in completely, and one that would inspire teams who worked
there for generations to come.
Former police officer
Kevin Hickman and
accountant John Ryder
began working together
in the early 1980s.
RYMAN HEALTHCARE
16
Right from the start, purpose and commerciality shone
A motel complex became their next development. Kevin lived
on site while they rebuilt and, as he says, “we needed to squeeze
every drop of cash flow out of it while we were rebuilding”.
While those early days were challenging, they remained true to their
ambition of making retirement the best period of older people’s
lives. “For some of our residents, it was the first time they’d lived in a
new house.”
They were now witnessing the difference that their exceptional care
model was making. However, Kevin and John were also acutely
aware that they needed to be commercially successful to maintain
that standard and to bring their model to a wider audience.
They believed in reinvesting to grow the company. Profits were
reinvested to lay the foundations for future earnings so that the
value of the investment was always compounding.
The Ryman model was to buy the right site in a well-established
suburb, use working capital to build the first stage of the village,
sell that and use the capital to fund the next stage. They’d then
build a care wing, which would be operated by our team who put
into practice every day what it means to be “good enough for Mum
or Dad”.
After almost 4 decades and 45 villages in total, that model has
become the benchmark in the retirement industry.
However, as Kevin would often say, “If you think you’ve made it,
you’ve had it.” So, with each new retirement generation that
chooses to call a Ryman village home, we continue to adapt and
innovate so we can maintain our exceptional standards. At our
core, we will always remain true to our purpose, as it’s the key to our
commercial success.
“
I thought, what
would I want
for Mum?”
Kevin Hickman,
Co-founder Ryman Healthcare
ANNUAL REPORT 2022
17
Artist’s impression of our Kevin Hickman Village in Christchurch.
Named in honour of our Co-founder, Kevin Hickman, we welcomed
our first residents to this village during the year.
18
RYMAN HEALTHCARE
18
Who we are
and how
we create value
19
ANNUAL REPORT 2022
19
We are a vertically-integrated
retirement living and
aged-care developer, owner
and operator. We create
beautiful homes and
supportive communities
and provide exceptional
care for older people.
Who we are
Nearly 40 years ago, our founders looked at the industry and
knew instantly that it could and should be better. This became
the purpose that would drive them to create the Ryman model
that is now seen as the benchmark in retirement living and
aged care today.
Ryman has grown to become the largest retirement village
operator in New Zealand with a 15 percent share of the retirement
village and aged-care market. We own and operate 38 villages
across New Zealand and 7 in Victoria, Australia. We have a further
17 villages in the pipeline.
We continue to establish a strong presence in Victoria, Australia, and
the growth opportunities ahead for us in this market are immense.
We provide a comprehensive range of retirement living options,
including independent apartments and townhouses, assisted living
in serviced apartments as well as resthome, hospital and
dementia care.
Our focus on innovation and improving people’s wellbeing as they
grow older has helped underpin our success.
How we create value
We build high-quality retirement village communities. Once
completed, these villages not only generate ongoing returns for our
shareholders, they provide meaningful careers for our people, they
act as supportive hubs to their surrounding communities and they
provide critical healthcare infrastructure.
Ryman village communities are places where older people can
choose to live in beautiful homes with access to superb amenities,
all while enjoying the support of a community of friends, neighbours
and a team of dedicated Rymanians.
Our villages are places where residents can relax knowing that
if their needs change, we can continue to care for them. Families
know their loved ones have the comfort, security and dignity that
comes with the highest standards in clinical care.
RYMAN HEALTHCARE
20
How we create value
K
i
n
d
n
e
s
s
a
n
d
c
a
r
e
R
e
s
i
l
i
e
n
c
e
a
n
d
c
o
m
p
o
s
u
r
e
C
o
m
m
u
n
i
c
a
t
i
o
n
S
t
r
i
v
e
f
o
r
e
x
c
e
l
l
e
n
c
e
S
t
r
o
n
g
t
e
a
m
s
L
e
a
d
a
n
d
e
m
p
o
w
e
r
V
e
r
t
i
c
a
l
i
n
t
e
g
r
a
t
i
o
n
B
u
i
l
d
S
e
l
l
O
p
e
r
a
t
e
C
o
n
t
i
n
u
u
m
o
f
c
a
r
e
m
o
d
e
l
It’s got
to be good
enough for
Mum or
Dad
o
f
c
a
r
e
f
o
r
a
g
e
i
n
g
w
e
l
l
O
ff
e
r
t
h
e
b
e
s
t
c
o
n
t
i
n
u
u
m
h
i
g
h
-
v
a
l
u
e
s
i
t
e
s
E
x
p
a
n
s
i
o
n
t
a
r
g
e
t
i
n
g
D
e
l
i
v
e
r
a
n
u
n
p
a
r
a
l
l
e
l
e
d
r
e
s
i
d
e
n
t
e
x
p
e
r
i
e
n
c
e
L
e
a
d
e
r
s
h
i
p
f
o
r
s
u
s
t
a
i
n
a
b
l
e
p
e
r
f
o
r
m
a
n
c
e
Our resources
Value created
Our
people
Our
relationships
Our
expertise
Our
environment
Our
communities
Our financial
strength
Developing
our
people
Strengthening
our
relationships
Enhancing
our
expertise
Protecting
our
environment
Growing
our
communities
Building
our financial
strength
ANNUAL REPORT 2022
21
Our business model draws
on six capitals to create value.
Our people
Our expertise
Our communities
Our relationships
Our environment
Our financial strength
Our culture of providing care that has got to
be “good enough for Mum or Dad” has shaped
our business model and powers our success.
We are committed to nurturing and protecting
this culture, and that starts with developing our
own people.
We have incredibly talented people within our
team. It is these people who drive our innovation
and allow us to deliver exceptional care, an
unparalleled resident experience and strong
financial returns. That’s why investing in the
training and development of our people
is paramount.
We strive to create an environment where people
feel included and empowered. In doing so, we
see improvements to overall wellbeing, enabling
our people to continue to thrive.
Our people
Our most precious resource is our team.
Ensuring we understand, value and celebrate
what each individual contributes is very
important to us. So is their health, safety and
wellbeing. We want them to love the experience
of working at Ryman, and we want to do
everything we can to help them develop and
build long-term careers with us.
Developing our people
RYMAN HEALTHCARE
22
Our villages are unique. The way they are
designed, the way they are built, how they feel
– it’s all uniquely Ryman.
Our in-house expertise in identifying sites,
designing, consenting, building, selling and
operating world-class retirement villages has
grown tremendously over our 38 years of
operation.
It plays a critical role in our ability to build
high-quality villages that meet the needs of our
residents and the provision of industry-leading
care and the associated clinical outcomes.
We listen to our residents, their families and
our team. This improved understanding means
we can continue to support our team to deliver
exceptional care and an unparalleled resident
experience while rapidly growing the number
of Ryman villages to meet demand.
The communities we build provide our
residents
with security, companionship, social
connectedness and environments that challenge
the conventions of ageing. They are people’s
homes and are in well-established areas
where people have lived and worked and want
to retire.
Our villages help to meet the demands of a
rapidly ageing population, take pressure off the
public health system, provide employment for
local communities and become an economic
driver for local businesses.
Each village we build represents a long-term
investment in care for the communities we
operate in, and each village creates a new
economic engine to support our future growth.
Our expertise
Over the past 38 years, we have built a wealth
of knowledge in how to build, sell and operate
communities where people thrive in retirement
and receive exceptional care. The collective
wisdom and experience of our team and the
systems we have developed over this time are
huge assets that are difficult to replicate.
We are well positioned to rapidly respond to
any changes in the operating and regulatory
environment, and we use our voice to educate
and lobby on behalf of the sector.
Our communities
The communities we serve have a common
social issue – the growing demand for the
care of older people and a scarcity of supply
and skill. Each of our 45 retirement villages
provides critical healthcare infrastructure.
Our new villages are built in areas where there
is unmet need, and they quickly become an
important asset to the wider community. They
also become a social hub for the communities
they serve.
Enhancing our expertise Growing our communities
ANNUAL REPORT 2022
23
Our environment
We want to make sure all decisions are made
with sustainability in mind so that we leave
the environment in a better condition for
generations to come. We are committed to a
zero-carbon future, we are actively pursuing
ways to cut our greenhouse gas emissions
and we are driven to ensure the growth of
our villages is sustainable within the broader
local, national and global contexts in which
we operate. Our aim is to lead by example,
so we encourage all our team and the people
who supply us to think the same way.
Sustainable growth means looking after the
environmental capital we use, including reducing
our carbon footprint and minimising the impact
of our operations on the environment.
We remediate and improve carefully selected
sites so they can be developed into integrated
retirement villages.
Our villages are an efficient way of providing
high-quality homes with minimum impact on
the environment.
The villages we build become homes for thousands
of residents, freeing up homes in existing
communities for new families to move into.
The homes vacated will be close to local amenities
including bus stops, libraries and schools. They
are immediately available, reducing the need for
further urban spread.
Our relationships
We value strong relationships across all
areas of our business – between residents,
their families, our teams, our suppliers and
contractors and our local communities.
We enjoy and invest in these relationships,
many of which are long term and are a key
part of our success.
Trust is the foundation of any great relationship,
and we are deeply aware of the many people
and organisations that put their trust in us.
Residents trust us to care for them into old age.
Their families trust us to care for their loved
ones. Our team trusts us to provide them with
a meaningful, reliable and safe place to work.
Our suppliers trust us to pay on time and our
shareholders trust us to continue providing
strong commercial returns on their investment.
This is a huge responsibility and one we never
take for granted. Trust begins with getting the
basics right – treating everyone with respect
and kindness and communicating in simple and
clear language.
The trust we have developed has contributed
to our achieving market-leading brand
awareness of 92 percent in New Zealand and
our continued growth of brand awareness in
Australia. This has led to strong waitlists, low
levels of stock available for resale and the ability
to pre-sell independent units off plan.
Strengthening our relationshipsProtecting our environment
RYMAN HEALTHCARE
24
Our financial strength
The interest-free source of funds we receive
from occupancy advances and refundable
accommodation deposits is a tremendous value
creator for the business. Our long-term success
and the financial strength it has created allows
us to reinvest to create even more value as well
as generate returns for shareholders to reward
them for investing in us. Our view is always
long term.
Our financial success underpins our ability to
invest in future villages, in innovation, in lifting
the experience of our residents and in the
development of our people.
We create value by building our own operating
assets and generating cash to invest in new
villages. Since listing in 1999, we have grown our
total assets from $103.0 million to $10.97 billion.
Alongside the growth in our total assets, we have
also grown our gross occupancy advances to
$4.86 billion. The value of these advances has
doubled over the last 5 years and reflects the
development of new villages, many of which have
been built in higher-value areas and generate
significant value for the company.
These gross occupancy advances or interest-free
capital sums are a key value creator for the
business. They fund the development of new
villages, and as units resell, these occupancy
advances are repriced and the deferred
management fee that we collect increases,
creating significant value for our shareholders.
“
The interest-free
source of funds
we receive from
occupancy
advances and
refundable
accommodation
deposits is a
tremendous
value creator for
the business.”
Building our financial strength
David Bennett,
Group Chief Financial Officer
ANNUAL REPORT 2022
25
Our residents, many of whom are shareholders, are some of our
key stakeholders. Pictured here is Suellen, a resident in our
William Sanders Village in Auckland.
26
RYMAN HEALTHCARE
Listening and
responding to our
stakeholders
27
ANNUAL REPORT 2022
27
Our influence goes beyond our village gates into the healthcare
community, research organisations, the arts and hundreds of
community groups.
We are constantly engaging with our stakeholders. Through regular
survey activities, our dedicated resident relations team keeps
abreast of what matters to residents, what we are doing well and
where we can improve.
We connect with our teams through multiple forums, including
annual staff and contractor surveys, weekly team huddles,
one-on-one catchups and focus groups, to ensure we stay on top
of what matters most to our team members and contractors.
Our community relations managers proactively engage with
members of the local community involving them in important
conversations from the start, including village naming and blessing
ceremonies. Our dedicated investor relations and corporate affairs
teams proactively engage with other stakeholders in New Zealand,
Australia and overseas, including investors, banking partners,
regulators and government.
These interactions help strengthen our relationships and identify
what matters most to our stakeholders. We review and collate the
information received and assess its effect on our ability to create
value in the short, medium and long term.
From our discussions, we have identified and grouped the
most-material issues into four areas.
We are responsible to
thousands of stakeholders,
from our residents and
their families, our teams
and our shareholders
through to our contracting
partners, providers of
debt and suppliers in the
communities we operate in.
RYMAN HEALTHCARE
28
Materiality matrix
Significance of impact
Stakeholder importance
Sustainable design
Carbon reduction
Capital management
Resident experience
Communication
Health, safety, wellbeing
Diversity and inclusion
Care quality
Culture
Growing underlying profit
Market dynamics
Staff recruitment, development
Corporate governance, cyber security
Waste and water management
Supply chain
Sponsorship, community engagement
Care and communityPeople
Care quality and continued innovation
Communication
Resident experience, safety and wellbeing
Sponsorship and community engagement
Culture of kindness and care
Diversity and inclusion
Health, safety and wellbeing
Staff recruitment and development
EnvironmentSustainable financial performance
Carbon reduction
Supply chain and material choice
Sustainable design
Waste reduction and water management
Capital management
Corporate governance, cyber security
Growing underlying profit
Market dynamics and regulation
Material issues
ANNUAL REPORT 2022
29
Artist’s impression of our upcoming Takapuna Village in Auckland.
The location of this village is a prime example of a high-value site that
will generate strong returns.
30
RYMAN HEALTHCARE
Providing sustainable
returns to
our shareholders
31
ANNUAL REPORT 2022
If you were to design a
challenge specific to our
sector, COVID would be it.
Like the rest of the world,
we were not immune to
the challenges of the last
2 years and the headwinds
still faced by the sector.
Government restrictions introduced during peak periods of the
pandemic hampered our ability to transact and led to a reduced
workforce on construction sites. This meant our build rate was
slower, delaying our cash collection and pushing out our debt profile.
We have come through this period in a strong position. We’ve
continued to operate, we’ve protected our residents and their families,
we’ve strengthened our brand, we’ve improved our systems and
processes, and demand for our continuum of care offering is stronger
than ever.
Nellie Melba Village Personal Care Worker Joeben Roxas
enjoying a stroll with resident Bernie. Joeben moved
into the village twice during the pandemic to help reduce
the risk of transmission.
RYMAN HEALTHCARE
32
A good business adapts itself to ride the wave of the
challenges it faces.”
“
A strong result in challenging conditions
We reported a 13.6 percent lift in underlying
profit to $255.0 million in FY22. This growth was
slightly below our stated corporate ambition of
growing underlying profit by 15 percent per annum
per share, reflecting the challenges of COVID
including the additional $20.9 million spent on
keeping residents and staff safe through the year.
Our reported (IFRS) profit of $692.9 million
was up 63.8 percent, driven by a $467.1 million
unrealised fair value movement on investment
property. While these gains are unrealised,
they are based on the pricing we have been able
to achieve over the last 12 months, and it shows
the growth in the value of our portfolio.
Ryman’s total assets grew to nearly $11 billion
during the year driven by our build programme,
investment in higher-value sites and investment
property fair value gains.
The high value nature of our sites means we
anticipate generating $6.80 billion of capital
proceeds from the 29 sites in our land bank
when they are fully occupied and sold down.
To put that into context, our 32 fully sold villages
have currently contributed $3.60 billion of
occupancy advances and refundable
accommodation deposits.
This shows the scale of the momentum we have
been building over recent years, which is well
timed with the demographic boom on our doorstep.
Richard Umbers, Group Chief Executive
To help manage rising construction costs,
we’ve shortened the length of time in which
we commence pre-selling our new stages.
This change means we are able to match
new sale prices to the latest market demand,
improving our ability to offset construction costs.
We spent over $780.0 million building new
villages and investing in our existing portfolio.
This investment ensures our villages remain
in strong demand and we can unlock the
embedded value – currently $2.45 billion
– on our existing portfolio.
The affordability of our units is something we
monitor closely and our residents are freeing
up more capital than ever when they move into
a Ryman village. We are in a strong position to
withstand any market correction with property
prices in Auckland needing to fall 27 percent
before residents stop freeing up capital. For
residents in Melbourne, property prices would
need to fall 47 percent to have the same impact.
We ended the year with $737.0 million of funding
headroom, and combined with our strong
pipeline of consented sites, this means we are
in a strong position to meet the demands of the
rapidly ageing population.
ANNUAL REPORT 2022
33
Demand for our continuum of care model
is unprecedented
Demand for what we do is underpinned by a rapidly ageing population.
In New Zealand, the number of people aged 75 and over is projected
to increase from 365,000 today to 938,000 in 40 years' time.
In Australia, it is a similar situation. The 75 and over age group is
projected to increase from 1.9 million today to 4.4 million in
40 years’ time.
Along with an ageing population, people are also living longer.
However, with increasing longevity comes a sharp increase in the
occurrence of age-related diseases. This could see many individuals
lose their ability to live independently due to a decline in physical or
cognitive functioning.
Our investment in providing exceptional care and support across
a full range of retirement living and aged-care options is an
important differentiator in both the New Zealand and Australian
markets. As a market leader in the retirement sector with a true
continuum of care offering, we are uniquely positioned to benefit
from this changing demographic.
current population in
New Zealand and Australia
aged 75 and over
2.3 million
projected population in
New Zealand and Australia aged
75 and over by 2062
5.3 million
While it has
been a disrupted
period, the
underlying
demand for our
model, and our
ability to deliver
and meet that
demand, is very
much there.”
“
Cameron Holland,
Chief Executive Officer
– Australia
RYMAN HEALTHCARE
34
Maintaining a sustainable pace
The Ryman ‘flywheel’ of efficiently building, selling and recycling
capital has slowed over recent years as the business has worked
through the challenges that come with building across a greater
number of larger and more-complex sites and increasing
construction costs.
Over this period, we have made significant investment in our people,
systems and processes to increase the growth capacity of the
organisation and to ensure that our ‘flywheel’ can keep turning at
a sustainable pace.
We are already seeing evidence that the enhancements made to our
processes are resulting in tighter capital management. Combined
with strong demand, we are well positioned to achieve our corporate
ambition of growing underlying profit by 15 percent per annum
per share.
Enhancements made over recent years include:
• the introduction of a new organisational structure
• continued strengthening of skills and lifting the capability of
our team
• the adoption of new systems and technologies to further enhance
efficiencies and improve project coordination across the business
• tighter discipline around the staging of capital-intensive sites
and the mix of sites in our land bank
• improved governance oversight across development and
construction through the establishment of a Development, Design
and Construction Committee
• diversification and extending the tenor of our debt.
What gives me
confidence as
to where we are
now and where
we’re going are
the significant
enhancements
we’ve made over
recent years.”
“
Anthony Leighs,
Director
ANNUAL REPORT 2022
35
Using debt to fund our growth ambitions
Over the year, our debt to debt-plus-equity gearing has improved to
43 percent reflecting the benefit of our investment in higher-value villages
over recent years.
Debt remains a function of our growth plans. We use debt to fund the
purchase of land and the development of a village. This debt is repaid via
the occupancy advances we receive for independent and serviced units
and refundable accommodation deposits for aged-care rooms.
This is a significant value creator for the business. The occupancy advances
and refundable accommodation deposits are effectively interest-free loans
that are repaid with the funds received from the next incoming resident
(less management fees). Any difference in value between the outgoing and
incoming resident is retained by Ryman. This interest-free source of funds
is what has enabled us to create significant value for our shareholders since
listing in 1999.
We aim to recycle capital by the time a village is completed, fully occupied
and sold down. This means that the majority of our debt is productive debt.
The increase we have seen in our debt over the past 4 years reflects the
investments we have been making, including lifting the number of sites we
are building across from four to 16.
At 31 March 2022, we had core debt (systems and other assets and
village capex) of $506.0 million. The remainder of our debt constitutes
undeveloped land, work in progress and new sale debtors.
Use of debt
fiffiffflbn
fiffiffflbn
fiffiffflbn
fiffiffflbn
fiffiffflbn
fiffiffflbn
Mar Mar
Systems and
other assets
Village capex
New sale
debtors
Development
work in progress
Undeveloped
land
True underlying
value creation
is
a co-equal
fundamental goal
of Ryman. This
takes vision,
commitment,
financial discipline
and excellent
execution. That is
what our founders
were seeking.”
“
Geoffrey Cumming,
Director
RYMAN HEALTHCARE
36
Our governance committees
Our governance committees have been established
at board and management level, according to key
areas of focus and potential risks to the business.
These committees have evolved over the years
in response to an ever-changing environment in
which we operate. Each of our committees made
invaluable contributions which helped us shape
and navigate our response to COVID.
The structure and support of our committees
ensures we are well positioned to manage
future challenges.
Our new organisational structure generates
additional capacity to deliver strong growth while
enabling the business to respond to local market
conditions. New Zealand and Australian CEOs
lead the regional executive teams, supported by
the shared group structure.
While the New Zealand and Australian markets
are similar in some respects, understanding the
nuances of each market – different legislation,
funding sources, competitor landscape, resident
needs and local councils – is essential to our
ability to grow and deliver great care and profit.
We are already seeing the benefits of the new
structure. Being able to quickly respond to
changing resident needs while building out
long-term projects means we stay relevant and
generate growing returns.
Strengthening the resilience of our
balance sheet
Since 2019, we have been on a journey to improve
the resilience of our balance sheet through the
diversification of our debt in terms of its tenor,
geographic origins and counterparties.
We considered a range of options and ultimately
executed four separate debt capital market
transactions resulting in $1.13 billion of diversification
across three geographies. This includes the
NZ$290.0 million USPP, which closed in April 2022.
Following the closure of our second USPP,
30 percent of our total debt is now fixed with an
average cost of debt of 3.8 percent and tenor of
approximately 6 years.
This work saw us named as a finalist in the
Bloomberg Excellence in Treasury Award for
demonstrating excellence in adaption and
execution of treasury financial management.
The proactive changes we have made to our capital
structure position us well to withstand future
challenges, whether related to the pandemic, rising
geopolitical tensions or an increasingly volatile
capital environment.
During the year, the board also approved a move
to a flexible dividend policy. The new policy
provides the flexibility to pay out 30 to 50 percent
of underlying profit as a dividend (previously fixed
at 50 percent of underlying profit). The change
in policy provides us the option to retain more
cash in the business to meet the extraordinary
growth ahead.
Adapting to changing market conditions
ANNUAL REPORT 2022
37
Rosemary, a resident in our Diana Isaac Village in Christchurch,
enjoys a stroll with Registered Nurse Sandra Hendriks.
38
RYMAN HEALTHCARE
An unwavering
commitment to care
ANNUAL REPORT 2022
39
Since January 2020,
we have invested over
$70 million in keeping our
residents and teams safe
from COVID. The work
we have done has been
greatly valued by our
residents and their families,
and we are very proud
of the resilience our team
has shown through this
challenging period.
Taking control of our COVID vaccination rollout
Key to ensuring the long-term safety of our residents, teams and
communities was the swift rollout of vaccinations. In preparation
for the arrival of the vaccines, we trained our own in-house
vaccination team of 50 nurses. This preparedness meant we were
one of only a few aged-care providers in Victoria to win a tender to
self-vaccinate our team members.
In New Zealand, our strong engagement with district health boards
(DHBs) and the Ministry of Health meant we could help on a
broader scale. When Canterbury DHB asked us to support them
to rapidly vaccinate other aged-care providers in the region,
our vaccination teams and efficiently-run clinics enabled us to
offer assistance.
Through our vaccination programme, we have administered more
than 36,800 vaccination doses to Ryman residents and 17,800 doses
to our team across Australia and New Zealand.
Initiating a vaccination programme of this scale and implementing
the rollout in the shortest timeframe possible was an extraordinary
feat. Our teams demonstrated incredible dedication and commitment
and operated like a well-oiled machine throughout.
The learnings we have garnered through the pandemic have been
well mined and will assist us greatly going forward.
RYMAN HEALTHCARE
40
Award-winning COVID response
in Victoria
With numerous extended lockdowns to contend
with, our villages in Victoria have endured more
than their fair share of COVID-related challenges.
Their marathon efforts were impressive and didn’t
go unrecognised.
Ryman leaders responsible for overseeing our
COVID response were named Team of the Year
for Victoria and Tasmania at the 2021 Excellence
in Age Services Awards.
In 2022, Ryman was named Innovation Award
Winner in the Victorian Chamber of Commerce
COVIDSafe Business Awards. This award was in
recognition of the innovative and industry-leading
steps taken to encourage COVIDSafe practices,
describing Ryman as an expert in how to execute
such a response.
Our response included Ryman team members
moving into villages to reduce the risk of
transmission, the development of a COVID GO
kit that provided our village teams with the
immediate actions they needed to take as soon
as a positive case was detected, the early
introduction of rapid antigen testing for all visitors
and contractors, and the development of our own
COVID digital contact tracing tool, which recorded
all team member and resident interactions.
We shared learnings gathered from our Australian
operations with the aged-care sector in
New Zealand to ensure everyone was well prepared
for the arrival of Omicron.
A fabulous response that was ahead of the curve
in preparedness. There was a clear level of care,
compassion and selflessness in the actions taken and
their efforts and commitment helped save lives.”
Victorian Chamber of Commerce judging panel
“
Image: Members of our award-winning COVID response
team in Victoria.
ANNUAL REPORT 2022
41
Hazel, Logan Campbell Village resident
It was time for us to give back to the Ryman
team for everything they’ve done, and the
exceptional kindness they’ve shown.”
“
RYMAN HEALTHCARE
42
While Ryman team members put their home and family
lives on hold to keep residents safe, residents also rallied
around to do their bit to reduce transmission.
Residents inspired
by Ryman team
COVID efforts
At the peak of the pandemic,
some villages faced considerable
staff shortages, with team
members either unwell or
isolating at home.
One of those was Auckland’s
Logan Campbell Village, which
had 30 workers on COVID
leave at one point.
Ryman villages provided the
option for team members to
live on site. For those workers
living in large households, often
alongside other healthcare
workers, it created a unique
opportunity to reduce
transmission even further.
A dozen team members
moved into Logan Campbell
Village, including Village
Manager Rebecca McMillan.
Inspired by their selfless
dedication, residents also
formed a ‘resident crew’ to do
their bit too.
Resident and former nurse
Dawn marvelled at village team
members putting residents
before themselves. She was
only too happy to help with
essential jobs such as folding
laundry and sanitising high-touch
points like lift buttons, banisters
and door handles. Fellow resident
Hazel also helped out by cooking
meals for the team.
Activities Coordinators Gerlie
Navaja and Keefe Martinez
were among the team members
who moved into the village.
Along with going above and
beyond to maintain exceptional
quality of care for their residents,
they also enjoyed participating
in activities with residents.
The collective effort of team
members and residents has
served to enhance the already
strong sense of family that
exists at Ryman villages.
Image: Logan Campbell resident Hazel and Activities Coordinator,
Keefe Martinez.
ANNUAL REPORT 2022
43
Continuing to exceed standards in
clinical excellence
The driving force behind our COVID response
was to keep everyone safe, and in doing so, it
shone a spotlight on the exceptional standard of
care that we simply call day-to-day operations.
We continue to lead the market in the provision
of a high quality of care – 91 percent of our
aged-care centres in New Zealand have now been
awarded 4-year certification, the ‘gold standard’
in care.
Despite the ongoing pressures of COVID,
our villages have not only maintained their
standards in aged care, they have continued
to exceed them.
Our custom-built technology proved
to be invaluable
Our custom-built myRyman Care app provides
nurses and carers access to clinical data and
detailed care tasks required for each care
resident. This award-winning technology ensures
all information is securely recorded – from
critical medical alerts to personal preferences.
The efficiency in which this information is recorded
enables our nurses and carers to spend more
quality time with residents and it makes the transfer
of care between team members seamless.
The app has proven to be an invaluable tool,
enabling us to be agile in responding to the
ever-changing demands of the pandemic. It
enhanced the efficiency of our vaccination rollout
and the management of isolation quarantines.
myRyman Life model of dementia care
Our villages are supportive and caring communities
that work to improve the experience of residents
living with dementia. We provide a safe environment
for residents to enjoy, with a focus on experiences
rather than processes.
We have researched and developed our own model
of dementia care, myRyman Life. The model
aims to challenge perspectives on dementia and
supports people to live in the moment and to feel
kindness, love and security. It promotes spontaneity,
laughter and happiness.
We have continued to enhance our innovative
approach to dementia care through the successful
trial of our Moove and Groove music therapy
programme and our new care companion model.
This model aims to reduce distressed behaviour
through individualised and more-purposeful
engagement and sees team members regularly
partnered with the same residents. These initiatives
will be rolled out to all Ryman dementia care
centres from July 2022.
RYMAN HEALTHCARE
44
myRyman Life awards
2020Winner
Innovation of the Year
– Dementia Care Model
Solution
Asia Pacific Eldercare
Innovation Awards
Refining our care offering
With 3,676 aged-care beds in New Zealand and
a further 563 in Australia, we are an integral part
of the healthcare system, providing a protective
moat around our public hospitals – there are only
12,035 public hospital beds in New Zealand.
We are committed to continuing to meet the
demands of an ageing population while ensuring
sustainable returns for the care that we provide.
In 2020, we introduced refundable accommodation
deposits in New Zealand. This offers our care
residents the choice around how they pay
their weekly room premium. This initiative has
been very popular with our residents, and following
a soft launch in late 2020, we have collected over
$100 million in refundable accommodation deposits.
With resthome care also available in our serviced
apartments, we have been refining the number
of care beds in new villages over recent years
to better align with the number of residents who
transition through to care.
2021Winner
Best Plain English Document
Private Sector
myRyman Life eLearning tool
Plain English Awards
2020Finalist
Best Dementia Care Programme
Asia Pacific Eldercare
Innovation Awards
2022Finalist
Learning and Development
Capability Award
myRyman Life education
HRNZ Awards
ANNUAL REPORT 2022
45
Ryman resident Terry at our Logan Campbell Village in Auckland,
who won an Olympics@RYMAN gold medal in swimming.
RYMAN HEALTHCARE
46
Raising the bar
on our
resident experience
ANNUAL REPORT 2022
47
Feeling connected to a
community that genuinely
cares is one of the highlights
of living in a Ryman village.
Amidst the extraordinary
challenges that COVID
presented, we found ways
to maintain that feeling
of connectedness.
Olympics@RYMAN
In the midst of the pandemic, our residents’ wellbeing was top of our
agenda. With the Tokyo Olympics on the horizon, we dreamt up an
ambitious initiative to enhance the social connection and wellbeing
of our residents: the Olympics@RYMAN.
We invested in innovative technology to make this a hybrid physical
and virtual tournament. Residents gathered to compete using
technology to link events across stadium venues, bowling greens
and village lounges across our villages in New Zealand and Australia.
In every event category – lawn bowls, cycling, swimming, a walking
relay and a ‘quiznastics’ event – our residents competed for the
chance to stand on the podium as an Olympics@RYMAN medallist.
Recognised as the Best Active Ageing Programme and
Innovation of the Year at the Asia Pacific Eldercare Innovation
Awards, our teams did an outstanding job bringing this event to life.
The Olympics@RYMAN provided a great opportunity to test some
very innovative and emerging technologies with our residents and
helped us better understand its potential going forward.
We appreciated the opportunity to
partner with the Olympic Committees
and create a truly unique experience
for our residents.”
“
Mary-Anne Stone, Chief Strategy Officer
RYMAN HEALTHCARE
48
Poem by Murray S. Lennox
Ryman resident
We yelled, we cried, we gasped and sighed
At victories won and places lost,
Emotions that we couldn’t hide
While they pushed on at what a cost.
That spirit we took up in our own Ryman way,
As residents walked and biked and bowled
While swimmers swam, and quizzers played
And none were left out in the cold.
Technology not seen before
Created a community across the land
While happy bags and food galore
Brought weeks of graft to the final grand!
“Well done” to all who were involved
From stewards to the athletes strong.
We admire your strength and fortitude,
And you all deserve a golden gong!
Robust systems and processes to
enhance our dining experience
When it comes to lasting impressions, enjoyable
dining is an experience that deserves continued
enhancement. Like any good restaurant, we
are constantly refining recipes and improving
systems and processes.
During the year, we introduced an end-to-end
food management system, Saffron.
Saffron gives us better access to nutritional,
allergen and cost data. We use this data to
inform our recipe and menu creation and have
seen significant improvements in resident
experience through the ability to select meals
from a device as well as track allergen
information. The introduction of this system
has also led to cost reductions and better
procurement and contract management.
We also rolled out the Safe Food Pro
digital software to our New Zealand villages,
and we’re implementing it across our
Australian villages. This system improves
our ability to efficiently capture all food
safety records, including refrigeration
and cooking temperatures as well as
food storage temperatures.
Image: Ryman resident Jane from our
Murray Halberg Village in Auckland, and her
support crew during our Olympics@RYMAN
cycling event.
ANNUAL REPORT 2022
49
attendees
103,000
copies of our
Botanical magazine issued
5,000
50
RYMAN HEALTHCARE
Partnering with the Melbourne International Flower and
Garden Show enabled us to be part of a high-profile
event with a wide appeal. It’s a great opportunity to
build brand awareness while also celebrating the lifestyle
and passions that are important to our current and
future residents.
Developing meaningful
partnerships in
our communities
Through our partnership with
the show, we offered a range
of experiences for attendees
to enjoy. This included our
Ryman stand where we offered
refreshing iced tea on tap, our
fully booked workshops with
Australian landscaping expert
Matt Leacy and our inaugural
Ryman Healthcare Balcony
Garden Competition which
sought to provide gardening
inspiration for smaller spaces.
Residents and friends of our
villages enjoyed access to
exclusive ticketing benefits,
and with 103,000 people in
attendance, we were able to
introduce Ryman to a broader
audience and lift our profile in
the Australian market.
Image: Show attendees enjoying the activities at our Ryman stand.
“Giving people the opportunity to
create their own sanctuary in a small
space is important. The benefits to
wellbeing and quality of life are huge.
”
Sara Correia from Tempest Landscapes, inaugural winner of the
Ryman Healthcare Balcony Garden Competition
ANNUAL REPORT 2022
51
Engaging with our communities
As a care business, building meaningful partnerships and
supporting our communities enables us to make a positive impact
on a larger scale. Through our support of over 400 clubs and
organisations, we have established strong relationships with the
communities outside of our village gates.
Every day we see the positive impact of the arts within our vibrant
village communities, where residents can connect through their
shared appreciation of music, dance and creative hobbies. Our
partnerships with organisations such as the Melba Opera Trust,
the Melbourne Symphony Orchestra, the Royal New Zealand Ballet
and The Court Theatre mean our residents and friends of our
villages benefit from access to wonderful cultural experiences.
Each year, our residents and team members vote to select an
annual charity partner to support. All money raised by them
is matched by Ryman, dollar for dollar. In 2021, we supported
Melanoma New Zealand and the Melanoma Institute Australia,
donating a combined total of $550,000. In New Zealand, these
funds allowed Melanoma New Zealand to buy a Spot Check Van
that has been touring community locations around New Zealand.
Our 2022 charity partners are the Prostate Cancer Foundation NZ
and the Prostate Foundation of Australia.
Our support extends beyond our local communities to causes
that also affect our team and their families abroad. This year, we
sent over 10,000 masks to support Fiji’s COVID relief efforts and
provided essential items, including water, pantry staples and face
masks to Tonga in the wake of the volcanic eruption and tsunami.
We are so grateful
to
Ryman for its
extraordinarily
generous support.
The impact the
van is already
having in the
community has
been significant.”
“
Andrea Newland,
Melanoma New Zealand
Chief Executive
RYMAN HEALTHCARE
52
Previous winners
2015 Gabi Hollows
(Restoring sight)
2016 Professor Henry Brodaty
(Alzheimers research)
2017 Professor Peter St George-Hyslop
(Neurodegenerative research)
Supporting the wellbeing of older
people globally
The Ryman Prize recognises the world’s best
advancements in the pursuit of enhancing the
quality of life for older people.
As a business that set out to improve the
standards in aged care, our implementation and
sponsorship of the prize has enormous potential
to bring awareness to an often-overlooked sector.
The work of our prizewinners often benefits the
entire aged-care sector, and we feel it’s important
to recognise and reward those who have
dedicated their work to benefit older people.
This year’s winner of the $250,000 prize was
Professor Kenneth Rockwood, a geriatrician,
researcher, academic and anti-ageism campaigner.
Professor Rockwood was selected for his
truly unique contribution to the understanding
of ageing. His Clinical Frailty Scale is used
internationally, and he has made a massive
contribution to scientific literature with hundreds
of peer-reviewed articles and contributions in
the world’s leading medical research journals.
Accepting the award from the Right Honourable
Jacinda Ardern, Prime Minister of New Zealand,
Professor Rockwood said, “This is fantastic
recognition, and the timing could not be better
given COVID. It will give momentum and
recognition to do a whole lot more research and
work for a greater good.’’
2018 Professor Takanori Shibata
(Robotics)
2019 Dr Michael Fehlings
(Degenerative cervical myelopathy research)
2020Miia Kivipelto
(Alzheimers research)
Image: Professor Kenneth Rockwood,
2021 Ryman Prize recipient.
ANNUAL REPORT 2022
53
Ryman Foreman Ian Lee on site at our Miriam Corban Village in Auckland.
Ian was attracted to Ryman’s scale and in-house capabilities.
54
RYMAN HEALTHCARE
Building a solid
platform to grow
55
ANNUAL REPORT 2022
Our villages are designed,
built, sold and operated
by Rymanians. Our ability
to manage every stage
of a village’s life cycle
means that our purpose
of exceptional care is
always at the forefront.
It influences all of our
conversations and drives
the decisions we make.
Design, development and construction under
one roof
The process of building a successful village is more than just buying
a piece of land and constructing buildings on it. Bringing design,
development and construction under one roof enables us to unify
the life cycle of a village. It means our teams work cohesively
throughout each step of the process. This collaboration creates a
better environment for success, with improvements and efficiencies
achieved at each stage.
Led by our chief construction officer, our team has the skills,
breadth of knowledge and capability to deliver at the complexity,
scale and pace required for our portfolio of villages. With expansive
experience in the construction industry and the introduction of new
technologies, systems and processes, we have lifted our approach
in this area and will continue to see the benefits of the changes and
additional rigour put in place.
Ryman is a major player in the construction industry in both
New Zealand and Victoria, Australia.
During the last financial year, we invested over $780.0 million into
building homes for Ryman residents, lifting our investment in
villages and critical healthcare infrastructure to $3.36 billion over
the last 5 years.
We delivered 560 new independent units and serviced apartments,
and 151 care rooms. We also opened three new village centres during
the year.
Despite COVID restrictions and outbreaks, our dedicated team
of 58 sales advisors welcomed over 1,500 new residents into our
independent units and serviced apartments and have booked over
$1 billion of gross occupancy advances.
RYMAN HEALTHCARE
56
Facing in to the construction headwinds
We have been using our scale and long-standing relationships with
suppliers to manage the headwinds currently facing the construction
sector, including supply chain constraints, material availability and
cost inflation.
As we navigate our way through the next 12 to 24 months, it is
critically important that we remain committed to forward planning.
We will continue driving efficiencies in the way we approach our
work for the delivery of each stage of development. We will continue
making the most of our scale and position in the market and we will
make sure we have the right people and resources in place at the
right time.
Lots of little efficiencies create great gains
As a company that provides exceptionally high standards in care,
our drive for continuous improvement never sleeps.
We’ve been developing our technology platforms to ensure we have
the best systems in place to meet the demands associated with
building and operating across an increasing number of sites. This
enhances our capabilities now and in the future.
This year, we will introduce the construction management platform
Procore. This will help streamline our processes at the project level,
leading to improved communication, documentation, accountability
and efficiencies.
The adoption of Salesforce over the coming year will enable us to
harness the advanced capabilities of this world-leading platform
to improve sales analysis and productivity. We will apply workflow
modifications across the business, from sales through to how we
modify and refurbish our units.
There’s plenty
of opportunity
for great gains
to be made by
introducing lots of
little efficiencies.
That is what
we’re focused on
right now.”
“
Chris Evans,
Chief Construction Officer
ANNUAL REPORT 2022
57
Expanding our growth runway
The population of people aged over 75 in Australia
is over five times larger than in New Zealand and
provides an enormous growth opportunity for
our business.
Having successfully launched in Victoria, we have
proven that our strategy and culture is transportable
to another jurisdiction.
We’ve learned an enormous amount since
we entered the market 10 years ago and have
celebrated a number of successes.
With the adoption of a new organisational structure,
the appointment of our first chief executive of the
Australian business, the opening of our seventh
operational village and a further eight villages
either under way or in the land bank, many of the
challenges we faced entering a new market are
now behind us.
Ryman is a major player in the construction industry
As a developer of retirement living and aged-care facilities,
we are a significant employer across the construction
sector. We have a large in-house team of designers, quantity
surveyors, project managers, health and safety advisors,
quality advisors and support staff.
Construction of our villages sees small communities formed
with upwards of 300 staff and subcontractors on site during
the peak development of any one village.
under construction across
New Zealand and Australia
16 sites
Having a CEO of the Australian business who is
supported by a highly capable local senior leadership
team with a deep understanding of the local market,
has bolstered our capabilities on
the ground
and further enhanced our understanding
of the
Australian market.
The purchase of three new sites in Victoria over
the year has lifted our Australian land bank to nearly
twice that of our current asset base.
With an aim of maintaining the land bank at around
2,800 beds and units, we continue to seek out
sites around the Melbourne metropolitan area.
Having the right mix of sites in the land bank means
we are well positioned to lift both our build rate and
the value we create from this portfolio over the
next 5 years.
We have proven that our strategy and culture
is transportable to another jurisdiction.”
“
Claire Higgins, Director
RYMAN HEALTHCARE
58
The benefit of higher-value locations
As we have grown, so too has our balance sheet
and our aspirations. This has seen us tilt our
portfolio towards higher-value areas, including
Auckland and Melbourne, over recent years.
While development in these areas can have
higher upfront costs associated with the
purchase of land and the style of village, this is
more than offset by the considerable future
value created.
This value can be seen in the resale bank we have
accumulated. Our resale bank, or the difference
between what our current residents paid and
what the next residents are expected to pay if
we sold that unit at current prices, is $1.87 billion.
This is up more than 146 percent over the last
5 years and in part reflects our push into these
higher-value markets along with wider property
market movements. Our resale bank underpins
our future resale gains, and we expect to realise
this amount over the next 6 to 7 years as the
portfolio turns over.
Even though our build rate has remained relatively
stable over the last 5 years, by focusing on
building villages in higher-value locations, we
have created significant value, and over the long
term the benefits of this will continue to accrue
to shareholders.
The value creation that comes from what we are
currently building and what we are primed to build
with our land bank is also significant. We anticipate
the 29 sites in our land bank will generate capital
proceeds of $6.8 billion when they are completed,
fully occupied and sold down.
A land bank with a great mix of sites
We are focused on ensuring we have the right
mix of sites in our land bank, including the style
of villages we are building. This is important as it
allows us to more effectively manage our working
capital requirements, the consenting process,
the needs of our communities, our build and the
speed at which we recycle capital.
During the year, this mix was enhanced by the
purchase of four new sites – Rolleston in
Canterbury and Mulgrave, Kealba and Coburg
North in Victoria. We also purchased additional
land adjacent to our Deborah Cheetham Village
in Ocean Grove and a small operating retirement
village next to our Essendon site. We now have
a land bank of sites that stretches over half a
decade in front of us.
While COVID has seen construction on some of
our sites halted at times during the year, it has also
presented opportunities. We have been able to
drive forward on the consenting process, and
57 percent of our pipeline is currently consented.
We believe that our focus on higher-value
locations will support the delivery of superior
long-term returns for investors through greater
upfront selling prices, which result in a higher
recurring earnings stream through management
fees collected and resale earnings.
This increase in profitability also allows us to
continue to invest in our people and our systems
and technologies, enabling us to enhance the
resident experience and ultimately bring Ryman
to more communities.
ANNUAL REPORT 2022
59
Auckland
DesignConsentingConstructionVillage
open
Final
stages
Council
approval
Targeted
village
completion
Our development pipeline
Rest of
New Zealand
2023
2023
2024
2025
2026
TBC
TBC
TBC
TBC
TBC
2024
2025
2026
2024
TBC
TBC
Linda Jones
James Wattie
Kevin Hickman
Northwood
Park Terrace
Cambridge
Karori
Newtown
Rolleston
William Sanders
Miriam Corban
Keith Park
Murray Halberg
Takapuna
Kohimarama
Karaka
Targeted village completion is a calendar year date. It is based on current estimates and may vary from the
final completion date.
RYMAN HEALTHCARE
60
DesignConsentingConstructionVillage
open
Final
stages
Council
approval
Targeted
village
completion
Australia
2022
2022
2022
2024
2024
2024
TBC
2026
TBC
TBC
TBC
TBC
TBC
Charles Brownlow
John Flynn
Raelene Boyle
Nellie Melba
Deborah Cheetham
Highett
Ringwood East
Mt Eliza
Mt Martha
Essendon
Mulgrave
Kealba
Coburg North
ANNUAL REPORT 2022
61
RYMAN HEALTHCARE
62
Having lived and breathed construction her whole life,
Senior Quantity Surveyor Liz De Villiers was looking for
an exciting new challenge – and Ryman fit the bill.
A great team that
values diversity
The opportunity to work
within a company where the
developer, contractor and
operator were all under one
roof is what initially attracted
Liz to Ryman.
A big drawcard was the ability
to regularly brainstorm and
problem solve with different areas
of the business. For Liz, that’s
where innovation flourishes.
Liz also loves the caring
aspect and says, “Ryman has
a reputation for looking after
its people and being a big
supporter of work-life balance.”
Ryman’s flexible working policy
enables mums like Liz to
structure work responsibilities
around home life.
Flexible options such as the
ability to work from home or
vary her working schedule
make a big difference to Liz and
her family.
Working both on site and in
the office, Liz enjoys the diverse
and resilient teams she works
with and has noticed the number
of women in construction
has grown.
“How great is that? Construction
is about teamwork. Having a
diverse team with different life
experiences and construction
backgrounds across residential,
commercial and civil projects
has been brilliant.”
“Ryman has a reputation for
looking after its people.
Liz De Villiers, Senior Quantity Surveyor
”
Image: Liz enjoying the on-site aspect of her role at our Kevin Hickman
Village in Christchurch.
ANNUAL REPORT 2022
63
Artist’s impression of our Raelene Boyle Village in Aberfeldie,
Melbourne which includes a host of sustainable design features
such as rain gardens and a solar energy generation system.
64
RYMAN HEALTHCARE
Caring for our
environment
65
ANNUAL REPORT 2022
As the science around
understanding climate
change and climate risk
has developed globally,
we have elevated our
activity on sustainability.
We’ve brought on
additional internal and
external expertise to
enhance our capabilities
and formalise our
approach in this area.
Our principles of sustainable design
Our 11 principles of sustainable design guide our approach to
designing villages. Each village is treated as unique, and homes are
designed utilising modern technologies that consider environmental
and social impacts and harness natural resources where possible
– all with the goal of improving the health and happiness of our residents.
Measuring our emissions
The care of our residents is our number one priority. We use a
large amount of electricity to keep our residents comfortable and
to ensure our safety systems are continuously operating. This
means electricity is the largest contributor to our operational
emissions footprint.
Despite our absolute emissions for the year to 31 March 2021
rising by 1.9 percent, we have achieved a 22 percent reduction
in our carbon mandatory scope 1, 2 and 3 emissions per $m of
turnover from 2017 to 2021. We are focused on meeting our
30 percent reduction target by 2023.
GHG operational emissions by source (year to 31 March 2021)
Electricity
fiNZffi fffl
Electricity
fiVICffi fffl
Natural gas
fiffifffl
Air travel
fiffifffl
fiffifffl
Waste
fiffifffl
Fuel
RYMAN HEALTHCARE
66
Total gross GHG emissions
(tCO
2
e)
fiffiffffff
fiffiffffff
fiffiffflflfl
fiffiffflflfl
Base)
Total gross emissions (LHS)
Number of residents (RHS)
Total gross GHG emissions per $m turnover
(tCO
2
e)
The unprecedented operating environment under
COVID resulted in a 74 percent decline in our air
travel-related emissions when
compared to 2020.
This offset a large proportion
of emissions related
to the opening of a new village.
Like all businesses, we have adapted to a new
approach in developing new ways of doing
business, and we expect to see a continuation
of the behaviours that enabled a reduction in
air travel-related emissions in the years ahead.
This year, we have extended our scope 3 emissions
inventory to include additional emissions related
to the disposal of waste and recycling, including
glass and composting.
In the coming year, we will carry out a materiality
assessment of the emissions associated with
our supply chain. Where supply chain emissions
are material relative to the total of our direct and
indirect emissions, we will look to report on these
and publish associated reduction plans.
Planning for the future
As we explore further opportunities to reduce our
impact on the environment, we have turned our
attention to the embodied carbon in our buildings.
Across the building sector, emissions associated
with the use of steel and concrete are significant
contributors to the sector’s carbon footprint.
The work we have been doing over the past
2 years will see us embark on our first
development using a cross-laminated timber
structure at our new Kevin Hickman Village
in Christchurch. The expected reduction in
embodied carbon in the cross-laminated structure
is approximately 80 percent.
(Base)
ANNUAL REPORT 2022
67
reduction in embodied
carbon for the CLT structure
80%
reduction in
build time
10%
reduction in heavy
vehicle movements
65%
RYMAN HEALTHCARE
68
We have committed to constructing our first mass
timber structure at our new Kevin Hickman Village using
cross-laminated timber in place of some structural
elements previously made from steel and concrete.
Detailed design is under way, with the construction of the
apartments due to commence in September 2022.
Reducing our
embodied carbon
Cross-laminated timber (CLT)
is one of the products produced
through mass timber construction.
This is where multiple layers
of timber are glued together to
form structural panels that can
be used for the floors and walls
of buildings.
Cross-laminated timber has
two significant advantages
over steel and concrete. Being
a natural product, its carbon
content is extremely low. It’s
also a carbon-positive material
– when trees are replanted,
their growth reduces carbon,
and oxygen is released into
the atmosphere.
By substituting concrete and
steel for cross-laminated
timber, we have also addressed
some high-risk health and
safety considerations, including
reducing heavy vehicle
movement
for on-site deliveries
by 65 percent.
We are now looking at future
opportunities for its use in
other new builds as well as
additional ways to reduce
the embodied carbon in our
buildings such as low-carbon
concrete. We are also pursuing
ways in which we can continue
to improve our waste and
recycling from construction sites.
Image: Artist’s impression of our Kevin Hickman Village apartment buildings.
ANNUAL REPORT 2022
69
Step by step we can make a difference
One of many sustainability initiatives being
undertaken across the business is our partnership
with City to Farm. Since 2019, in partnership with
City to Farm, our Evelyn Page Village in Auckland
has been diverting food scraps away from landfill.
The food scraps are composted on local farms
and used to transform heavy, infertile clay into rich
soil that can support food production, in this case,
banana palms.
50 tonnes of food scraps have now been
diverted from landfill, removing the possibility
that this waste could have emitted 138 tonnes of
greenhouse gases into the environment.
The building of predator traps by our residents
for the Department of Conservation and Predator
Free New Zealand has gathered a huge amount
of momentum over the past year.
Our residents have partnered with charity
Doubtless Conservation and have been busy
building predator traps to protect some of our
most precious species in the South Island high
country. All materials are supplied by Ryman, and
our fantastic residents provide the muscle and
know-how.
The recycling and diverting of construction waste
from landfill at our Auckland and Melbourne
sites continued to improve over the year. We are
currently recycling 87 percent of construction
waste from these sites. We have seen a consistent
improvement in this trend since we began
collecting data in 2019.
Image: Ryman-made predator traps being transported
to the Doubtful Valley.
RYMAN HEALTHCARE
70
Strengthening our expertise
Along with a lift in individual initiatives happening around the group,
we are maturing our understanding around sustainability. This is
reflected in the additional internal and external expertise we have
incorporated into our structure.
During the year, we appointed a dedicated sustainability manager.
In addressing our climate-related risks, we have begun a
programme of work that will ensure we are taking the necessary
steps to address climate change risks while taking advantage of
any opportunities that will arise.
Our board has acknowledged its responsibility for identifying and
managing our climate-related risks and opportunities, and our
disclosure responsibilities have been assigned to a member of the
senior executive team with extensive expertise in sustainability.
The next step in our journey
As part of this programme of work, we have completed a climate
change maturity assessment of our structures, policies and
processes against international standards. We have developed
a roadmap of priority actions to improve our climate-related
risk management policies and processes across the areas of
governance, strategy, risk management, and metrics and targets.
This comprehensive roadmap will be actioned over the next 3 years
as we work to build organisational resilience and capture value
associated with the net-zero transition.
We have engaged the expertise of KPMG to identify the impact of
a range of climate scenarios on our operations, now and in the
future, and to develop adaptive measures to manage the identified
risks and opportunities. A 3-year action plan has been developed to
ensure we meet our climate-related disclosure requirements, which
are expected to be confirmed by the External Reporting Board in
late 2022.
This body of work positions us well to meet these disclosure
requirements, which will be included in our 31 March 2024
annual report.
We want to
leave our planet
in good shape
for generations
to come.
Our residents,
our team and
our investors all
share this goal.”
“
Greg Campbell,
Chair
ANNUAL REPORT 2022
71
Area
Governance
Establish governance
processes and update
policies
to incorporate
climate change risks.
Assign climate change
responsibilities to key
oversight groups at both
senior executive team
and board level.
Provide climate risk training
to our senior leaders.
Consider the appropriateness
of establishing a technical
advisory committee.
Assess climate change
skills gap across board and
senior executive team on
an ongoing basis.
Enhance governance skills
and performance across board
and senior executive team
on an ongoing basis,
including
integrating climate
change
issues with governance
performance reviews/audits.
Year 1
activities
Year 2
activities
Year 3
activities
Our 3-year action plan
Roadmap to addressing
climate-related risks
This comprehensive roadmap of
priority actions will be carried out
over the next 3 years.
RYMAN HEALTHCARE
72
Strategy
Carry out a risk and
opportunity assessment
using scenario analysis.
Develop a strategy to
address our material
climate change risks
and opportunities.
Establish an action plan
to address our material
climate-related risks
and opportunities.
Carry out a capacity
assessment for
effective climate-related
decision making.
Integrate climate change
considerations into our
business, strategy and
financial planning.
Execute a second iteration
of our climate risk and
opportunity assessment.
Develop a process for
systematically identifying and
analysing
climate-related risks.
Develop a plan to manage
climate-related risks.
Document the extent to
which our climate-related
targets have been informed by
external parameters (such as
science-based targets).
Integrate climate change
risk management processes
into our operations.
Select climate change
metrics based on a
materiality and/
or risk and
opportunity assessment.
Document target setting
objectives and establish targets
for capital deployment and
climate-related opportunities.
Broaden metrics to include
our other climate-related
impacts and risks including
supply chain.
Enhance measurement
processes of our overall
climate-change risk
management progress by
establishing targets to
encompass the delivery of
our climate-related strategies,
plans and policies.
Risk managementMetrics and targets
ANNUAL REPORT 2022
73
Clinical Manager Madelyn Premacio (far right) with her care team at
our Charles Upham Village in Canterbury, whose outstanding daily
efforts demonstrate what it means to be a Rymanian.
74
RYMAN HEALTHCARE
74
Investing in our
people
ANNUAL REPORT 2022
75
Our greatest asset is the
people who work here,
and our culture remains
one of our most unique
differentiators.
Our team is the backbone
of our business, and they
have been outstanding
throughout the past
2 years in what can only
be described as a very
challenging period for
the business.
Our people have worked tirelessly to keep themselves and our
residents safe through the extended lockdowns in New Zealand and
Australia. This has included wearing N95 masks and face shields
through the hot summer period, moving to 12-hour shifts during the
height of the Omicron outbreak, undergoing regular testing and, in
some cases, moving out of their homes and into villages to reduce
their potential exposure to COVID.
Our teams are incredibly supportive of each other, and our
culture of kindness and excellence has been invaluable through
the pandemic. Like many other businesses, our workforce was
impacted by the need for people to self-isolate, and our office and
sales teams stepped up to help on site at our villages. Their support
meant that we were able to cover over 400 shifts during this period
and maintain the quality of our resident care at critical times.
We continued to support our people behind the scenes. We’ve been
focused on how we can improve life for our team members and how
we can show appreciation for the incredible work being done to
keep our residents safe.
Culture is not invented. It is
constantly evolving, which is
why it must be nurtured.”
“
applications to join our team
54,741
hours of facilitated
leadership development
5 ,70 8
Greg Campbell, Chair
RYMAN HEALTHCARE
76
Andrew Roberts, Regional Facilities Manager in Victoria,
was one of hundreds of team members who chipped in
at villages to lend a hand during the pandemic and keep
operations running smoothly.
ANNUAL REPORT 2022
77
Investing in the health and wellbeing of our people
We have been very conscious of not only the physical stress
that COVID has had on our teams but also the impact on their
overall wellbeing.
Given the wide range of roles our teams perform every day, they
have faced vastly different experiences.
Some of our people have been working from home for extended
periods of time, some have moved out of home and into our villages,
many are working long hours in face masks and face shields and
everyone has had to deal with the stress of keeping themselves
and our residents safe from an invisible disease.
Strengthening the health and wellbeing of our people is a priority.
With input from the New Zealand Institute of Wellbeing and Resilience,
we have continued to develop our health and wellbeing plan and have
conducted a series of resilience workshops facilitated by renowned
expert Dr Lucy Hone.
The response to these workshops was overwhelming, and as a
result, we commenced a programme of online masterclasses
designed to promote and support wellbeing, resilience and mental
health across our broader team.
As part of our mental health awareness campaign to help
destigmatise mental illness and encourage conversations, we shared
video stories from members of the wider Ryman team. These videos
were viewed over 1,000 times, and our teams were provided access
to health and wellbeing resources through our dedicated wellbeing
channel, accessible by all 6,700 team members.
I have complete
admiration for
our team. Many
had to wear full
PPE for hours
on end. It’s just
amazing, they’ve
been incredible.”
“
Paula Jeffs,
Director
hours of special leave provided
to team members since the
beginning of COVID
110,000
meals a day provided to village
teams during lockdown
3,000
RYMAN HEALTHCARE
78
Supporting our teams through COVID
Maintaining our villages as safe havens meant
asking our team members to stay home if they
or anyone in their household was feeling unwell.
It was important to us that our teams were not
financially impacted when needing to stay
away so we put in place uncapped special leave
through this period. To date, we have provided
over 110,000 hours of this special leave to our
team members.
As further recognition of the role our teams
played in providing essential services during
Level 4 lockdown, we paid our New Zealand
village team members an additional $2 per hour.
In Australia, we made an application on behalf of
all village team members for the essential worker
retention bonus, which was subsequently granted
and paid to our teams.
We also provided our village teams with meals
during these periods, which saw us serving an
additional 3,000 meals a day. We established
hydration stations with electrolyte drinks and
nibbles to ensure our team members working
in face shields and masks were taking micro
breaks every hour and staying hydrated.
To date, more than 1,000 Ryman team
members have tested positive for Omicron.
Our People and Culture team continue to make
wellness calls to check on how those team
members are feeling and whether they need any
assistance, and to encourage them to rest and
take the time they need to recover. As a gesture
from their Ryman family, we are also sending
recovery packs to their homes that include treats
and essentials such as paracetamol, throat
lozenges, tissues, soup and other goodies as well
as a useful guide on how to aid their recovery.
Celebrating our people
The annual Ryman Awards is a time for our
teams to come together and celebrate their
achievements over the year. COVID restrictions
meant that for the second year running our awards
night was hosted virtually with Rymanians and their
families beaming in from around the world.
This year’s awards, hosted by New Zealand
TV personalities Hillary Barry and Laura Daniels,
were watched by over 2,500 people. Throughout
the night, team members took to their keyboards
to send messages of congratulations to their fellow
team winners with over 650 messages posted.
ANNUAL REPORT 2022
79
Recruitment, development
and happiness
We say it a lot, but for good reason – our people
are our most precious resource.
We spend quality time recruiting our team members.
Our culture of caring is unique, and it’s something
that we work hard to nurture and protect.
Qualifications, experience and intelligence are
of course very important. However, as a care
business, we hold care, kindness, integrity and
the ability to be a team player in very high regard.
These are the defining qualities of a Rymanian.
Our Ryman characteristics empower our people
to act with kindness and excellence, and we
have developed our own bespoke training and
leadership development programmes to reinforce
these values across the organisation. These
learning activities equip our teams with the tools
and skills necessary to meet our high standards.
Journeying into care
Our nurses, care team and wider village teams are
the front line of our organisation. Every interaction
with a resident or family member, no matter how
small, contributes to our purpose of caring. It takes
a special kind of person to demonstrate this level
of care each and every day.
Our nurses perform a very special role in our
villages and we have invested in ways to nurture
their careers with us. We visit nursing students
and attend career fairs accompanied by a Ryman
nurse to tell our story, providing an open and
supportive forum where nursing students can ask
questions and learn more about nursing in aged care.
Kindness and care
Kindness is in our DNA;
it underpins everything
we do.
Strong teams
We build positive,
trusting teams who
work together as one.
Resilience and
composure
We keep going despite
the bumps in the road.
Strive for
excellence
We innovate and
work hard to earn
our success.
Core characteristics
Communication
We use simple, clear
language that gets
straight to the point.
Lead and empower
We lead others with
kindness, clarity
and support.
Leadership characteristic
RYMAN HEALTHCARE
80
Supporting nurses through their graduate training
Launched in 2019, Ryman’s nurse graduate programme, also known
as Nursing Entry to Practice (NETP), provides support and ongoing
education for graduate nurses as they take their first steps into
the profession. Each NETP graduate is assigned an experienced
clinician who mentors them throughout the year. They are also
supported by the clinical leadership team at their dedicated Ryman
village and our NETP support team.
The majority of our NETP graduate nurse applications are a result
of our presentations to nursing students and attendance at career
fairs. The programme began with two graduates in 2019 and has
grown to nine graduates in 2022. Our aim is to grow this number
each year.
Helping our teams pursue their dreams
We are huge believers in the power of education to change lives,
and we offer several scholarships each year.
The Cashin Scholarship, set up in memory of former Ryman Director
Mike Cashin, is open to all Ryman team members and their immediate
family, including spouses, children and grandchildren. Each year,
members of the Cashin family help to select the winner.
The Graeme Rabbits scholarship is open to all of our team members,
contractors and suppliers. Graeme’s family choose one deserving
person every year to receive 3 years of funding and support to pursue
their choice of education or a community project.
We also offer scholarships to nursing students as a way of supporting
graduates during their final year of study. The scholarship provides
a $6,000 lump sum for graduates to use at their discretion. Since
2020, we have awarded four nursing scholarships – three in
New Zealand and one in Australia.
In total, we offer over $40,000 in scholarships every year to deserving
people both inside and outside of Ryman.
We have nine
graduates in
our nursing
programme.
Our aim is
to grow this
number
each year.”
“
Cheyne Chalmers,
Chief Executive Officer
– New Zealand
ANNUAL REPORT 2022
81
Shanlee Barnes-Webber, Serviced Apartment Coordinator
Working for Ryman under
their values and support is truly
a blessing.”
“
RYMAN HEALTHCARE
82
After becoming the inaugural recipient of the Ryman
Nursing Scholarship, Shanlee Barnes-Webber has
become a real Ryman success story.
From Ryman
scholarship to
unit coordinator
Shanlee’s career has moved
in leaps and bounds since she
was first awarded the $6,000
scholarship in 2017, an award
specifically aimed at third-year
nursing undergraduates.
It was the perfect segue into
Ryman’s NETP programme,
which gives new graduate
nurses the support and
supervision they need during
their first year in the profession.
Shanlee worked as a registered
nurse in the hospital at our
Diana Isaac Village in
Christchurch for a further
6 months after the NETP
programme. During this time,
she made a point of grabbing
every opportunity that came
her way.
“I put my hand up to do any
training and extra tasks I could.
“I was part of the COVID
vaccination team,
PCR testing,
catheterisation and I am trained
to do mask fit testing too.”
Then in February 2022, the
serviced apartment unit
coordinator role came up.
“I was unsure if I was going to
apply, but I had a lot of support
and encouragement from my
co-workers, and it’s the best job
I’ve ever had.”
Shanlee’s story is a recurring
theme at Ryman, and the
happiness she enjoys in her
role is one of the many reasons
why investing in our people is
so important.
Image: Shanlee enjoying a regular visit with serviced-apartment residents
June and Jack – the trio share a special bond.
ANNUAL REPORT 2022
83
Artist’s impression of our upcoming Highett Village located in the sought-after
suburb of Bayside in Melbourne – a prime example of a high-value site that will
generate strong returns.
84
RYMAN HEALTHCARE
Our
financials
85
ANNUAL REPORT 2022
Our history of strong
financial performance
and development pipeline
of 29 new villages sets
us up for sustainable
future growth.
86
RYMAN HEALTHCARE
6-year summary
FOR THE YEAR ENDED 31 MARCH 2022
20222021202020192018
2017
Financial
Underlying profit (non-GAAP)$m255.0224.4242.02 27.0203.5178.3
Reported net profit after tax$m692.9423.1264.7326.0388.2356.7
Net operating cash flows$m586.0413.1449.8401.4349.3322.8
Net assets$m3,434.52,829.22,301.02 ,170.11,940.51,652 .1
Interest-bearing debt to interest-
bearing debt-plus-equity ratio%43%44%42%38%35%34%
Dividend per sharecents22 .422 .424.222 .720.41 7. 8
Villages
New sales of occupation rightsno.560503513414458600
Resales of occupation rightsno.983925923824825718
Total sales of occupation rightsno.1,5431,4281,4361,2381,2831,318
Land bank (to be developed)
1,2
no.6,3066,1466,5956,5935,9525,554
Portfolio:
Aged-care bedsno.4,2394,0873,9113,6603,3673,281
Retirement-village unitsno.8,5387, 9 8 37,4 2 36,8786,4145,968
Total units and bedsno.12,77712,07011,33410,5389,7819,249
1 Includes retirement-village units and aged-care beds.
2 Of the 6,306 units and beds in the land bank, 2,581 are subject to resource and building consent.
20222021202020192018
2017
Underlying profit (non-GAAP)$m255.0224.4242.02 27.0203.5178.3
Plus unrealised fair-value movement
on retirement-village units$m4 67.1201.2(70.9)102.4185.3184.7
Plus deferred tax movement
$m
(29.2)12 .693.6(3.4)(0.6)(6.3)
Less impairment – loss on disposal
$m
-(15.1)----
Reported net profit after tax$m692.9423.1264.7326.0388.2356.7
Underlying profit is a non-GAAP* measure and differs from NZ IFRS profit for the year. Underlying profit does not have a standardised
meaning prescribed by GAAP and so may not be comparable to similar financial information presented by other entities.
The Group uses underlying profit, with other measures, to measure performance. Underlying profit is a measure that the Group
uses consistently across reporting periods.
Underlying profit includes realised movement on investment property for units in which a right to occupy has been sold during the period
and for which a legally binding contract is in place at the reporting date. The occupancy advance for these units may have
been received or be included within the trade receivables balance at reporting date.
Underlying profit excludes deferred taxation, taxation expense, unrealised movement on investment properties, and impairment losses
on non-trading assets because these items do not reflect the trading performance of the Company. Underlying profit determines the
dividend payout to shareholders.
* Generally Accepted Accounting Principles.
ANNUAL REPORT 2022
87
88
RYMAN HEALTHCARE
Financial statementsFinancial statements
Consolidated financial statements
90 Consolidated income statement
91 Consolidated statement of comprehensive income
92 Consolidated statement of changes in equity
93 Consolidated balance sheet
94 Consolidated statement of cash flows
Notes to the consolidated financial statements
95 Statement of compliance
95 Basis of preparation
96 Measurement base
96 Critical judgements in applying accounting policies
96 Adopting new and amended standards and interpretations
96 Standards and Interpretations on issue but not yet adopted
97 COVID-19
97 Summary of significant accounting policies
108 Other notes
108 Operating expenses
109 Depreciation and amortisation expense
109 Finance costs
110 Income tax
112 Trade and other receivables
113 Property, plant and equipment
116 Investment properties
118 Intangible assets
118 Cash and cash equivalents
118 Trade and other payables
119 Employee entitlements
119 Interest-bearing loans and borrowings
122 Lease liabilities
123 Occupancy advances (non-interest bearing)
124 Share capital
124 Reserves
126 Dividends
126 Related-party transactions
127 Key management personnel compensation
128 Financial instruments
139 Commitments
139 Contingent liabilities
139 Reconciliation of net profit after tax with net cash flow from operating activities
140 Subsidiary companies
141 Segment information
143 Employee share schemes
145 Subsequent events
145 Authorisation
Independent auditor’s report
146
90
95
ANNUAL REPORT 2022
89
The accompanying notes form part of these financial statements.
Consolidated income statement
FOR THE YEAR ENDED 31 MARCH 2022
Notes20222021
$000
$000
Care fees398,206359,241
Management fees105,55293,170
Interest received41103
Other income4,9983,280
Total revenue508,797455,794
Fair-value movement of investment properties7745,885416,847
Total income1,254,682872,641
Operating expenses1(466,238)(395,306)
Depreciation and amortisation expense2(35,698)(32,368)
Finance costs3(30,664)(19,365)
Loss on disposal6-(15,102)
Total expenses(532,600)(4 6 2 ,1 4 1 )
Profit before income tax722,082410,500
Income tax (expense)/credit4(29,209)12,561
Profit for the year692,873423,061
Earnings per share
Basic and diluted (cents per share) 15138.684.6
RYMAN HEALTHCARE
90
Consolidated statement of comprehensive income
FOR THE YEAR ENDED 31 MARCH 2022
Notes20222021
$000$000
Profit for the year692,873423,061
Items that will not be later reclassified to profit or loss
Revaluation of property, plant and equipment (unrealised)6, 16a-195,793
-195,793
Items that may be later reclassified to profit or loss
Fair-value movement and reclassification of cash-flow hedge reserve16b38,4107,0 57
Deferred tax movement recognised in cash-flow hedge reserve16b(10,857)(1,976)
Movement in cost of hedging reserve16c1,3193,753
Deferred tax movement in cost of hedging reserve16c(369)(1,051)
Gain/(Loss) on hedge of foreign-owned subsidiary net assets16d690(4,414)
(Loss)/Gain on translation of foreign operations16d(1,977)16,546
27, 2 1 619,915
Other comprehensive income2 7, 2 1 6215,708
Total comprehensive income720,089638,769
All profit and total comprehensive income is attributable to parent company shareholders and is derived from continuing operations.
The accompanying notes form part of these financial statements.
ANNUAL REPORT 2022
91
The accompanying notes form part of these financial statements.
Consolidated statement of changes in equity
FOR THE YEAR ENDED 31 MARCH 2022
Notes
Issued
capital
Asset
revaluation
reserve
Cash-
flow
hedge
reserve
Cost of
hedging
reserve
Foreign-
currency
translation
reserve
Treasury
stock
Retained
earnings
Total
equity
$000$000$000$000$000$000$000$000
Balance at
1 April 202033,2902 5 7,7 7 5(1 7,1 4 3 )-(10,345)(32,359)2,069,7592,300,977
Profit for the year16------423,061423,061
Other comprehensive
income for the year
16
-195,7935,0812 ,70212,132--215,708
Total comprehensive
income for the year
16
-195,7935,0812 ,70212,132-423,061638,769
Treasury stock
movement
16
-----(3,030)-(3,030)
Dividends paid to
shareholders
17
------(107,500)(107,500)
Balance at
31 March 202133,290453,568(12,062)2 ,70 21,7 87(35,389)2,385,3202,829,216
Balance at
1 April 202133,290453,568(12,062)2 ,70 21,7 87(35,389)2,385,3202,829,216
Profit for the year16------692,873692,873
Other comprehensive
income for the year
16
--27,553950(1,287)--27, 2 1 6
Total comprehensive
income for the year
16
--27,553950(1,287)-692,873720,089
Treasury stock
movement
16
-----(2 ,785)-(2 ,785)
Dividends paid to
shareholders
17
------(112,000)(112,000)
Balance at
31 March 202233,290453,56815,4913,652500(38,174)2,966,1933,434,520
RYMAN HEALTHCARE
92
The accompanying notes form part of these financial statements.
Consolidated balance sheet
AT 31 MARCH 2022
Notes20222021
$000
$000
Assets
Cash and cash equivalents928,30920,171
Trade and other receivables5671,463542,798
Inventory26,31226,738
Advances to employees2615,41511,141
Property, plant and equipment62,091,0011,658,583
Investment properties78,027,2676, 8 3 7, 278
Intangible assets851,68442,444
Derivative financial instruments201 9,574-
Deferred tax asset 435,05732,456
Total assets10,966,0829,171,609
Equity
Issued capital1533,29033,290
Reserves16435,037410,606
Retained earnings16f2,966,1932,385,320
Total equity3,434,5202,829,216
Liabilities
Trade and other payables10264,254106,072
Employee entitlements1139,81232,034
Revenue in advance81,25171,817
Derivative financial instruments2027, 2 9 128,611
Refundable accommodation deposits199,783113,666
Interest-bearing loans and borrowings122 ,576,7372,274,093
Occupancy advances (non-interest bearing) 144,286,4593,702,215
Lease liabilities1313,49413,885
Deferred tax liability 442 ,481-
Total liabilities 7,531,5626,342,393
Total equity and liabilities10,966,0829,171,609
Net tangible assets
Basic and diluted (cents per share)15676.65 57.4
ANNUAL REPORT 2022
93
The accompanying notes form part of these financial statements.
Consolidated statement of cash flows
FOR THE YEAR ENDED 31 MARCH 2022
Notes20222021
$000
$000
Operating activities
Receipts from residents231,396,1551,176,401
Interest received266229
Payments to suppliers and employees(4 35,170)(421,135)
Payments to residents(346,030)(323,810)
Interest paid(29,243)(18,566)
Net operating cash flows23585,978413,119
Investing activities
Purchase of property, plant and equipment(284,288)(219,416)
Purchase of intangible assets(14,346)(9,462)
Purchase of investment properties(434,395)(577,504)
Capitalised interest paid(50,006)(37,179)
Advances to employees(4, 275)(917)
Net investing cash flows(787,310)(844,478)
Financing activities
Drawdown/(repayment) of bank loans (net)57,6 74(36,712)
Proceeds from the Institutional Term Loan269,243-
Proceeds from the issue of retail bonds-150,000
Proceeds from US Private Placement notes-416,874
Dividends paid(112,000)(107,500)
Purchase of treasury stock (net)(2 ,785)(3,030)
Repayment of lease liabilities (2,662)(2 ,476)
Net financing cash flows209,470417,156
Net increase/(decrease) in cash and cash equivalents8,138(14,203)
Cash and cash equivalents at the beginning of the year20,17134,374
Cash and cash equivalents at the end of the year28,3092 0,1 7 1
RYMAN HEALTHCARE
94
Notes to the consolidated financial statements
FOR THE YEAR ENDED 31 MARCH 2022
The notes to the financial statements include information which is considered relevant and
material to assist the reader in understanding changes in the Group’s financial position
and performance. Information is considered relevant and material if:
• the amount is significant because of its size or nature
• it is important for understanding the results of the Group
• it helps explain changes in the Group’s business
• it relates to an aspect of the Group’s operations that is important to future performance.
STATEMENT OF COMPLIANCE
The financial statements presented are those of Ryman Healthcare Limited (the Company),
and its subsidiaries (the Group). Ryman Healthcare Limited is a profit-oriented entity
incorporated in New Zealand that develops, owns, and operates integrated retirement
villages, resthomes, and hospitals for the elderly within New Zealand and Australia.
Ryman Healthcare Limited is a Financial Markets Conduct reporting entity under the Financial
Reporting Act 2013 and the Financial Markets Conduct Act 2013. Its financial statements
comply with these Acts.
The consolidated financial statements have been prepared in line with Generally Accepted
Accounting Principles in New Zealand (NZ GAAP). The statements comply with New Zealand
equivalents to International Financial Reporting Standards (NZ IFRS) and other applicable
financial reporting standards.
The consolidated financial statements also comply with International Financial Reporting
Standards (IFRS).
BASIS OF PREPARATION
Accounting policies are selected and applied in a way that ensures the resulting financial
information satisfies the concepts of relevance and reliability, and the substance of the
underlying transactions or other events is reported.
The accounting policies set out below have been consistently applied in preparing the financial
statements for the year ended 31 March 2022. These policies have also been applied to the
comparative information presented for the year ended 31 March 2021.
The information is presented in thousands of New Zealand dollars (NZD).
All reference to AUD refers to Australian dollars.
All reference to USD refers to US dollars.
ANNUAL REPORT 2022
95
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
MEASUREMENT BASE
The Group follows the accounting principles recognised as appropriate for measuring and
reporting financial performance and financial position on a historical-cost basis, except when:
•certain property, plant and equipment is subject to revaluation (note 6)
•investment property is measured at fair value (note 7)
•certain financial assets and liabilities are measured at fair value (note 20).
CRITICAL JUDGEMENTS IN APPLYING ACCOUNTING POLICIES
In applying the Group’s accounting policies, management must make judgements, estimates,
and assumptions about the carrying value of assets and liabilities that are not readily apparent
from direct sources.
The estimates and associated assumptions are based on historical experience and various
other factors that are reasonable under the circumstances. The results form the basis of
making the judgements. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to
accounting estimates are recognised in the period in which the estimate is revised, if the
revision affects only that period. Revisions to accounting estimates are recognised in the
period of the revision and future periods, if the revision affects both current and future periods.
The following accounting policies and notes contain information about significant areas of
estimation uncertainty and critical judgements in applying accounting policies that have the
most significant effect on the amounts recognised in the financial statements.
•
Valuation of property, plant and equipment – policy (d) and note 6
•
V
aluation of investment property – policy (f) and note 7.
ADOPTING NEW AND AMENDED STANDARDS AND INTERPRETATIONS
In the current year, the Group adopted all mandatory new and amended standards
and interpretations.
STANDARDS AND INTERPRETATIONS ON ISSUE BUT NOT YET ADOPTED
We are not aware of any NZ IFRS Standards or Interpretations that have recently been issued
or amended that have not yet been adopted by the Group that would materially impact the
Group for the annual report period ending 31 March 2022.
RYMAN HEALTHCARE
96
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
COVID-19
The outbreak of COVID-19, declared by the World Health Organization as a global pandemic
on 11 March 2020, resulted in some uncertainty in both global and local markets in the years
following. New Zealand and Australia responded to the virus with strong public health
measures and a range of economic stimulus packages. Increased vaccination rates and a
move from an elimination to a minimisation strategy with the Omicron variant continues to
reduce the severity of the impact of the pandemic.
The Group continues to adapt its policies and procedures to operate in the conditions created
by COVID-19. Operating within the COVID-19 environment is now considered part of our
business-as-usual environment. The Group has assessed the impact of COVID-19 on the
financial statements. Key accounting judgements in respect of property, plant, and equipment
and investment property no longer have material uncertainties in respect of COVID.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The following significant accounting policies have been adopted to prepare and present
the financial statements of the Group.
a. Basis of consolidation – acquisition method
The consolidated financial statements are prepared by combining the financial statements
of all the entities that comprise the Group, being the Company (the parent entity) and
its subsidiaries as defined in NZ IFRS 10 – Consolidated Financial Statements. A list of
subsidiaries appears in note 24 to the financial statements.
Consistent accounting policies are used to prepare and present the consolidated financial
statements. All significant inter-company transactions and balances are eliminated in full
on consolidation.
The financial statements of subsidiaries are prepared for the same reporting period as the
parent company, using consistent accounting policies.
Income and expenses for each subsidiary whose functional currency is not New Zealand
dollars are translated at exchange rates that approximate the rates at the actual dates of the
transactions. Assets and liabilities of such subsidiaries are translated at exchange rates at
balance date.
All resulting exchange differences are recognised in the foreign-currency translation reserve,
which is a separate component of equity.
ANNUAL REPORT 2022
97
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
b. Revenue recognition
The Group recognises revenue and income from the following major sources.
• Care fees
• Management fees
• Interest received.
Revenue and income are recognised as follows.
Care fees
Care facility and retirement-village service fees are linked to providing service on a specific
day (service date). Revenue from care and retirement-village service fees are recognised
on completion of the service date.
Management
fees
Residents of the Group’s independent-living units and serviced apartments pay a management
fee for the right to share in the use of the village centre and other common facilities. The
management fee is calculated as a percentage of the occupation-right agreement amount.
The fee accrues monthly, for a set period, based on the terms of individual contracts.
Management fees are recognised on a straight-line basis over the period of service.
The period is determined as being the greater of the expected period of tenure, or the
contractual right to management fees.
The expected periods of tenure, based on historical experience across our villages,
are estimated to be 7 years for independent units and 3 to 4 years for serviced units.
The estimated expected periods of tenure are unchanged from last year.
The timing of when management fees are recognised is an accounting estimate.
Historical experience across all villages is used in determining periods of tenure.
Interest
received
Interest income is recognised in the income statement as it accrues, using the effective
interest method.
c. Borrowing costs
Borrowing costs directly attributable to the acquisition, construction, or production of
qualifying assets (assets that take a substantial period of time to get ready for their intended
use) are added to the cost of those assets until the assets are substantially ready for use.
All other borrowing costs are recognised in profit and loss in the period in which they are incurred.
RYMAN HEALTHCARE
98
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
d. Property, plant and equipment
Property, plant and equipment comprises completed care facilities, corporate assets and land
(including long-term leases of land), and care facilities under development.
All property, plant and equipment is initially recorded at cost. Typically, these costs include the
cost of land, materials, wages, and interest incurred during the period required to complete
and prepare the asset for its intended use.
Following initial recognition at cost, completed care-facility land and buildings are carried at
a revalued amount, which is the fair value at the date of the revaluation, less any subsequent
accumulated depreciation on buildings and accumulated impairment losses.
Independent valuations are performed with sufficient regularity to ensure that the carrying
amount does not differ materially from the asset’s fair value at the balance-sheet date.
Any revaluation surplus is recorded in other comprehensive income and credited to the
asset revaluation reserve included in the equity section of the balance sheet, unless it reverses
a revaluation decrease of the same asset previously recognised in the income statement.
In this case, the increase is credited to the income statement to the extent of the decrease
previously charged.
Any revaluation deficit is recognised in the income statement unless it directly offsets
a previous surplus of the same asset in the asset revaluation reserve, in which case the
revaluation deficit is recorded in other comprehensive income.
In addition, any accumulated depreciation at the revaluation date is eliminated against the
gross carrying amount of the asset, and the net amount is restated to the revalued amount
of the asset.
On disposal, any revaluation reserve relating to the particular asset being sold is transferred
to retained earnings.
An item of property, plant and equipment is derecognised on disposal or when no future
economic benefits are expected to arise from the continued use of the asset.
Any gain or loss arising on disposal of the asset (calculated as the difference between the net
disposal proceeds and the carrying amount of the item) is included in the income statement
in the period the item is derecognised.
ANNUAL REPORT 2022
99
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
f. Investment properties
Investment properties include land and buildings (including long-term leases of land),
equipment and furnishings relating to retirement-village units and community facilities,
including units and facilities under development. They are intended to be held for the long
term to earn rental income and for capital appreciation.
Retirement-village units and community facilities are revalued on a semi-annual basis and
restated to fair value as determined by the Directors having taken into consideration the
valuation report produced by the independent registered valuer and the requirement of
NZ IFRS 13 – Fair Value Measurement to assume that market participants act in their economic
b
est interest. Any change in fair value is taken to the income statement. The fair value is
determined using discounted cash-flow methodology.
Rental income from investment properties, being the management fee and retirement-village
service fees, is accounted for in line with accounting policy (b).
e.Depreciation
Depreciation is provided on all property, plant and equipment, other than freehold land,
at straight-line (SL) rates calculated to allocate the asset’s cost or valuation, less estimated
residual value, over their estimated useful lives, starting from the time the assets are ready
for use, as follows.
•
Buildings 2% SL
•Plant and equipment 10–20% SL
•Furniture and fittings20% SL
•
Motor vehicles20% SL
The estimated useful lives, residual value and depreciation method are reviewed at the
end of each reporting period, with the effect of any changes in estimate accounted for on
a prospective basis.
No depreciation is provided for investment properties.
Right-of-use assets relating to leases are depreciated on a straight-line basis over the term
of the lease.
RYMAN HEALTHCARE
100
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
g. Intangible assets
Expenditure on research activities is recognised as an expense in the period in which
it is incurred.
An internally generated intangible software asset arising from development (or from the
development phase of an internal project) is only recognised if all the following criteria have
been demonstrated.
• It is technically feasible to complete the intangible asset so that it is available for use or sale.
• The Group intends to complete the intangible asset and use or sell it.
• The intangible asset can be used or sold.
• Probable future economic benefits of the intangible asset can be generated.
• Adequate technical, financial, and other resources are available to complete the
development and use or sell the intangible asset.
• The expenditure attributable to the intangible asset can be measured during its development.
The amount initially recognised for internally generated intangible assets is the sum of the
expenditure incurred from the date when the intangible asset first meets the recognition
criteria listed above. Where no internally generated intangible asset can be recognised,
development expenditure is recognised in profit or loss in the period in which it is incurred.
After initial recognition, internally generated intangible assets are reported at cost less
accumulated amortisation and accumulated impairment losses, on the same basis as
intangible assets that are acquired separately.
Internally generated intangible assets are amortised using the straight-line method at a rate
of 10 percent from the point at which the asset is ready for use. Amortisation is recognised in
profit or loss.
ANNUAL REPORT 2022
101
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
i. Leases
Group as
a lessee
Apart from short-term or low-value assets, leases are included on the balance sheet through the
recognition of right-of-use assets and associated lease liabilities. Right-of-use assets related to
buildings and plant and equipment are presented within property, plant and equipment. Long-
term leases of land are recognised within property, plant and equipment and investment property.
At inception of the lease a lease liability is calculated based on the present value of the
remaining cash flows, discounted using the Group’s incremental borrowing rate. Subsequently,
the lease liability is adjusted for interest and lease payments, as well as the impact of lease
modifications. The right-of-use asset is initially measured at the value of the initial lease
liability, and subsequently measured at cost less accumulated depreciation, adjusted for
any remeasurement of the lease liability.
Where a lease contract contains both lease and non-lease components (for example, tower
cranes), the Group does not separate non-lease components from lease components, and
instead accounts for the whole contract as a lease.
h. Impairment of assets
At each interim and annual balance-sheet date, the Group reviews the carrying amounts of
its assets to determine whether there is any indication that those assets have suffered an
impairment loss. If such an indication exists, the recoverable amount of the asset is estimated
to determine the extent of any impairment loss.
Where the asset does not generate cash flows that are independent from other assets,
the Group estimates the recoverable amount of the cash-generating unit to which the
asset belongs.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing
value in use, the estimated future cash flows are discounted to their present value. The Group
uses a discount rate that reflects current market assessments of the time value of money
and the risks specific to the asset, for which the estimates of future cash flows have not
been adjusted.
If the recoverable amount of an asset (cash-generating unit) is estimated to be less than its
carrying amount, the carrying amount of the asset (cash-generating unit) is reduced to its
recoverable amount.
An impairment loss is immediately recognised as an expense, unless the asset is carried
at fair value. In this case, the impairment loss is treated as a revaluation decrease.
Where an impairment loss subsequently reverses, the carrying amount of the asset
(cash-generating unit) is increased to the revised estimate of its recoverable amount.
However, this is only to the extent that the increased carrying amount does not exceed
the carrying amount that would have been determined had no impairment loss been
recognised for the asset (cash-generating unit) in prior years.
A reversal of an impairment loss is immediately recognised as income, unless the asset
is carried at fair value. In this case, the reversal of the impairment loss is treated as a
revaluation increase.
RYMAN HEALTHCARE
102
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
Cash and cash
equivalents
Group as
a lessor
The Group acts as a lessor under occupation right agreements with village residents.
The assets leased by the Group as a lessor are classified as investment properties and are
accounted for in line with accounting policy (f). Lease income on occupation right agreements
is generated in the form of deferred management fees and is accounted for in line with
accounting policy (b).
Cash and cash equivalents comprise cash on hand, cash in banks and on-demand deposits,
and other short-term, highly liquid investments readily convertible to a known amount of cash
and subject to an insignificant risk of changes in value. This includes all call borrowing, such as
bank overdrafts, used by the Group as part of its day-to-day cash management.
Financial
assets at
amortised
costs
Trade receivables are held to collect contractual cash flows. The cash flows are the payment
of principal and interest.
Trade receivables are measured at amortised cost, less any impairment. This is equivalent
to fair value, being the receivable face (or nominal) value, less appropriate allowances for
estimated irrecoverable amounts.
The allowance recognised is the lifetime expected credit losses based on an assessment of
each individual debtor. It is estimated based on the Group’s historical credit loss experience
and general economic conditions. Expected credit loss represents the expected credit losses
that will result from all possible default events over the expected life of the debtor.
Trade receivables are written off when there is no realistic chance of recovery.
j. Revenue in advance
Revenue in advance represents those amounts by which the management fees over the
contractual period exceed recognition of the management fee based on expected tenure.
k. Financial instruments
Financial assets and financial liabilities are recognised on the Group’s balance sheet when the
Group becomes party to the contractual provisions of the instrument.
The Group calculates its incremental borrowing rate with reference to the external
borrowing facilities available to the Group. The incremental borrowing rate is used to
measure lease liabilities.
Depreciation and finance costs associated with right-of-use assets and lease liabilities
associated with equipment used in the construction of assets are capitalised as a cost of
constructing the asset.
The lease payment for short-term leases and leases of low-value assets is recognised
in the profit and loss over the lease term.
ANNUAL REPORT 2022
103
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
Trade and
other payables
Trade and other payables are measured at amortised cost. This is equivalent to the face
(or nominal) value of payables, which is assumed to approximate their fair value.
Interest-bearing
loans and
borrowings
Bank loans and borrowings are initially recorded at fair value, less directly attributable
transaction costs. After initial recognition, loans and borrowings are measured at amortised
cost. Any differences between the initial amount recognised and the redemption value is
recognised in profit and loss using the effective interest-rate method.
Fair value
estimation
The fair value of financial assets and financial liabilities must be estimated for recognition
and measurement, or for disclosure purposes.
The face (or nominal) value less estimated credit adjustments of trade receivables and
payables is assumed to approximate their fair values.
Occupancy
advances
Occupation agreements confer to residents the right of occupancy of the retirement-village
unit for life, or until the resident terminates the agreement.
Amounts payable under occupation agreements (occupancy advances) are non-interest
bearing and recorded as a liability in the balance sheet, net of management fees and resident
loans receivable. The resident-occupancy advance is initially recognised at fair value and later
at amortised cost.
As the resident may terminate their occupancy with limited notice, and the occupancy
advance is non-interest bearing, the occupancy advance has demand features and so is
carried at face value, which is the original advance received.
The advance, net of management fee, is repayable following both the termination of the
occupation agreement and the settlement of a new occupancy advance for the same
retirement-village unit.
Refundable
accommodation
deposits
Refundable accommodation deposits relate to deposits held on behalf of residents who
reside in rooms in the care centres in Australia and New Zealand. Refundable accommodation
deposits confer to residents the right of occupancy of the room for life, or until the resident
terminates the agreement.
Amounts payable under refundable accommodation deposits are non-interest bearing and
recorded as a liability in the balance sheet.
As the resident may terminate their occupancy with limited notice, and the refundable
accommodation deposit is non-interest bearing, the refundable accommodation deposit
has demand features and so is carried at face value, which is the original deposit received.
The deposit is repayable following the termination of the right to occupy.
RYMAN HEALTHCARE
104
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
Hedges of a net investment in a foreign operation, including a hedge of a monetary item that
is accounted for as part of the net investment, are accounted for in two ways. Gains or losses
relating to the effective portion of the hedge are recognised in other comprehensive income.
Any gains or losses relating to the ineffective portion of the hedge are recognised in profit or loss.
Hedge
accounting
The Group designates certain derivatives as hedging instruments. At the start of the hedge
relationship, the Group documents the relationship between the hedging instrument and the
hedged item. Risk management objectives and strategies for undertaking hedge transactions
are documented. The Group also documents at the start and on an ongoing basis whether
the hedging instrument is expected to be effective. Hedge accounting is discontinued when
the hedge instrument expires or is sold, terminated, exercised or no longer qualifies for
hedge accounting.
Derivative
financial
instruments
The Group uses derivative financial instruments to manage cash flow, interest rate and foreign
currency risk.
Interest-rate swaps and cross-currency interest-rate swaps (CCIRS) are initially recognised
at fair value on the date a contract is entered into and remeasured to their fair value at each
reporting date.
When Group’s swap arrangements meet the requirements of cash flow hedge accounting,
changes in the fair value of the swaps are recognised in other comprehensive income and
accumulated as a separate component of equity. Amounts deferred in equity are recycled
in profit or loss in the periods when the hedged item is recognised in profit.
When Group’s swap arrangements meet the requirements of fair value hedge accounting,
changes in the fair value of the swaps are taken directly to the income statement for the year,
to offset the change in fair value of the hedged item also recorded in the income statement.
Changes in the fair value of the cost to convert foreign currency to New Zealand dollars (NZD)
of cross-currency interest-rate swaps are separately accounted for as a cost of hedging and
recognised within a new reserve within equity (cost of hedging reserve).
l. Employee entitlements
A liability for benefits accruing to employees for wages and salaries, annual leave, and
long-service leave is accrued and recognised in the balance sheet when it is probable that
settlement will be required, and the liabilities are capable of being measured reliably. The
liability is equal to the present value of the estimated future cash outflows as a result of
employee services provided at balance date.
m. Taxation
Income tax on the profit or loss for the year comprises current and deferred tax. Income tax
is recognised in the income statement except when it relates to items recognised in other
comprehensive income or directly in equity. In this case, it is recognised in other comprehensive
income or in equity.
Hedges
of a net
investment
ANNUAL REPORT 2022
105
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
n. Treasury stock
Shares purchased on market under the leadership share scheme are treated as treasury stock
on acquisition at cost. On vesting to the employee, treasury stock shares are credited to equity
and an employee advance is recorded initially at fair value and later at amortised cost.
Any loss on disposal by the Company (for example, when the employee elects not to take full
responsibility for the loan or leaves before the end of the 3-year restrictive period) accrues to
the Company and is taken directly against equity.
o. GST
Revenues, expenses, assets, and liabilities are recognised net of the amount of Goods and
Services Tax (GST) except when:
• the GST incurred on a purchase of goods and services is not recoverable from the
taxation authority
• receivables and payables are stated with the amount of GST included.
Deferred tax
Deferred tax is provided using the comprehensive balance-sheet liability method. This method
provides for temporary differences between the carrying amount of assets and liabilities for
financial reporting purposes and the amounts used for taxation. Deferred tax is not provided
for on:
• non-depreciating assets (land) included within property, plant and equipment, and
investment properties; and
• temporary differences arising from the initial recognition of assets or liabilities that affects
neither accounting profit nor taxable profit, and does not give rise to equal taxable and
deductible temporary differences.
The amount of deferred tax provided is based on the way the carrying amount of assets and
liabilities are expected to be realised and settled. The tax rates used are those expected to
apply in the period of settlement, based on tax rates enacted or substantively enacted.
A deferred tax asset is recognised only when it is probable that future taxable profits will be
available, and against which the asset can be used. Deferred tax assets are reduced if it is no
longer probable that the related tax benefit will be realised.
Deferred tax assets and liabilities are offset when they relate to income taxes levied by the
same taxation authority and the Group intends to settle current tax assets and liabilities on
a net basis.
Current tax
Current tax is the expected tax payable on the taxable income for the year, using tax rates
enacted or substantively enacted at the balance-sheet date, and any adjustment to tax
payable for previous years. Current tax for current and prior periods is recognised as a liability
(or asset) if it is unpaid (or refundable).
RYMAN HEALTHCARE
106
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
p.Statement of cash flows
The statement of cash flows is prepared exclusive of GST. This is consistent with the method
used in the income statement.
Cash and cash equivalents comprise:
• cash on hand and demand deposits
•
other short-term, highly liquid investments.
Short-term, highly liquid investments are investments that are readily convertible to a known
amount of cash and are subject to an insignificant risk of changes in value. These investments
include all call borrowing such as bank overdrafts used by the Group as part of its day-to-day
cash management.
Operating activities represent all transactions and other events that are not investing or
financing activities and includes receipts and repayments of occupancy advances.
Investing activities are those activities relating to the acquisition and disposal of investments
and any other property, plant and equipment, or investment properties.
Financing activities are those activities relating to changes in the equity and debt capital
structure
of the Group and those activities relating to the cost of servicing the Company’s equity capital.
q. Foreign-currency translation
Functional and
presentation
currency
Both the functional and presentation currency of Ryman Healthcare Limited and its
New Zealand subsidiaries is New Zealand dollars ($). The functional currency for its Australian
subsidiaries is Australian dollars (AUD).
Transactions
and balances
Transactions in foreign currencies are initially recorded in the functional currency by applying the
exchange rates ruling at the date of the transaction. Monetary assets and liabilities denominated
in foreign currencies are retranslated at the rate of exchange ruling at the balance-sheet date.
All exchange differences relating to the following two items are recognised in other
comprehensive income and accumulated in reserves.
•
The effective portion of a hedge of a net investment in foreign operations
• Differences arising on translation of a foreign operation.
Non-monetary items that are measured at historical cost in a foreign currency are translated
using the exchange rate as at the date of the initial transaction. Non-monetary items carried at
fair value that are denominated in foreign currencies are retranslated at the rates at the date
when the fair value was determined.
The net amount of GST recoverable from, or payable to, the taxation authority is included
as part of the receivables or payables in the balance sheet.
Commitments and contingencies are disclosed net of the amount of GST recoverable from,
or payable to, the taxation authority.
ANNUAL REPORT 2022
107
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
1. OPERATING EXPENSES
20222021
$000
$000
Employee costs (see below)305,759264,400
Property-related expenses64,04454,911
Other operating costs (see below)96,43575,995
Total operating expenses466,238395,306
Employee costs and other operating costs include:
Post-employment benefits (KiwiSaver/Superannuation)10,3338,842
Auditor’s remuneration to Deloitte Limited comprises:
• Audit of financial statements452358
• Australia aged-care reporting87
Directors’ fees (note 19)1,3651,094
Donations^517433
^ No donations have been made to any political party (2021: $Nil).
RYMAN HEALTHCARE
108
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
2. DEPRECIATION AND AMORTISATION EXPENSE
20222021
$000
$000
Depreciation (note 6)
• Buildings9,1668,353
• Plant and equipment12,84910,598
• Furniture and fittings4,4754,391
• Motor vehicles1,4401,413
• Right-of-use assets2,6622 ,476
30,59227, 2 3 1
Amortisation (note 8)
• Software5,1065,137
5,1065,137
Total35,69832,368
3. FINANCE COSTS
20222021
$000
$000
Total interest paid on loans and borrowings (including related fees)59,94550,816
Release of cash-flow hedge reserve (note 16)20,5235,354
Amount of interest capitalised (note 6 and note 8)(50,006)(37,179)
Net interest expense on borrowings30,46218,991
Interest on lease liabilities (note 13)2023 74
Total finance costs30,66419,365
ANNUAL REPORT 2022
109
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
4. INCOME TAX
a. Income tax recognised in income statement
20222021
$000
$000
Tax expense comprises:
Current tax expense--
Deferred tax expense/(credit)29,209(12,561)
Total income tax expense/(credit)29,209(12,561)
The income tax expense on pre-tax accounting profit from operations reconciles to the income tax expense
in the financial statements as follows.
2022202220212021
$000%$000
%
Profit before income tax expense 722,082410,500
Income tax expense calculated at 28%202,18328.0%114,94028.0%
Tax effect of:
Non-taxable income(208,894)(28.9)%(116,717)(28.4)%
Property temporary differences69,5979.3%15,5023.8%
Tax losses recognised(59,636)(8.0)%(45,122)(11.0)%
Other25,9593.5%18,8364.6%
Total tax expense/(credit)29,2093.9%(12,561)(3.0)%
The tax rate used in the above reconciliation is the corporate tax rate of 28 percent (2021: 28 percent)
payable by New Zealand corporate entities on taxable profits under New Zealand tax law. The corporate
tax rate in Australia is 30 percent (2021: 30 percent).
Non-taxable income arises principally from the fair value movement of investment property.
During the period, the Group revised its approach for calculating deferred tax on investment properties
and its estimate of the useful life of buildings included within investment properties and property, plant
and equipment. As a result of this change in accounting estimate, the Group recognised an additional
deferred tax expense and deferred tax liability of $45.3 million.
Total Group tax losses available in New Zealand and Australia amounted to $567.6 million
(2021: $410.7 million) and AU$156.0 million (2021: AU$105.8 million), respectively. Recognition
of the deferred tax asset is based on expected taxable earnings in future periods. There are no
unrecognised tax losses in New Zealand (2021: $Nil) and Australia (2021: AU$Nil).
RYMAN HEALTHCARE
110
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
4.INCOME TAX (CONTINUED)
b.Deferred tax asset/liability
Opening
balance
Recognised
in income
Recognised
in equity
Closing
balance
$000$000$000
$000
2022
Property, plant and equipment(43,226)(16,706)(26)(59,958)
Investment properties(15,563)(52,891)455(67,999)
Deferred management fee (68,892)(20,619)(30)(89,541)
Derivative financial instruments3,640-(11,315)( 7,675 )
Other6,9521,371-8,323
Tax loss carry-forwards recognised149,54559,636245209,426
Total deferred tax asset/(liability)32,456(29,209)(10,671)(7,424)
Opening
balance
Recognised
in income
Recognised
in equity
Closing
balance
$000$000$000
$000
2021
Property, plant and equipment
(34,894)(8,292)(40)(43,226)
Investment properties(7,845)(7,210)(508)(15,563)
Deferred management fee(49,623)(18,868)(401)(68,892)
Derivative financial instruments6,667-(3,027)3,640
Other5,1321,809116,952
Tax loss carry-forwards recognised103,01845,1221,405149,545
Total deferred tax asset/(liability)22,45512,561(2,560)32,456
Deferred tax assets and liabilities are offset when they relate to income taxes levied by the same taxation
authority and the Group intends to settle current tax assets and liabilities on a net basis.
The net deferred tax liability of $7.4 million as at 31 March 2022 is reflected in the statement of financial
position as deferred tax asset of $35.1 million and deferred tax liability of $42.5 million. The deferred
tax asset relates to the Australian subsidiaries and the deferred tax liability relates to the New Zealand
group companies.
ANNUAL REPORT 2022
111
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
4. INCOME TAX (CONTINUED)
c. Imputation credit memorandum account
20222021
$000
$000
Closing balance87494
Imputation credits available directly and indirectly
to shareholders of the parent company, through:
• parent company870-
• subsidiaries494
Closing balance87494
5. TRADE AND OTHER RECEIVABLES
20222021
$000
$000
Trade debtors 654,769498,695
Other receivables16,69444,103
Total trade and other receivables671,463542,798
Debtors are non-interest bearing, although the Group has the right to charge interest on overdue settlements of
occupancy advances or overdue care fees. Debtors principally comprise amounts due for occupancy advances
and care fees.
Occupancy advances are payable by residents on occupation of a retirement-village unit. The receivable for
the occupancy advance is recognised when a legally binding contract with the resident is in place. At the same
time as recognising the occupancy advance receivable the Group recognises the corresponding occupancy
advance liability.
Care fees are received from residents (payable 4-weekly in advance) and various government agencies.
Government-agency payment terms vary but are typically paid fortnightly in arrears for care services provided
to residents.
There is no significant concentration of credit risk as trade debtors are either individual residents or government
agencies. No changes have been made in the techniques or significant assumptions used in determining expected
credit losses during the reporting period.
RYMAN HEALTHCARE
112
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
6. PROPERTY, PLANT AND EQUIPMENT
Freehold
land at
valuation
Buildings
at
valuation
Property
under
development
at cost
Plant and
equipment
at cost
Furniture
and fittings
at cost
Motor
vehicles
at cost
Right-of-
use
assetsTotal
$000$000$000$000$000$000$000$000
2022
Gross carrying amount
Balance at 1 April 2021540,259415,577599,746126,58156,34514,95428,2841,781,746
Additions1,0476,251435,34913,5821,7521,8618,193468,035
Net foreign-currency
exchange difference(938)(390)(2 ,445)(56)(45)(15)(50)(3,939)
Transfer from property
under development24,95081,472(115,117)4,3534,342---
Transfer (to)/from
investment property--4,816----4,816
Disposals--------
Balance at 31 March 2022565,318502,910922,349144,46062,39416,80036,4272,250,658
Accumulated depreciation
Balance at 1 April 2021-(1,079)-(50,080)(47,6 2 6 )(9,714)(14,664)(123,163)
Depreciation-(9,166)-(12,849)(4,475)(1,440)(2,662)(30,592)
Depreciation capitalised
to property under
development------(5,902)(5,902)
Balance at 31 March 2022-(10,245)-(62,929)(52,101)(11,154)(23,228)(159,657)
Total book value565,318492,665922,34981,53110,2935,64613,1992,091,001
ANNUAL REPORT 2022
113
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
6. PROPERTY, PLANT AND EQUIPMENT (CONTINUED)
Freehold
land at
valuation
Buildings
at
valuation
Property
under
development
at cost
Plant and
equipment
at cost
Furniture
and fittings
at cost
Motor
vehicles
at cost
Right-of-
use
assetsTotal
$000$000$000$000$000$000$000$000
2021
Gross carrying amount
Balance at 1 April 2020328,972391,336584,810100,85252,03813,84920,6011,492,458
Additions1497,906117,09122,9611,2321,0587,4 1 1157,808
Net foreign-currency
exchange difference2 ,6112,27516,7051901464727222,246
Transfer from property
under development12,73431,118(49,359)2,5782,929---
Transfer (to)/from
investment property--(31,429)----(31,429)
Disposals--(38,072)----(38,072)
Revaluation195,793(17,058)-----178,735
Balance at 31 March 2021540,259415,577599,746126,58156,34514,95428,2841,7 8 1,74 6
Accumulated depreciation
Balance at 1 April 2020-(9,784)-(39,482)(43,235)(8,301)(5,584)(106,386)
Depreciation-(8,353)-(10,598)(4,391)(1,413)(2 ,476)(27, 2 3 1 )
Depreciation capitalised
to property under
development------(6,604)(6,604)
Revaluation-17,058-----17,058
Balance at 31 March 2021-(1,079)-(50,080)(47,6 2 6 )(9,7 1 4 )(14,664)(123,163)
Total book value540,259414,498599,74676,5018,7195,24013,6201,658,583
All completed resthomes and hospitals included within the definition of freehold land and buildings were
revalued to fair value based on an independent valuation report prepared by registered valuers, CBRE Limited,
at 31 March 2021, in line with NZ IFRS 13 – Fair Value Measurement. These revaluations are undertaken every
2 years, unless there is sustained market evidence of a significant change in fair value.
The valuers used multiple valuation techniques to estimate and determine fair value. The valuer made key
assumptions that include capitalisation of earnings (using capitalisation rates ranging from 11.0 percent to
15.0 percent), together with observed transactional evidence of the market value per care bed (ranging from
$70,000 to $230,000 per care bed).
As the fair value of land and buildings is determined using inputs that are unobservable, the Group has
categorised property, plant and equipment as Level 3 under the fair-value hierarchy in line with NZ IFRS 13
– Fair Value Measurement.
The significant unobservable inputs used in the fair-value measurement of the Group’s freehold land and
buildings are the capitalisation rate and the market value per care bed.
RYMAN HEALTHCARE
114
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
6. PROPERTY, PLANT AND EQUIPMENT (CONTINUED)
As the valuer uses several valuation techniques, a significant decrease in the capitalisation rate could but may
not necessarily result in a significantly higher fair-value measurement. Conversely, a significant increase in the
capitalisation rate could but may not necessarily result in a significantly lower fair-value measurement.
A significant increase in the market value per care bed could but may not necessarily result in a significantly
higher fair-value measurement. Conversely, a significant decrease in the market value per care bed could but
may not necessarily result in a significantly lower fair-value measurement.
Property under development includes land held pending the development of a retirement village amounting
to $636.4 million (2021: $343.4 million) and is valued at cost.
Interest for the Group of $49.0 million (2021: $36.4 million) has been capitalised during the period of construction
in the current year. The weighted-average capitalisation rate on funds borrowed is 3.45 percent per annum
(2021: 2.72 percent per annum).
The assets shown at cost are care-facility assets under development, plant and equipment, furniture and fittings,
and motor vehicles, plus additions since the last valuation.
The carrying amount at which each revalued class of property, plant and equipment would have been carried
had the assets been measured under historical cost is shown below.
Freehold landBuildingsTotal
$000$000
$000
Carrying amount (at cost)
Carrying amount at 31 March 2022128,789491,357620,146
Carrying amount (at cost)
Carrying amount at 31 March 2021103,730414,268517,998
The completed resthomes and hospitals were last valued at 31 March 2021. The Group has considered the fair
value of these assets and determined that there is no indication that the carrying value of the assets is materially
different from fair value at 31 March 2022. In reaching this conclusion, the Group has considered capitalisation
rates, market evidence of comparable sales, market demand, occupancy and earnings per bed.
Right-of-use assets
Included within property, plant and equipment are the right-of-use assets relating to leases.
Buildings
Plant and
equipmentTotal
$000$000
$000
Balance at 1 April 2021
10,5213,09913,620
Additions6587,5358,193
Net foreign-currency exchange difference(50)-(50)
Depreciation(2,662)-(2,662)
Depreciation capitalised to property under development(158)( 5,74 4 )(5,902)
Balance at 31 March 20228,3094,89013,199
ANNUAL REPORT 2022
115
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
6.PROPERTY, PLANT AND EQUIPMENT (CONTINUED)
Disposal of land
No land was disposed of in 2022. During 2021, the Group sold the land in Coburg, Melbourne. The sale led to a loss
on disposal of $15.1 million, which was recognised in the income statement.
7.INVESTMENT PROPERTIES
20222021
$000
$000
At fair value
Balance at beginning of financial year6, 8 3 7, 2785,760,060
Additions452,068624,926
Fair-value movement:
Realised fair-value movement:
•
new retirement-village units110,681108,377
• existing retirement-village units168,071107,317
278,752215,694
Unrealised fair-value movement4 67,1 3 3201,153
745,885416,847
Net foreign-currency exchange differences(7,964)35,445
Net movement for the year1,189,9891 ,07 7, 2 1 8
Balance at end of financial year8,027,2676 , 8 3 7, 2 7 8
The realised fair-value movement arises from the sale and resale of rights to occupy to residents. Investment
properties are not depreciated and are fair valued. As the fair value of investment property is determined using
inputs that are unobservable, the Group has categorised investment property as Level 3 under the fair-value
hierarchy in line with NZ IFRS 13 – Fair Value Measurement. NZ IFRS 13 requires that the inputs are consistent with
the characteristics of the asset that a market participant would take into account in a transaction for the asset.
The carrying value of completed investment property is the fair value as determined by the Directors having taken
into consideration the valuation report produced by the independent registered valuer, CBRE Limited, at 31 March
2022. This report combines discounted future cash flows and occupancy advances received from residents for
retirement-village units that are complete, or nearing completion, for which there is an agreement to occupy. From
time-to-time the Directors obtain additional independent valuations for consideration in their determination of
investment property carrying value.
Key assumptions used in determining the fair value and the sensitivity of the valuation to these assumptions are
detailed below.
The carrying amount of completed investment properties as determined by the Directors is based on the
independent valuers report and also includes occupancy advances received from residents, adjusted for accrued
deferred management fees and revenue in advance.
RYMAN HEALTHCARE
116
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
7.INVESTMENT PROPERTIES (CONTINUED)
Total investment property carrying value included in the balance sheet also includes, at cost, investment property
work in progress and retirement-village units that are complete or nearing completion for which there is no
agreement to occupy in place.
Key assumptions
The valuer used significant assumptions that include growth rate (ranging from 0.50 percent to 4.24 percent
nominal) (2021: 0.50 percent to 4.20 percent) and discount rate (ranging from 12.00 percent to 16.00 percent)
(2021: 12.00 percent to 16.50 percent).
Sensitivity
A 0.5 percent decrease in the 5-year plus growth rate would result in a $194.7 million lower fair-value
measurement. Conversely, a 0.5 percent increase in the 5-year plus growth rate would result in a
$214.9 million higher fair-value measurement.
A 0.5 percent decrease in the discount rate would result in a $125.7 million higher fair-value measurement.
Conversely, a 0.5 percent increase in the discount rate would result in a $115.8 million lower fair-value
measurement.
Other inputs used in the fair-value measurement of the Group’s investment property portfolio include the average
age of residents and the occupancy period. A significant increase in the average age of entry of residents or
a decrease in the occupancy period would result in a significantly higher fair-value measurement. Conversely,
a significant decrease in the average age of entry of residents or increase in the occupancy period would result
in a significantly lower fair-value measurement.
Work in progress
Investment property includes investment property work in progress of $494.7 million (2021: $653.0 million),
which has been valued at cost. The Directors have determined that for work in progress cost represents fair
value. No independent valuation of investment property work in progress is obtained.
Operating expenses
Direct operating expenses arising from investment property that generated income from management fees
during the period amounted to $13.1 million (2021: $7.9 million). All investment property generated income from
management fees during the period for the Group, except for investment property work in progress.
Security
Residents make interest-free advances (occupancy advances) to the retirement villages in exchange for the right
to occupy retirement-village units. Under the terms of the occupancy agreement, the resident receives a unit title
for life and a first mortgage over the residual interest for security purposes, or a first mortgage is held over the
individual title by the statutory supervisor.
ANNUAL REPORT 2022
117
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
8. INTANGIBLE ASSETS
20222021
$000
$000
Gross carrying amount
Opening balance55,31845,856
Additions14,3469,462
Closing balance69,66455,318
Accumulated amortisation
Opening balance(12,874)(7,737)
Amortisation (note 2)(5,106)(5,137)
Closing balance(17,980)(12,874)
Total book value51,68442,444
All intangible assets relate solely to internally generated software.
Interest for the Group of $1.0 million (2021: $0.8 million) has been capitalised to intangible assets during
the current year. The weighted-average capitalisation rate on funds borrowed is 3.45 percent per annum
(2021: 2.72 percent per annum).
9. CASH AND CASH EQUIVALENTS
The Group has an arrangement with ANZ that on a nightly basis a sweep is performed across all transactional
bank accounts. This consolidates all transactional bank accounts into a single account.
There is a right to offset cash balances against bank debt documented in the Group’s facility agreement.
The Group has access to an overdraft facility. The bank overdraft facilities are secured by a general security
agreement and mortgages over the freehold land and buildings of the Group in the same manner as the bank
loans (note 12). Interest would be payable at the 3-month BKBM rate, plus a specified margin. The interest rate
on all overdraft facilities at 31 March 2022 was 9.65 percent (2021: 8.90 percent).
10. TRADE AND OTHER PAYABLES
20222021
$000
$000
Trade payables78,94672,366
Other payables185,30833,706
Total trade and other payables264,254106,072
Trade payables are typically paid within 30 days of the invoice date or on the 20th of the month following the
invoice date. Other payables at 31 March 2022 includes $174.4 million for the purchase of land (2021: $26.0 million).
RYMAN HEALTHCARE
118
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
11. EMPLOYEE ENTITLEMENTS
20222021
$000
$000
Holiday-pay accrual and other benefits39,81232,034
12. INTEREST-BEARING LOANS AND BORROWINGS
Interest-bearing loans and borrowings include secured bank loans, institutional term loan, unsubordinated
fixed-rate retail bonds and USPP notes.
20222021
$000$000
Bank loans12a1,780,6191,728,018
Institutional term loan (ITL)12b269,658-
Retail bonds – RYM01012c150,000150,000
USPP notes - using contracted fixed USD FX rate12d416,557416,874
2,616,8342,294,892
FX movement of USD USPP notes12d14,61511,862
Total loans and borrowings at face value2,631,4492,306,754
Issue costs for the ITL capitalised12b(876)-
Issue costs for the retail bond capitalised12c(2,605)(3,139)
Issue costs for the USPP capitalised12d(2,170)(2,049)
Total loans and borrowings at amortised cost2,625,7982,301,566
Revaluation of ITL debt in fair-value hedge relationship12b(5,690)-
Revaluation of USPP debt in fair-value hedge relationship12d(43,371)(27,473 )
Total loans and borrowings2 ,576,7 3 72,274,093
a. Bank loans (secured)
20222021
$000
$000
Bank loans (secured) – NZD1 , 2 74 ,74 01,162,000
Bank loans (secured) – AUD in NZD505,879566,018
Total bank loans (secured) 1,780,6191,728,018
Less cash and cash equivalents (note 9)(28,309)(20,171)
Net bank loans1,752,3101,707,847
Less than 1 year-25,000
Within 1–5 years1,780,6191,703,018
Total bank loans (secured)1,780,6191,728,018
Average interest rates for bank loans – NZD3.94%2 .71%
Average interest rates for bank loans – AUD2.37%1.86%
The bank loan facilities have varying maturity dates through to May 2027 (2021: April 2025). The average
interest rates disclosed above exclude the impact of interest-rate swap agreements described in note 20.
ANNUAL REPORT 2022
119
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
12.INTEREST-BEARING LOANS AND BORROWINGS (CONTINUED)
b.Institutional Term Loan (secured)
20222021
$000
$000
Institutional Term Loan269,658-
Total ITL at face value 269,658-
Issue costs for the ITL capitalised
Opening balance--
Capitalised during the year(1,000)-
Amortised during the year124-
(876)-
Total ITL at amortised cost268,782-
Revaluation of debt in fair-value hedge relationship(5,690)-
Total Institutional Term Loan263,092-
During the year, the Group entered into an AU$250.0 million 7-year institutional term loan which matures
in May 2028. The average interest rate for the loan is 3.84 percent.
c. Retail bonds (secured)
20222021
$000
$000
Retail bond – RYM010150,000150,000
Total retail bonds at face value 150,000150,000
Issue costs for the retail bond capitalised
Opening balance(3,139)-
Capitalised during the year(22)(3,297)
Amortised during the year556158
(2,605)(3 ,1 3 9 )
Total retail bonds at amortised cost147,395146,861
The Group issued a retail bond for $150.0 million in December 2020. The retail bond has a maturity date
of 18 December 2026 and is listed on the NZX Debt Market (NZDX) with the ID RYM010.
The coupon rate for the retail bond is 2.55 percent.
Retail bond issue expenses, fees and other costs incurred in arranging retail bond finance are capitalised
and amortised over the term of the relevant debt instrument.
RYMAN HEALTHCARE
120
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
12.INTEREST-BEARING LOANS AND BORROWINGS (CONTINUED)
d. USPP notes
20222021
$000
$000
USPP notes416,557416,874
FX movement of USD USPP notes14,61511,862
Total USPP notes at face value 431,172428,736
Issue costs for the USPP notes capitalised
Opening balance(2,049)-
Capitalised during the year(300)(2,070)
Amortised during the year17921
(2,170)(2,049)
Total USPP notes at amortised cost429,002426,687
Revaluation of debt in fair-value hedge relationship(43,371)(27,473 )
Total USPP notes385,631399,214
On 17 February 2021 the Group completed a United States Private Placement (USPP) note issuance,
securing US$300 million of long-term debt. In conjunction with the USPP issuance, the Group entered
into cross-currency interest-rate swaps to formally hedge the exposure to foreign-currency risk over the
term of the notes. The USPP amount received in AUD (equivalent of US$25 million) is not hedged, the
remaining US$275m is hedged with a contracted USD FX rate of 0.7202.
This debt is carried at amortised cost and translated to New Zealand dollars using foreign exchange rates
at balance date.
USPP note expenses, fees and other costs incurred in arranging USPP finance are capitalised and amortised
over the term of the relevant debt instrument.
Security
The bank loans, institutional term loan, retail bonds and USPP notes are secured by a general security
agreement over the parent and subsidiary companies and supported by first mortgages over the freehold
land and buildings (excluding retirement-village unit titles provided as security to residents – note 7).
The subsidiary companies listed at note 24 have all provided guarantees for the Group’s secured loans
as parties to the general security agreement.
Contractual cash outflows are disclosed in note 20.
ANNUAL REPORT 2022
121
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
13. LEASE LIABILITIES
a. Group as a lessee
The Group leases office buildings, sales offices, office equipment (such as photocopiers), and plant and
equipment used in the construction of retirement-village units and aged-care beds.
The right-of-use assets relating to these leases are included within property, plant and equipment (note 6).
Amounts recognised in profit and loss
20222021
$000
$000
Depreciation of right-of-use assets (note 6)2,6622 ,476
Interest expense on lease liabilities (note 3)2023 74
Expenses relating to short-term or low-value leases9251,212
Maturity profile for lease liabilities
The maturity profile for lease liabilities and how the Group manages liquidity risk is included in note 20
– financial instruments.
The Group has lease contracts that include extension options. These options, which have been included to
provide operational flexibility, are exercisable only by the Group and not the lessors. The Group assesses at
lease commencement date whether it is reasonably certain to exercise the extension options. The Group
estimates that the potential future lease payments, should it exercise all the extension options, would result
in an increase in lease liability of $12.0 million (2021: $8.9 million).
At 31 March 2022 the Group is committed to $8.0 million for short-term leases (including short-term
construction equipment leases) (2021: $5.7 million).
b. Group as a lessor
The Group acts as a lessor under occupation right agreements with village residents. The assets leased by
the Group as a lessor are disclosed as investment property and lease income on occupation right agreements
is generated in the form of deferred management fees. The lease term is determined to be the greater of
the expected period of tenure or the contractual right to management fees. The Group uses the portfolio
approach to account for leases of units to village residents and allocates individual leases to different
portfolios depending on the type of unit. The Group does not have any sub-leases.
RYMAN HEALTHCARE
122
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
14.OCCUPANCY ADVANCES (NON-INTEREST BEARING)
20222021
$000
$000
Gross occupancy advances (see below)4,864,7134,205,105
Less management fees and resident loans(578,254)(502,890)
Closing balance4,286,4593,702,215
Movement in gross occupancy advances
20222021
$000
$000
Opening balance4,205,1053,686,813
Plus net increases in occupancy advances:
•
ne
w retirement-village units455,855395,094
•
existing retirement-village units. 168,072107,317
Net foreign-currency exchange differences(4,640)21,807
Increase/(decrease) in occupancy advance balances40,321(5,926)
Closing balance4,864,7134,205,105
Gross occupancy advances are non-interest bearing and occupancy advances are not discounted. The fair value
of net occupancy advances is $2,667 million using the relevant discount rate for each village.
The change in occupancy advance balances shows the net movement in occupancy advance that has
resulted from:
•
units tha
t have been re-sold but the previous resident has yet to be repaid; and
•
units that have been repaid but the unit remains unsold at balance date.
ANNUAL REPORT 2022
123
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
15. SHARE CAPITAL
Issued and paid-up capital consists of 500,000,000 fully paid ordinary shares (2021: 500,000,000) less
treasury stock of 2,741,246 shares (2021: 2,655,017 shares) (note 26). All shares rank equally in all respects.
Basic and diluted earnings and net tangible assets per share have been calculated on the basis of 500,000,000
ordinary shares (2021: 500,000,000 shares).
Shares purchased on market under the leadership share scheme (note 26) are treated as treasury stock (note 16)
until vesting to the employee.
Basic and diluted earnings per share (EPS)
20222021
Profit for the year ($000)692,873423,061
Weighted average number of shares (in ‘000)500,000500,000
Basic and diluted EPS (cents per share)138.684.6
Net tangible asset (NTA) per share
20222021
NTA ($000)3,382,8362 ,786,7 72
Ordinary shares at the end of period (‘000)500,000500,000
Basic and diluted NTA per share (cents per share)676.65 5 7. 4
NTA is calculated as total assets less intangible assets and less total liabilities.
16. RESERVES
20222021
$000$000
Reserves
Asset revaluation reserve16a453,568453,568
Cash-flow hedge reserve16b15,491(12,062)
Cost of hedging reserve16c3,6522 ,702
Foreign-currency translation reserve16d5001,787
Treasury stock16e, 26(38,174)(35,389)
435,037410,606
RYMAN HEALTHCARE
124
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
16. RESERVES (CONTINUED)
20222021
$000$000
a. Asset revaluation reserve
Opening balance453,5682 57,7 75
Revaluation-195,793
Closing balance453,568453,568
b. Cash-flow hedge reserve
Opening balance(12,062)( 1 7,1 4 3 )
Valuation of interest-rate swap31,8941,116
Valuation of cross-currency interest-rate swap(14,007)587
Released to income statement20,5235,354
Deferred tax movement on cash-flow hedge reserve(10,857)(1,976)
Closing balance15,491(12,062)
c. Cost of hedging reserve
Opening balance2 ,702-
Valuation of cross-currency interest-rate swap1,3193,753
Released to income statement--
Deferred tax movement on cost of hedging reserve(369)(1,051)
Closing balance3,6522 ,70 2
d. Foreign-currency translation reserve
Opening balance1,787(10,345)
Gain/(Loss) on hedge of foreign-owned subsidiary net assets690(4,414)
(Loss)/Gain on translation of foreign operations(1,977)16,546
Closing balance5001,7 87
e. Treasury stock (note 26)
Opening balance(35,389)(32,359)
Acquisitions(15,625)(13,425)
Vesting /forfeiture of shares12,84010,395
Closing balance(38,174)(35,389)
f. Retained earnings
Opening balance2,385,3202,069,759
Net profit attributable to shareholders692,873423,061
Dividends paid(112,000)(107,500)
Closing balance2,966,1932,385,320
The cost of hedging reserve captures changes in the fair value of the cost to convert foreign currency to NZD
of the cross-currency interest-rate swaps on USPP debt.
ANNUAL REPORT 2022
125
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
17.DIVIDENDS
2022202220212021
Cents per shareTotal $000Cents per share
Total $000
Recognised amounts
Final dividend paid – prior year13.6068,00012 .7063,500
Interim dividend paid – current year8.8044,0008.8044,000
112,000107,500
Unrecognised amounts
Final dividend – current year13.6068,00013.6068,000
Full-year dividend – current year22 .40112,00022 .40112,000
18.RELATED-PARTY TRANSACTIONS
Parent company
The parent entity in the Group is Ryman Healthcare Limited.
Equity interests in related parties
Details of the percentage of ordinary shares held in subsidiaries are disclosed in note 24.
Transactions with companies associated with directors
20222021
$000
$000
Rental costs1,72 11,654
Sub-contractor labour and equipment hire19690
Since August 2012 Ryman Healthcare Limited has leased office accommodation from the Airport Business Park
Christchurch Limited (the Airport Business Park).
On 1 December 2019 Warren Bell became an independent director or trustee of the Airport Business Park’s
shareholders. He does not have any personal ownership interest.
The lease of the office accommodation is recognised as a right-of-use asset and associated lease liability.
Rental costs detailed in the table above are the total cash payments made in the current financial year in
respect of the lease agreement.
Anthony Leighs is Managing Director of Leighs Construction Limited, which has supplied sub-contractor labour
and equipment hire to Ryman Healthcare Limited since December 2019. This arrangement ceased during 2021.
Jo Appleyard is a Partner at Chapman Tripp who provide the Group with legal services. George Savvides is a
Director of Insurance Australia Group Limited (IAG) who provide, through their New Zealand subsidiary NZI, the
Group with insurance coverage. Neither Director is involved in the quoting or provision of services to the Group.
Any transactions undertaken with these entities have been entered into on an arm’s-length basis and in the
ordinary course of business.
RYMAN HEALTHCARE
126
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
19. KEY MANAGEMENT PERSONNEL COMPENSATION
20222021
$000
$000
Compensation
Short-term employee benefits (senior executive team)7,4703,971
Directors’ fees1,3651,094
Total key management personnel and directors’ compensation8,8355,065
Key management personnel are the senior executive team of the Group and include the group chief executive and
eight senior executive team members at 31 March 2022 (2021: group chief executive and six senior executive team
members). The composition and number of senior executive team members fluctuated throughout the year.
Short-term employee benefits included in the 2022 financial year include payments to our former CEO who resigned
in May 2021 after 15 years of services. This payment relates to both short term and medium terms incentives and his
willingness to continue in the role until October 2021 while the board conducted a global search for the new CEO.
In addition, NZ IAS 24 - Related Party Disclosures requires directors’ fees to be included within key management
personnel compensation. All directors are non-executive and are not involved in the day-to-day operations of the
Group (2021: all directors).
Directors’ fees relate to the fees paid to nine directors that were in place for the full financial year (2021: eight directors).
Post-employment benefits (KiwiSaver/Superannuation) employer contributions included in short-term employee
benefits (senior executive team) above are $237,259 (2021: $111,769 senior executive team).
In addition, the Company provides certain senior employees with limited recourse loans on an interest-free basis
to support employees’ participation in the leadership share scheme (note 26).
ANNUAL REPORT 2022
127
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
20. FINANCIAL INSTRUMENTS
The financial instruments consist of cash and cash equivalents, trade and other receivables, trade and other
payables, occupancy advances, refundable accommodation deposits, employee advances, loans, overdrafts,
cross-currency interest rate swaps, interest rate swaps and lease liabilities.
Categories of financial instruments
20222021
$000
$000
Financial assets
Cash and cash equivalents (note 9)28,30920,171
Financial assets at amortised cost (loans and receivables)686,878553,939
Derivative instruments in designated hedge accounting
relationships (interest rate swaps)
1 9,574-
7 3 4 ,76 1574,110
Financial liabilities
Amortised cost7,3 27, 2 3 36,196,046
Derivative instruments in designated hedge accounting
relationships (interest rate swaps)5,43117,339
Derivative instruments in designated hedge accounting
relationships (cross-currency interest rate swaps (CCIRS))21,86011,272
Lease liabilities13,49413,885
7,368,0186,238,542
a. Credit risk management
Credit risk is the risk of the failure of a debtor or counterparty to honour its contractual obligation resulting
in financial loss to the Group.
Financial assets, which potentially subject the Group to credit risk, consist principally of cash and cash
equivalents, trade and other receivables, advances to employees, and derivative financial instruments.
The maximum credit risk at 31 March 2022 is the fair value of these assets.
Credit risk relating to cash and cash equivalents and derivative financial instruments is managed by restricting
the amount of cash and marketable securities that can be placed with any one institution. The Group minimises
its credit risk by spreading such exposures across a range of institutions with reference to the credit ratings of
these institutions. The Group’s cash equivalents are placed with high-credit, quality financial institutions. The
Group does not require collateral from its debtors.
RYMAN HEALTHCARE
128
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
20. FINANCIAL INSTRUMENTS (CONTINUED)
The directors consider the Group’s exposure to any concentration of credit risk from trade and other
receivables and advances to employees to be minimal, given that (typically):
• the occupation of a retirement-village unit does not take place until an occupation advance
has been received
• care fees are payable 4-weekly in advance when due from residents
• care fees not due from residents are paid by government agencies
• advances to employees are subject to the terms of the employee share schemes (note 26).
The total credit risk to the Group from trade and other receivables and advances to employees at
31 March 2022 was $686.9 million (2021: $553.9 million) and there were no material overdue debtors
at 31 March 2022 (2021: $Nil). The composition of financial assets is shown in the table below.
20222021
$000
$000
Trade and other receivables (note 5)671,463542,798
Advances to employees (note 26)15,41511,141
686,878553,939
b. Interest-rate risk
Interest rate risk is the risk that fluctuations in interest rates impact the Group’s financial performance,
future cash flows or the fair value of its financial instruments.
The Group’s interest rate risk arises from loans and borrowings. Loans and borrowings issued at variable
interest rates expose the Group to changes in interest rates. Loans and borrowings issued at fixed rates
expose the Group to changes in the fair value of the borrowings.
The Group’s policy is to manage its interest rate exposure using a mix of fixed and variable rate debt and
interest rate derivatives that are accounted for as cash flow hedges or fair value hedges.
The interest rate applicable to the bank overdraft is variable. The interest rates applicable to the bank loans
are reviewed at each 3-monthly rollover. The Group always seeks to obtain the most competitive interest rate.
Cash flow and fair value hedges
Each hedge relationship is formalised in hedge documentation at inception. The Group uses Bancorp
Treasury Services Limited (BTSL), as an independent valuer, to determine the existence of an economic
relationship between the hedging instrument and the hedged item based on the currency, amount and timing
of respective cash flows, interest rates, tenors, repricing dates, maturities and notional amounts. BTSL then
assesses whether the derivative designated in each hedging relationship is expected to be, and has been,
effective in offsetting the changes in cash flows of the hedged item.
ANNUAL REPORT 2022
129
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
20. FINANCIAL INSTRUMENTS (CONTINUED)
The details of the Group’s hedging instruments are as follows. All hedging instruments are recorded under
Derivative Financial Instrument in the statement of financial position.
CurrencyInterest ratesMaturity
Notional amount of
hedging instrument
Fair value
or carrying
amount of
the hedging
instrument:
Asset /
(Liability)
Change in
value used for
calculating
hedge
effectiveness
(years) NZ$000 NZ$000
2022
Cash flow hedges
Interest rate swaps
NZD2.066%–2.825%3–6NZ$402 million14,73014,730
Interest rate swaps
AUD1.463%–1.785%2–5AU$130 million4,8444,844
Fair value hedge
Interest rate swaps
AUDFloating6AU$54 million(5,431)(5,431)
Fair value and
cash flow hedges
Cross-currency interest
rate swaps (CCIRS)
USD:NZDFloating9–14US$275 million(21,860)(21,860)
(7,717)(7,717)
CurrencyInterest ratesMaturity
Notional amount of
hedging instrument
Fair value
or carrying
amount of
the hedging
instrument:
Asset /
(Liability)
Change in
value used for
calculating
hedge
effectiveness
(years) NZ$000 NZ$000
2021
Cash flow hedges
Interest rate swaps
NZD2.750%–2.825%5NZ$250 million(17,339)(17,339)
Fair value and
cash flow hedges
Cross-currency interest
rate swaps (CCIRS)
USD:NZDFloating10–15US$275 million(11,272)(11,272)
(28,611)(28,611)
The fair value of interest rate swaps is determined by discounting the future cash flows using the yield curves
at the end of the reporting period and the credit risk inherent in the contract. The fair value of the CCIRS
has been calculated using the discounted cash flow method, estimated using forward interest and foreign
exchange rates (from observable yield curves and forward exchange rates).
RYMAN HEALTHCARE
130
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
20. FINANCIAL INSTRUMENTS (CONTINUED)
Interest rate swaps as cash flow hedges
The Group has entered into various interest rate swaps to provide an effective cash flow hedge against
floating interest rate variability on a defined portion of core debt.
These interest rate swaps qualify for cash flow hedge accounting. Interest rate swaps are initially recognised
at fair value on the date a contract is entered into and remeasured to their fair value at each reporting date.
The effective portion of the change in the fair value of the swaps is recognised in other comprehensive income
and accumulated as a separate component of equity. The ineffective portion is recognised in the income
statement. The balance of the interest rate swap reserve is expected to be released to the income statement
over the maturity profile of the underlying debt.
The hedge ratio is 1:1. The face value of the interest rate swaps is the same value as the face value of the bank
loans. As the critical terms of the interest rate swap contracts and the hedged item are the same, significant
hedge ineffectiveness is not expected.
At 31 March 2022, the Group had several interest rate swaps in place with total notional principal amount
of approximately NZ$542 million, which is made up of NZ$402 million and AU$130 million (2021: NZ$250
million). These swaps cover terms of up to 7 years (2021: 5 years) and are effective for various periods.
Some of these swaps will become effective at a future date.
20222021
$000
$000
Current321,640250,000
Forward starting220,222-
541,862250,000
These interest rate swaps effectively change the Group’s interest rate exposure on the principal covered
from a floating rate to an average fixed rate ranging between 2.094 percent and 2.335 percent (2021: 2.757
percent). The notional principal amounts covered by these swaps and the average contracted fixed interest
rate for their remaining maturities are shown below.
Average contracted fixed interest rateNotional principal amount covered
2022202120222021
%%$000
$000
Within 1 year2.228%2 .757%461,862250,000
1–2 years2.231%2 .757%481,862250,000
2–3 years2.231%2 .757%481,862200,000
3–4 years2.335%2 .757%450,504150,000
4–5 years2.094%2 .757%275,504150,000
5–6 years2.200%-180,000-
ANNUAL REPORT 2022
131
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
20. FINANCIAL INSTRUMENTS (CONTINUED)
Interest rate swap as a fair value hedge
During the year, the Group entered into an interest rate swap to mitigate its exposure to fair value changes
arising from the fixed rate portion of the institutional term loan. The swap, which has a total notional principal
amount of AU$53.85 million and a term of 7 years, effectively changes the Group’s interest rate exposure
on the principal covered from a fixed to floating rate. The Group has designated AU$53.85 million of its
institutional term loan in a fair value hedge relationship.
Under a fair value hedge, the change in the fair value of the hedged risk is attributed to the carrying value of
the underlying institutional term loan. This debt revaluation is recognised in the income statement to offset
the mark-to-market revaluation of the hedging derivative.
Cross-currency interest rate swaps (CCIRS) as fair value and cash flow hedges
The Group manages its interest rate risk on USPP notes using CCIRS. The CCIRS transform a series of known
fixed interest rate USD cash flows to floating rate NZD cash flows, mitigating exposure to fair value changes
in USPP notes. The USPP amount received in AUD (equivalent of US$25 million) is not hedged.
The details of the CCIRS are as follows.
AmountCurrencyMaturityNote coupon
2022
Fair value
Asset /
(Liability)
2021
Fair value
Asset /
(Liability)
US$000%$000
$000
Swap participants
Bank of New Zealand55,000USD:NZD18/02/20314.06%(3,564)(932)
MUFG45,000USD:NZD18/02/20314.06%(4,07 7)(2,001)
Bank of New Zealand60,000USD:NZD16/02/20334.16%(4,4 47)(2,152)
ANZ Bank New Zealand Ltd40,000USD:NZD16/02/20334.16%(3,309)(1,877)
ANZ Bank New Zealand Ltd75,000USD:NZD16/02/20364.26%(6,463)(4,310)
275,000(21,860)(11,272)
For hedge accounting purposes, the CCIRS are aggregated and designated as both fair value hedges
and cash flow hedges.
The hedge ratio is 1:1. The face value of the CCIRS is the same value as the face value of the USPP notes.
The maturity of the USPP notes and associated CCIRS is matched. As the critical terms of the CCIRS
contracts and the hedged item are the same, significant hedge ineffectiveness is not expected.
The hedge accounting treatment is as described for interest rate swaps above.
The cross-currency basis elements of the CCIRS are excluded from the designation and are separately
recognised in other comprehensive income in a cost of hedging reserve (note 16).
RYMAN HEALTHCARE
132
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
20. FINANCIAL INSTRUMENTS (CONTINUED)
Interest rate sensitivity
The following table demonstrates the Group’s sensitivity to a change in floating interest rates of plus/(minus)
50 basis points, with all other variables held constant, of the Group’s profit and equity.
20222021
$000
$000
Increase in interest rates of 50 basis points
Effect on profit after taxation – increase/(decrease)(2,503)(2 ,671)
Effect on equity after taxation – increase/(decrease)(9,337)(13,526)
Decrease in interest rates of 50 basis points
Effect on profit after taxation – increase/(decrease)2 ,4492,543
Effect on equity after taxation – increase/(decrease)9,86114,202
Managing interest rate benchmark reform
In the prior year, the Group adopted Phase 1 of the International Accounting Standards Board’s amendments
for the benchmark reform. These amendments modify specific hedge accounting requirements to allow
hedge accounting to continue for the affected hedges.
In the current year, the Group adopted Phase 2 of the amendments which became mandatory for adoption
for reporting periods beginning on or after 1 January 2021.
The Group does not have any financial instruments which are directly affected by the interbank offered rates
(“IBOR”) reform.
However, the Group has an indirect exposure to USD LIBOR as the designation of the Group’s CCIRS as fair
value hedges and cash flow hedges for the Group’s USPP notes reference the USD LIBOR. The total notional
principal amount of the CCIRS is USD $275 million.
As at 31 March 2022, the Group’s hedge designation and documentation has not yet been updated to
reference an alternative benchmark rate on the basis that market practice has yet to be established
determining the calculation of the alternate benchmark rate. The Group continues to work with its external
adviser to monitor the relevant market developments and to assess any impact that the transition may have.
The Group expects to amend its hedging documentation to reference the US Secured Overnight Financing
Rate when widespread market practice is established.
ANNUAL REPORT 2022
133
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
20. FINANCIAL INSTRUMENTS (CONTINUED)
c. Foreign-currency risk
Foreign currency risk is the risk that the value of the Group’s assets, liabilities, and financial performance
will fluctuate due to changes in foreign currency rates.
The Group is exposed to currency risk in Australian (AUD) and US dollars (USD).
Exposure to the Australian dollar arises primarily as a result of its subsidiaries in Australia as well as the USPP
borrowings received in AUD. The risk to the Group is that the value of the overseas Australian subsidiaries’
financial position and financial performance will fluctuate in economic terms and, as recorded in the
consolidated accounts, due to changes in the overseas exchange rates.
The Group hedges the currency risk relating to its Australian subsidiaries by holding a portion of its borrowings
(both bank debt and USPP notes) in Australian dollars. Any foreign currency movement in the net assets of the
Australian subsidiary is partially offset by an opposite movement in the Australian dollar debt.
Exposure to the US dollar arises from the USPP borrowings. This exposure has been fully hedged by way of
cross-currency interest rate swaps (CCIRS) hedging both principal and interest. The CCIRS correspond in
amount and maturity to the relevant US dollar borrowings with no residual foreign currency risk exposure.
The CCIRS consist of a fair value hedge component and a cash flow hedge component. The effective
movements of the fair value hedge component are taken to the income statements along with all movements
of the hedged risk on the USPP notes (USD only). The effective movements of the cash flow hedge
components are all taken to the cash flow hedge reserve.
Foreign exchange sensitivity
The following sensitivity analysis is based on the foreign currency risk exposures in existence at the reporting
date. At 31 March 2022, had the New Zealand dollar moved either up or down by 10 percent, with all other
variables held constant, profit and equity would have been affected as follows.
20222021
$000
$000
Increase in value of NZ dollar of 10%
Impact on profit after taxation – increase/(decrease)(9,384)(2,939)
Impact on equity after taxation – increase/(decrease)(39,952)(32,397)
Decrease in value of NZ dollar of 10%
Impact on profit after taxation – increase/(decrease)11,4703,592
Impact on equity after taxation – increase/(decrease)48,83039,596
The net exposure at balance date is representative of what the Group was and is expecting to be exposed
to in the next 12 months from balance date.
RYMAN HEALTHCARE
134
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
20. FINANCIAL INSTRUMENTS (CONTINUED)
d. Liquidity risk
Liquidity risk is the risk that the Group will not be able to meet its financial obligations as they fall due without
incurring unacceptable losses or risking reputational damage.
The Group manages liquidity to ensure that it has sufficient liquidity to meet its liabilities when due. This
includes under both normal and stressed conditions. Ultimate responsibility for liquidity risk management
rests with the directors, who have built an appropriate liquidity risk management framework for the
management of the Group’s short, medium, and long-term funding and liquidity management requirements.
Occupancy advances and refundable occupation deposits
The Group manages the liquidity risk on occupancy advances through the contractual requirements in the
occupation agreement.
Following termination of the agreement, in New Zealand the occupancy advance is repaid at the earlier of:
• receipt of the new occupancy advance from the incoming resident
• at the end of 3 years.
Following termination of the agreement, in Australia the occupancy advance is repaid at the earlier of:
• 14 days after a new resident takes up residence
• receipt of the new occupancy advance from the incoming resident
• at the end of 6 months.
The repayment obligation for refundable occupation deposits in New Zealand is within 30 working days
of the resident vacating their care room.
The repayment obligation for refundable occupation deposits in Australia is within 14 days of the resident
vacating their care room.
Lines of credit and undrawn facilities
The Group manages liquidity risk by maintaining adequate reserves, banking facilities, and reserve borrowing
facilities, and by regularly monitoring forecast and actual cash flows and the maturity profiles of financial
assets and liabilities.
The Group maintains the following lines of credit.
• Secured overdraft facility of $2.8 million (2021: $2.8 million) (note 9).
• Syndicated NZD and AUD bank loan facilities totalling NZ$1.9 billion (2021: NZ$1.9 billion)
and AU$529.5 million (2021: AU$471.0 million), respectively (note 12(a)).
• Institutional term loan of AU$250 million (note 12(b)).
• Retail bonds of $150.0 million (note 12(c)).
• USPP notes of US$300 million (note 12(d)).
At balance date, the Group had NZ$592.1 million (2021: NZ$647.3 million) and AU$136.5 million
(2021: AU$36.0 million) of undrawn facilities at its disposal to further reduce liquidity risk.
ANNUAL REPORT 2022
135
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
20. FINANCIAL INSTRUMENTS (CONTINUED)
Lease liabilities
The Group does not face a significant liquidity risk with regard to lease liabilities (note 13).
Maturity profile
The following table details the Group’s exposure to liquidity risk (including contractual interest obligations
for interest-bearing loans and borrowings).
Contractual maturity dates
20222021
On
demand
Less
than
1 year1–5 years
Greater
than
5 yearsTotal
On
demand
Less
than
1 year1–5 years
Greater
than
5 yearsTotal
$000$000$000$000$000$000$000$000$000$000
Financial
liabilities
Trade and other
payables
-264,254--264,254-106,072--106,072
Interest rate
swaps
-(125)4,8281,4776,180-17,339--17,339
CCIRS-5,82239,078(33,226)1 1 ,6 74-11,272--11,272
Refundable
accommodation
deposits (non-
interest bearing)
199,783---199,783113,666---113,666
Bank loans
(secured)
--1,072,855712,9561,785,811-26,0351,703,018-1,729,053
Institutional term
loan (secured)
-6,78928,436278,514313,739-----
Retail bond
(secured)
-3,687164,344-168,031-3,68715,300152,869171,856
USPP notes-15,63553,345538,005606,985-16,44158,755518,302593,498
Occupancy
advances (non-
interest bearing)
1
-526,8453,759,614-4,286,459-438,9263,263,289-3,702,215
Lease liabilities-7,6036,817-14,420-6,2558,230-14,485
199,783830,5105,129,3171 , 4 9 7,7 2 67,657,336113,666626,0275,048,592671,1716,459,456
1 The above figures have been calculated on the anticipated level of occupancy advance repayments based on historical
experience. To date, new occupancy advances received have always exceeded repaid occupancy advances (net of
management fees) and represent a positive net operating cash flow to the Group.
RYMAN HEALTHCARE
136
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
20. FINANCIAL INSTRUMENTS (CONTINUED)
Changes in liabilities arising from financing activities
Opening
balance
Financing
cash flow
Foreign
exchange
movement
Net
changes in
fair valuesOther
Closing
balance
$000 $000 $000 $000 $000 $000
2022
Derivatives (net)
28,611--(20,894)-7,7 1 7
Interest-bearing loans
and borrowings
2,274,093326,917(2,222)(21,588)(463)2 ,576,737
Lease liabilities
13,885(2,662)--2,27113,494
Liabilities arising from
financing activities
2,316,589324,255(2,222)(42,482)1,8082,597,948
Opening
balance
Financing
cash flow
Foreign
exchange
movement
Net
changes in
fair valuesOther
Closing
balance
$000 $000 $000 $000 $000 $000
2021
Derivatives (net)
23,809--4,802-28,611
Interest-bearing loans
and borrowings
1,741,613530,16134,980(27,473 )(5,188)2,274,093
Lease liabilities
15,145(2 ,476)--1,21613,885
Liabilities arising from
financing activities
1,780,567527,68534,980(22,671)(3,972)2,316,589
ANNUAL REPORT 2022
137
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
20. FINANCIAL INSTRUMENTS (CONTINUED)
e.Fair values
Apart from the financial instruments noted below, the carrying amounts of financial instruments in the
Group’s balance sheet are the same as their fair value in all material aspects, due to the demand features
of these instruments and/or their interest rate profiles.
2022
Carrying amount
2022
Fair value
2021
Carrying amount
2021
Fair value (Restated)
$000$000$000
$000
Institutional term loan
263,092272,035
--
Retail bond
147,3951 3 7,7 75
146,861149,880
USPP notes
385,631442,017
399,214482,696
The fair value of the fixed rate portion of the institutional term loan has been determined at balance date on
a discounted cash flow basis and applying discount factors to the future AUD interest payment and principal
payment cash flows. The fair value of the floating rate portion is assumed to be the same as its carrying
amount. The fair value of the institutional term loan is categorised as Level 2 under the fair value hierarchy
in accordance with NZ IFRS 13 – Fair Value Measurement.
The fair value of the retail bond is based on the price traded at on the NZX market at 31 March 2022.
The fair value of the retail bond is categorised as Level 1 under the fair value hierarchy in accordance
with NZ IFRS 13 – Fair Value Measurement.
The fair value of the USPP notes has been determined at balance date on a discounted cash flow basis
and applying discount factors to the future USD interest payment and principal payment cash flows.
The fair value of the USPP is categorised as Level 2 under the fair value hierarchy in accordance with
NZ IFRS 13 – Fair Value Measurement.
The fair value of interest rate swaps and CCIRS are derived using inputs supplied by third parties that are
observable, either directly (prices) or indirectly (derived from prices). The fair value of these derivatives is
categorised as Level 2 under the fair value hierarchy contained within NZ IFRS 13 – Fair Value Measurement.
f. Market risk
The Group is primarily exposed to interest rate risk (note 20 (b)) and foreign currency risk (note 20 (c)).
g.Capital management
The Group’s capital includes share capital, reserves, and retained earnings. The objective of the Group’s capital
management is to ensure a strong credit rating to support business growth and maximise shareholder value.
The Group’s capital is managed at the parent company level. The Group is subject to capital requirements
imposed by its bank and the lenders included in the banking syndicate through covenants agreed as part of the
lending facility arrangements, bond holders through covenants in the Master Trust Deed and USPP note holders
through covenants in the Note Purchase Agreement.
The Group has met all externally imposed capital requirements for the 12 months ended 31 March 2022
and 31 March 2021.
The Group’s capital structure is managed, and adjustments are made with board approval to the structure,
considering economic conditions at the time. There were no changes to objectives, policies, or processes
during the year.
RYMAN HEALTHCARE
138
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
21. COMMITMENTS
Capital expenditure commitments
The Group had commitments relating to construction contracts amounting to $361.5 million at 31 March 2022
(2021: $180.6 million).
The Group has an ongoing commitment for maintaining the land and buildings of the integrated retirement
villages, resthomes, and hospitals.
22. CONTINGENT LIABILITIES
The Group had no contingent liabilities at 31 March 2022 (2021: $Nil).
23. RECONCILIATION OF NET PROFIT AFTER TAX WITH NET CASH FLOW FROM
OPERATING ACTIVITIES
20222021
$000
$000
Net profit after tax692,873423,061
Adjusted for:
Movements in balance-sheet items
Occupancy advances659,608518,292
Accrued management fees(73,827)(59,116)
Refundable accommodation deposits8 6 ,47432 ,470
Revenue in advance9,4357,5 1 5
Trade and other payables9,1724,845
Trade and other receivables(129,017)(92,565)
Inventory390(26,738)
Employee entitlements7,7 786,356
Non-cash items:
Depreciation and amortisation33,02629,892
Depreciation of right-of-use assets2 ,6722 ,476
Loss on disposal-15,102
Deferred tax29,209(12,561)
Unrealised foreign-exchange (gain)/loss4,070(19,063)
Adjusted for:
Fair-value movement of investment properties(745,885)(416,847)
Net operating cash flows585,978413,119
Net operating cash flows includes net occupancy advance receipts from retirement-village residents of
$908.1 million (2021: $787.7 million).
Also included in operating cash flows are net receipts from refundable accommodation deposits of $87.4 million
(2021: $27.9 million).
Net operating cash flows also include management fees collected of $50.2 million (2021: $48.0 million).
ANNUAL REPORT 2022
139
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
24. SUBSIDIARY COMPANIES
All trading subsidiaries operate in the aged-care sector in New Zealand and Australia, are 100 percent owned,
and have a balance date of 31 March. The operating subsidiaries are listed below.
• Anthony Wilding Retirement Village Limited
• Bert Sutcliffe Retirement Village Limited
• Bob Owens Retirement Village Limited
• Bob Scott Retirement Village Limited
• Bruce McLaren Retirement Village Limited
• Café Ryman Russley Road Limited
• Charles Brownlow Retirement Village Pty Ltd
• Charles Fleming Retirement Village Limited
• Charles Upham Retirement Village Limited
• Deborah Cheetham Retirement Village Pty Ltd
• Diana Isaac Retirement Village Limited
• Edmund Hillary Retirement Village Limited
• Ernest Rutherford Retirement Village Limited
• Essie Summers Retirement Village Limited
• Evelyn Page Retirement Village Limited
• Frances Hodgkins Retirement Village Limited
• Grace Joel Retirement Village Limited
• Hilda Ross Retirement Village Limited
• James Wattie Retirement Village Limited
• Jane Mander Retirement Village Limited
• Jane Winstone Retirement Village Limited
• Jean Sandel Retirement Village Limited
• John Flynn Retirement Village Pty Ltd
• Julia Wallace Retirement Village Limited
• Keith Park Retirement Village Limited
• Kevin Hickman Retirement Village Limited
• Kiri Te Kanawa Retirement Village Limited
• Linda Jones Retirement Village Limited
• Logan Campbell Retirement Village Limited
• Malvina Major Retirement Village Limited
• Margaret Stoddart Retirement Village Limited
• Miriam Corban Retirement Village Limited
• Murray Halberg Retirement Village Limited
• Nellie Melba Retirement Village Pty Ltd
• Ngaio Marsh Retirement Village Limited
• Possum Bourne Retirement Village Limited
• Raelene Boyle Retirement Village Pty Ltd
• Rita Angus Retirement Village Limited
• Rowena Jackson Retirement Village Limited
• Ryman Aged Care (Australia) Pty Ltd
• Ryman Construction Pty Ltd
• Ryman Healthcare (Australia) Pty Ltd
• Ryman Napier Limited
• Shona McFarlane Retirement Village Limited
• Weary Dunlop Retirement Village Pty Ltd
• William Sanders Retirement Village Limited
• Yvette Williams Retirement Village Limited
RYMAN HEALTHCARE
140
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
25. SEGMENT INFORMATION
Products and services from which reportable segments derive their revenue
The Ryman Group operates in one industry, being the provision of integrated retirement villages for older people
in New Zealand and Australia. The service provision process for each of the villages is similar, and the class of
customer and methods of distribution and regulatory environment are consistent across all the villages.
Segment revenues and results
The accounting policies of the reportable segment are the same as the Group’s accounting policies. The segment
profit represents profit earned for the segment after all costs including all administration costs, directors’ fees,
interest revenue, finance costs, and income-tax expense.
The board makes resource allocation decisions to the segment, based on the expected cash flows and results of
Group operations as a whole. No operations were discontinued during the year. To monitor segment performance
and allocate resources to the segment, the board monitors assets attributable to the segment. All assets are
allocated to the reportable segment.
Information about major customers
Included in total revenue are revenues that arose from sales to the Group’s largest customers.
The Group derives care-fee revenue for eligible government-subsidised, aged-care residents who receive
resthome, hospital, or dementia-level care. The government aged-care subsidies received from the New Zealand
Ministry of Health included in Group care fees amounted to $133.7 million (2021: $122.5 million). There are no other
significant customers.
ANNUAL REPORT 2022
141
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
25. SEGMENT INFORMATION (CONTINUED)
Geographical information
The Group operates in New Zealand and Australia.
In presenting information based on geographical areas, net profit, underlying profit, and revenue are based on the
geographical location of operations. Assets are based on the geographical location of the assets.
New ZealandAustraliaGroup
$000$000
$000
Year ended 31 March 2022
Revenue435,33773,460508,797
Underlying profit (non-GAAP)203,76351,186254,949
Deferred tax credit (note 4)
(50,923)2 1,714(29,209)
Unrealised fair-value movement (note 7)436,80430,3294 67,1 3 3
Profit for the year589,644103,229692,873
Non-current assets8,322,2361,902,34710,224,583
New ZealandAustraliaGroup
$000$000
$000
Year ended 31 March 2021
Revenue405,39650,398455,794
Underlying profit (non-GAAP)192,28632,163224,449
Deferred tax credit (note 4)
5,8616,70012,561
Unrealised fair-value movement (note 7)192,5828,571201,153
Impairment – loss on disposal (note 6)-(15,102)(15,102)
Profit for the year390,72932,332423,061
Non-current assets7,230,2981,340,4638,570,761
Underlying profit is a non-GAAP (Generally Accepted Accounting Principles) measure and differs from NZ IFRS
profit for the year. Underlying profit does not have a standardised meaning prescribed by GAAP and so may not
be comparable to similar financial information presented by other entities. The Group uses underlying profit, with
other measures, to measure performance. Underlying profit is a measure that the Group uses consistently across
reporting periods.
Underlying profit includes realised movement on investment property for units in which a right-to-occupy
has been sold during the period and for which a legally binding contract is in place at the reporting date.
The occupancy advance for these units may have been received or be included within the trade receivables
balance at reporting date (see note 5).
Underlying profit excludes deferred taxation, taxation expense, unrealised movement on investment properties,
and impairment losses on non-trading assets because these items do not reflect the trading performance of the
Company. Underlying profit determines the dividend payout to shareholders.
RYMAN HEALTHCARE
142
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
26. EMPLOYEE SHARE SCHEMES
Leadership share scheme
The Group operates an employee share scheme for certain senior employees, other than non-executive
directors, to purchase ordinary shares in the Company.
The Group provides the employees with limited recourse loans on an interest-free basis to support employees’
participation in the scheme. These shares are treated as treasury stock when purchased on market, due to the
features of the scheme.
The loans are applied to the purchase of shares on market, so the number of shares and the consideration
for each share are determined by the market price at that time. The scheme holds 2,741,246 fully allocated
shares, which represents 0.55 percent of the total shares on issue (2021: 2,655,017 fully allocated shares, which
represented 0.53 percent of the total shares on issue). All net dividends received in respect of the shares must
be applied to repayment of the loans.
Shares purchased under the scheme are held by two directors as custodians, and the shares carry the same
rights as all other ordinary shares. The loan is repayable at the discretion of the employee but is repayable
when the employee leaves the Group. Shares subject to this scheme vest 3 years from the date of purchase.
Due to the features of the scheme, it is accounted for as a share option plan under NZ IFRS 2 – Share-based Payment.
The following table reconciles the shares purchased on market under the scheme at the beginning and end of the
financial year. The weighted average exercise price is calculated based on the share price on purchase date less
any net dividends received since purchase date.
2022202220212021
Number
of shares
Weighted average
exercise price
Number
of shares
Weighted average
exercise price
Balance at beginning of the financial year2,655,01713.122,711,24411.75
Purchased on market during the year1,065,25914.67994,86013.49
Forfeited during the financial year(241,716)13.19(236,003)9.19
Vested during the financial year(737,314)12.54(815,084)8.88
Balance at end of the financial year2,741,24613.722,655,0171 3 .1 2
Represented by:
Shares granted in August 2018--753,06812.64
Shares granted in August 2019804,14312.03915,98313.19
Shares granted in August 2020871,84413.28985,96613.43
Shares granted in August 20211,065,25914.61--
Balance at end of the financial year2,741,24613.722,655,0171 3 .1 2
ANNUAL REPORT 2022
143
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
26. EMPLOYEE SHARE SCHEMES (CONTINUED)
Shares vested in August 2021 were originally purchased at $12.98 per share in 2018 and are now held directly by
employees. The amounts owed by employees in these vested shares are included within advances to employees.
This balance includes $464,130 owing by the senior executive team (as defined in note 19) in the share scheme
(2021: $277,083).
Under NZ IFRS 2, the Group measures the fair value of the services received by reference to the fair value
of the share options granted.
The directors estimate the fair value of the share options granted using the Black-Scholes pricing model.
Due to the on-market purchase and sale features of the scheme, and the scheme agreement arrangements,
the directors consider any such value to be immaterial.
All employee share scheme
In addition, the Group operates a share scheme that is available for all employees.
Participants of this scheme contribute a minimum of $500 (and up to a maximum amount of $10,000) towards
the on-market purchase of Ryman Healthcare Limited shares. To help the employee purchase more shares,
the Group advanced an interest-free loan equal to the employee’s contribution towards the share purchase
(financial assistance).
The loan is repayable at the discretion of the employee but is repayable when the employee leaves the Group.
Shares purchased under the scheme are held in the employee’s name. The financial assistance provided by the
Group is recorded in advances to employees.
RYMAN HEALTHCARE
144
Notes to the consolidated financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2022
27. SUBSEQUENT EVENTS
The directors resolved to pay a final dividend of 13.6 cents per share or $68 million, with no imputation
credits attached, to be paid on 17 June 2022.
United States Private Placement (USPP) note issuance
Subsequent to 31 March 2022, the Group completed a United States Private Placement (USPP) notes issuance,
securing US$200m of long-term debt. The USPP issuance is made up of three tranches with maturity dates of 10,
12 and 15 years. In conjunction with the issuance, the Group entered into cross-currency-interest-rate swaps to
formally hedge the exposure to foreign-currency risk over the term of the notes. The proceeds from the issuance
were used to repay bank loans.
28. AUTHORISATION
The directors authorised the issue of these financial statements on 19 May 2022.
Claire Higgins
Non-Executive Director and
Chair of Audit and Financial Risk Committee
Greg Campbell
Chair
ANNUAL REPORT 2022
145
OpinionWe have audited the consolidated financial statements of Ryman Healthcare Limited and its
subsidiaries (the ‘Group’), which comprise the consolidated balance sheet as at 31 March 2022, and
the consolidated income statement, statement of comprehensive income, statement of changes in
equity and statement of cash flows for the year then ended, and notes to the consolidated financial
statements, including a summary of significant accounting policies.
In our opinion, the accompanying consolidated financial statements, on pages 90 to 145, present
fairly, in all material respects, the consolidated financial position of the Group as at 31 March 2022,
and its consolidated financial performance and cash flows for the year then ended in accordance with
New Zealand Equivalents to International Financial Reporting Standards (‘NZ IFRS’) and International
Financial Reporting Standards (‘IFRS’).
Basis for opinionWe conducted our audit in accordance with International Standards on Auditing (‘ISAs’) and
International Standards on Auditing (New Zealand) (‘ISAs (NZ)’). Our responsibilities under those
standards are further described in the Auditor’s Responsibilities for the Audit of the Consolidated
Financial Statements section of our report.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis
for our opinion.
We are independent of the Group in accordance with Professional and Ethical Standard 1
International Code of Ethics for Assurance Practitioners (including International Independence
Standards) (New Zealand) issued by the New Zealand Auditing and Assurance Standards Board and
the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional
Accountants (including International Independence Standards), and we have fulfilled our other ethical
responsibilities in accordance with these requirements.
Our firm carries out other assurance assignments for the Group relating to Australian aged care.
These services have not impaired our independence as auditor of the Company and Group.
In addition to this, partners and employees of our firm deal with the Company and its subsidiaries
on normal terms within the ordinary course of trading activities of the business of the Company and
its subsidiaries. The firm has no other relationship with, or interest in, the Company or any of
its subsidiaries.
Audit materialityWe consider materiality primarily in terms of the magnitude of misstatement in the financial
statements of the Group that in our judgement would make it probable that the economic decisions
of a reasonably knowledgeable person would be changed or influenced (the ‘quantitative’ materiality).
In addition, we also assess whether other matters that come to our attention during the audit would in
our judgement change or influence the decisions of such a person (the ‘qualitative’ materiality). We use
materiality both in planning the scope of our audit work and in evaluating the results of our work.
We determined materiality for the Group financial statements as a whole to be $22.5m.
Key audit
matters
Key audit matters are those matters that, in our professional judgement, were of most significance
in our audit of the consolidated financial statements of the current period. These matters were
addressed in the context of our audit of the consolidated financial statements as a whole, and in
forming our opinion thereon, and we do not provide a separate opinion on these matters.
Independent Auditor’s Report
TO THE SHAREHOLDERS OF RYMAN HEALTHCARE LIMITED
RYMAN HEALTHCARE
146
Key audit matterHow our audit addressed the key audit matter
Valuation of Investment Property
As explained in policy (f) and note 7 in the consolidated
financial statements, investment properties are carried
at fair value on the consolidated balance sheet. The
fair value of these properties is determined based
on a Directors valuation at 31 March 2022, which is
supported by an independent external valuation.
The valuation is subject to a number of complex
estimates and assumptions.
The valuation model is a discounted cash flow model.
The Directors adjust the value for occupancy advances
received from residents, deferred management fees
and revenue in advance. The valuation relies on various
estimates and underlying assumptions, including
current unit pricing, discount rates, future long term
house price growth rates and the occupancy periods
of residents. A small percentage difference in certain
input assumptions could result in a material change to
the valuation.
These properties were valued at $8,027m
(2021: $6,837m). The revaluation gain recognised
in the consolidated income statement was $746m
(2021: $417m).
We included the valuation of investment properties
as a key audit matter for two reasons:
1. The significance to the financial statements:
The investment properties account for 73% of the
total assets (2021: 75%), making it the most significant
balance on the balance sheet.
2. The complexity of the valuation model that
supports the Directors valuation.
Our procedures focused on:
• The appropriateness of the valuation methodology, including
the appropriateness of assessments made by the Directors
in determining the carrying value of investment property;
• The reasonableness of underlying assumptions in the
valuation model.
Our procedures included, amongst others:
• Evaluating the Group’s processes for determining the
Directors valuation of the investment properties, including
their consideration of the valuations obtained from the
independent valuer;
• Reading the valuation reports for properties within the
group and reviewing the valuation methodology and the
reasonableness of the significant underlying assumptions;
• Discussing with management the nature of key assumptions;
• Assessing the reasonableness of adjustments made by
the Directors;
• Assessing the competence, objectivity, and integrity of
the independent registered valuers. We assessed their
professional qualifications and experience. We also obtained
representation from them about their independence and the
scope of their work and considered restrictions imposed on
the valuation process (if any);
• Meeting with the valuers to understand the valuation process
adopted. The purpose of the meeting was to identify and
challenge the critical judgment areas in the valuation model
and to confirm the valuation approach was in accordance
with NZ IFRS 13 Fair Value Measurement. We critically
challenged the changes made to key assumptions and their
reasonableness relative to the 31 March 2021 valuation;
• Using our in-house valuation specialists to assess the
appropriateness of the valuation methodology;
• Agreeing a sample of sales and resales to contracts,
calculating actual growth rates on resales for the sample
to compare to growth rates applied by the valuer, and
calculating the average tenure of residents based on a
sample of contracts to compare to assumed occupancy
periods applied by the valuer;
• Comparing a sample of current unit market values
determined by the valuer to actual prices received at
comparable units within the village;
• Assessing the discount rates for reasonableness by
comparing the rates to those adopted in the previous year
and the rates adopted by comparable entities; and
• Considering the appropriateness of the disclosures in note 7.
ANNUAL REPORT 2022
147
Key audit matterHow our audit addressed the key audit matter
Valuation of care-facility land and buildings
As explained in policy (d) and note 6 in the financial
statements, care facility land and buildings are
carried at their fair value at the date of revaluation
less any subsequent accumulated depreciation and
impairment losses.
The net book value of care facility land and buildings
as reflected in note 6 is $1,058m (2021: $955m).
The Group obtains independent valuations at least
every 2 years and performs internal assessments in the
intervening years to determine whether there are any
indications that the carrying amount differs materially
from fair value at the balance sheet date.
The last independent valuation was completed as
at 31 March 2021. A revaluation gain of $196m was
recognised in other comprehensive income in 2021.
The valuer used a combination of capitalised earnings
data and comparable market evidence to derive
fair value.
In the current year, the Group has determined that
there are no indications that the fair value of care
facility land and buildings differs materially from their
carrying value. In reaching this assessment the Group
has considered capitalisation rates, market evidence
of comparable sales, market demand, occupancy,
and earnings.
We included the valuation of care facility land and
buildings as a key audit matter in the current year due
to the significant judgement exercised by the Group
in determining that there are no indications that the
carrying value differs materially to the fair value at
31 March 2022.
Our procedures included, amongst others:
• Critically assessing the documentation prepared by the
Group supporting their assessment of whether there have
been any significant changes to the inputs and assumptions
used in the 2021 valuation that would lead to the carrying
value of care facility land and buildings being materially
different to fair value at 31 March 2022;
• Challenging the Group’s analysis of the following inputs and
assumptions used in the Group’s assessment:
- occupancy rates;
- capitalisation rates; and
- market comparative sales;
• Analysing care centre earnings data for the current period
compared to prior period;
• Critically assessing the documentation prepared by the
Group supporting their assessment that there were no
indicators that the fair value of developing villages not subject
to revaluation in 2021 were materially different to their
carrying amount at 31 March 2022;
• Agreeing material additions to supporting documentation;
and
• Considering the appropriateness of the disclosures in note 6.
RYMAN HEALTHCARE
148
Other
information
The directors are responsible on behalf of the Group for the other information. The other information
comprises the information in the Annual Report that accompanies the consolidated financial
statements and the audit report. The Annual Report is expected to be made available to us after the
date of this auditor’s report.
Our opinion on the consolidated financial statements does not cover the other information and we will
not express any form of assurance conclusion thereon.
Our responsibility is to read the other information identified above when it becomes available and
consider whether the other information is materially inconsistent with the consolidated financial
statements or our knowledge obtained in the audit or otherwise appears to be materially misstated.
When we read the other information in the Annual Report, if we conclude that there is a material
misstatement therin, we are required to communicate the matter to the directors and consider further
appropriate actions.
Directors’
responsibilities
for the
consolidated
financial
statements
The directors are responsible on behalf of the Group for the preparation and fair presentation of the
consolidated financial statements in accordance with NZ IFRS and IFRS, and for such internal control
as the directors determine is necessary to enable the preparation of consolidated financial statements
that are free from material misstatement, whether due to fraud or error.
In preparing the consolidated financial statements, the directors are responsible on behalf of the Group
for assessing the Group’s ability to continue as a going concern, disclosing, as applicable, matters
related to going concern and using the going concern basis of accounting unless the directors either
intend to liquidate the Group or to cease operations, or have no realistic alternative but to do so.
Auditor’s
responsibilities
for the audit of
the consolidated
financial
statements
Our objectives are to obtain reasonable assurance about whether the consolidated financial
statements as a whole are free from material misstatement, whether due to fraud or error, and to issue
an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is
not a guarantee that an audit conducted in accordance with ISAs and ISAs (NZ) will always detect a
material misstatement when it exists. Misstatements can arise from fraud or error and are considered
material if, individually or in the aggregate, they could reasonably be expected to influence the
economic decisions of users taken on the basis of these consolidated financial statements.
A further description of our responsibilities for the audit of the consolidated financial statements is
located on the External Reporting Board’s website at:
https://www.xrb.govt.nz/standards-for-assurance-practitioners/auditors-responsibilities/audit-report-1
This description forms part of our auditor’s report.
Restriction
on use
This report is made solely to the Company’s shareholders, as a body. Our audit has been undertaken
so that we might state to the Company’s shareholders those matters we are required to state to them
in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept
or assume responsibility to anyone other than the Company’s shareholders as a body, for our audit
work, for this report, or for the opinions we have formed.
Mike Hoshek, Partner for
Deloitte Limited
Christchurch, New Zealand
19 May 2022
ANNUAL REPORT 2022
149
Artist’s impression of our upcoming Northwood Village in Christchurch
– a great example of a townhouse-style village that lends itself to an
efficient build process and therefore accelerated returns.
150
RYMAN HEALTHCARE
Corporate
governance
151
ANNUAL REPORT 2022
Greg Campbell (Chair)
MBA (DIST) FNZIM
Greg joined the board in
March 2021 and was appointed
chair in January 2022. He is
an experienced chief executive
and board director with more
than 25 years’ experience in
leading large organisations.
Greg has strong governance
and commercial skills, a deep
operational understanding of
business and a strong interest
in sustainability.
Claire Higgins
BCOM, FCPA, FAICD
Based in Victoria, Claire is a
non-executive director with
experience across a range
of sectors in Australia and
New Zealand. Claire joined
the board in 2014, is chair
of REI Superannuation and
GMHBA and holds director
positions in the medical device
and philanthropic sectors.
Dr David Kerr
CNZM, MBCHB, FRNZCGP
David joined Ryman’s board in
1994 and was chair from 1999
until he stepped down in January
2022. David is a fellow and past
president of the New Zealand
Medical Association and has
been awarded a Fellowship
with Distinction by the Royal
New Zealand College of General
Practitioners. He was made a
Companion of the New Zealand
Order of Merit in 2020. David
has announced his intention
to retire from the board in
July 2022.
Our directors
Image: Warren Bell, Paula Jeffs, Geoffrey Cumming, Dr David Kerr, Jo Appleyard, George Savvides,
Greg Campbell, Claire Higgins, Anthony Leighs.
RYMAN HEALTHCARE
152
George Savvides
AM, BE (HONS), MBA, FAICD
Based in Melbourne, George
joined the board in 2013. He
has extensive experience in
Australia’s healthcare industry,
including 14 years as managing
director of Medibank, Australia’s
largest health insurer. George
is chair of SBS (Broadcasting),
a non-executive director of
IAG (Insurance Australia Group)
and a Fellow of the Australian
Institute of Directors. In 2020,
George was made a Member
of the Order of Australia for
significant service to the
community, charitable groups
and business.
Anthony Leighs
NZCB
Anthony joined the board
in 2018. He is also director
of leading commercial
construction firm Leighs
Construction, which
he founded in 1995 and built
into one of New Zealand’s
leading commercial
construction contractors.
He is a former chairman of
the New Zealand Registered
Master Builders Association.
Paula Jeffs
BA, GRAD DIP (IR), GAICD,
CAHRI
Paula is a Melbourne-based
human resources executive
with experience across the
healthcare, finance and
government sectors and deep
expertise in workforce planning,
organisational capability and
executive coaching. In the early
stages of her working life, Paula
spent several years as a carer
in the aged and disability sector.
Paula joined the board in 2019.
Geoffrey Cumming
BA (HONS), MSC (ECON), LLD
Geoff rejoined the board in
June 2018, having previously
served as a director from 1999
to 2000. Geoff is a Melbourne-
based New Zealand citizen who
is an economist, investor and
philanthropist. He has more
than 30 years’ experience as a
chief executive and company
director and has served on
more than 25 boards. In 2019,
Geoff was inducted into the
Alberta Business Hall of Fame.
Jo Appleyard
LLB (HONS)
Jo joined the board in
2009 and is also a partner
at Chapman Tripp. She is a
skilled advocate and litigator
specialising in commercial,
employment and resource
management law. Jo was a
member of the NZ Markets
Disciplinary Tribunal
between 2011 and 2020.
Warren Bell
MCOM, FCA
Warren joined the board in
2011. He is an experienced
public and private company
director and was previously
an audit partner. Warren is
currently chair of Hallenstein
Glasson and has a long
history in the New Zealand
retail sector. He is also chair
of Christchurch-based
St George’s Hospital and
is a director of several
private companies.
ANNUAL REPORT 2022
153
Richard Umbers
GROUP CHIEF EXECUTIVE
Richard joined Ryman in 2021.
Richard is an internationally
experienced CEO with a
background in leading large
businesses. Richard was
previously divisional director
of buying at Kaufland in
Germany and CEO and
managing director of Myer
Australia. He also held senior
roles at Woolworths in Australia
and was managing director of
Progressive Enterprises Limited
in New Zealand.
Cheyne Chalmers
CHIEF EXECUTIVE
OFFICER – NEW ZEALAND
Cheyne joined Ryman in 2020
as chief operations officer and
was appointed CEO NZ in June
2022. As a registered nurse
with a Master in Management,
Cheyne has held senior public
health roles including executive
director of residential and
support services and chief
nursing and midwifery officer
at Monash Health, Melbourne.
Cheyne is also an adjunct
professor at Deakin University
in Victoria.
David Bennett
GROUP CHIEF
FINANCIAL OFFICER
Dave joined Ryman in 2013
and was promoted to group
chief financial officer in 2017.
He is a board member of the
Retirement Villages Association
of New Zealand and the
New Zealand Aged Care
Association. Dave has a
Bachelor of Commerce
and is a chartered accountant.
Before joining Ryman, he worked
as an accountant and auditor.
Our senior executives
Image: Rick Davies, Andrew Crerar, Cheyne Chalmers, David Bennett, Marsha Cadman, Richard Umbers,
Cameron Holland, Mary-Anne Stone, Chris Evans.
RYMAN HEALTHCARE
154
Cameron Holland
CHIEF EXECUTIVE
OFFICER – AUSTRALIA
Cameron is an experienced
business leader with over
15 years’ experience leading
the commercial and operational
arms of some of Australasia’s
largest and most well-known
brands, including Jetstar and
Lonely Planet. Cameron also
has extensive experience
in the aged care, home care
and retirement living sector
in Australia. Cameron joined
Ryman in 2021.
Rick Davies
CHIEF TECHNOLOGY AND
INNOVATION OFFICER
Rick is an experienced
technology and commercial
leader, having worked
extensively within the
ecommerce sector. Rick has
held a range of senior roles
including leading Trade Me’s
iconic retail marketplace
division. Rick has a Bachelor
of Science and joined Ryman
in 2019.
Marsha Cadman
CHIEF SALES AND
MARKETING OFFICER
Marsha has extensive
experience across both
sales and marketing and
has a Master in Business
Administration. Before joining
Ryman in 2021, she was general
manager strategy, customer
and sustainability at Waste
Management New Zealand.
Marsha also held senior roles
at South East Water in
Melbourne and MyState
Financial in Tasmania.
Chris Evans
CHIEF CONSTRUCTION
OFFICER
Chris joined Ryman in 2021.
He is an experienced
construction leader having
enjoyed more than 25 years
working for John Holland Group
in a range of operational and
senior leadership positions
in Australia. More recently
Chris worked at Sydney Airport,
where he was chief assets
and infrastructure officer.
Andrew Crerar
CHIEF PEOPLE AND
SAFETY OFFICER
Andrew joined Ryman in
2018 as people development
manager. He was promoted
to group people development
manager in 2019 before moving
into his current role in 2020.
Prior to this, Andrew completed
a Master of Arts (Economic
Psychology) and worked in
the public health sector in
the United Kingdom and
in professional services in
New Zealand.
Mary-Anne Stone
CHIEF STRATEGY OFFICER
Mary-Anne has over 25 years’
experience in the healthcare
sector including senior
management roles in primary
health, retirement living and
home and community care.
Mary-Anne has a Master in
Population Health focused
on health systems for ageing
populations and health equity.
Mary-Anne rejoined Ryman
in 2020.
ANNUAL REPORT 2022
155
Ryman believes in the
benefit of good corporate
governance and the
value it provides for our
shareholders, residents,
employees and other
stakeholders.
Ryman’s board of directors is responsible for the company’s
corporate governance. The board undertakes this role with
reference to best practice and takes into consideration the
recommendations outlined in the NZX Corporate Governance
Code (the Code).
The company’s approach to applying the recommendations
outlined in the Code are set out on the following pages.
The section is set out in the order of the principles detailed
in the Code and explains how Ryman is applying the
Code’s recommendations.
Ryman’s policy documents referred to in this section
are available at:
rymanhealthcare.co.nz/about-us/investors/governance
.
BOARD COMPOSITION
At 31 March 2022, we had
nine directors on our board:
Greg Campbell, Dr David Kerr,
Geoff Cumming, George Savvides,
Paula Jeffs, Claire Higgins,
Warren Bell, Jo Appleyard
and Anthony Leighs.
All are non-executive directors,
and seven are independent
for the purposes of the NZX Main
Board Listing Rules. The board
has stated that the appropriate
size of the board is between seven
and nine directors.
8
5
4
9
56
7
2
6
9
S
t
r
a
t
e
g
y
H
u
m
a
n
r
e
s
o
u
r
c
e
s
D
i
g
i
t
a
l
a
n
d
H
e
a
l
t
h
,
c
l
i
n
i
c
a
l
a
n
d
H
e
a
l
t
h
a
n
d
s
a
f
e
t
y
P
r
o
p
e
r
t
y
a
n
d
R
i
s
k
m
a
n
a
g
e
m
e
n
t
F
i
n
a
n
c
e
,
a
c
c
o
u
n
t
i
n
g
E
x
e
c
u
t
i
v
e
l
e
a
d
e
r
s
h
i
p
G
o
v
e
r
n
a
n
c
e
a
n
d
t
a
x
a
t
i
o
n
c
o
n
s
t
r
u
c
t
i
o
n
a
g
e
d
c
a
r
e
t
e
c
h
n
o
l
o
g
y
AREAS OF
EXPERTISE
RYMAN HEALTHCARE
156
* Geoff Cumming is a citizen of both New Zealand and Canada who resides in Melbourne, Australia.
** Attendance in the financial year to 31 March 2022.
2 nationalities
(6 New Zealanders and 3 Australians *)
are independent
78%
are female
33%
Average age
61
BOARD STATS AND FACTS
Board meeting
attendance
100%
BOARD COMMITTEES
Director
members
Director
independence
Director
attendance**
Audit, Finance and Risk
667%94%
People and Safety
683%100%
Clinical Governance
3100%100%
Development, Design
and Construction
580%92%
Governance, Nominations
and Remuneration
475%92%
ANNUAL REPORT 2022
157
Statement of corporate governance
NZX Listing
Rules
The company applies the NZX Main Board Listing Rules (the Listing Rules). At the date of
this report, the current version of the Listing Rules are those dated 10 December 2020.
PRINCIPLE 1 – CODE OF ETHICAL BEHAVIOUR
“Directors should set high standards of ethical behaviour, model this behaviour and hold
management accountable for these standards being followed throughout the organisation.”
Code of
ethics
As part of the board’s commitment to the highest standards of behaviour and accountability,
Ryman has adopted a code of ethics that outlines our position on the things that are most
important in upholding our shared standards.
Our code of ethics sets out the core principles of behaviour that are expected of every
person who works for and with Ryman, regardless of where they are or what they do.
These expectations are the same for everyone, including directors, senior leaders, team
members, consultants, business partners and anyone who works with us.
The code is intended to support decision making that is consistent with Ryman’s
characteristics, business goals and legal and policy obligations rather than to prescribe an
exhaustive list of acceptable behaviour and the things that fall outside of our expectations.
The board approves the code of ethics, which covers:
• who we are – our values and characteristics
• our commitment to health, safety and wellbeing – we do it safely or not at all
• our people – supporting, developing and leading our team members
• environment and community – the work we do to protect our environment and be positive
members of our community
• protecting our assets and property – being good stewards of company information,
property and value
• freedom to speak up – supporting people to raise concerns, including whistleblowing
and protected disclosures, free from reprisal or victimisation
• how we do business – accepting gifts or other benefits, dealing with conflicts of interest
and maintaining confidentiality
• complying with the law and reporting breaches.
Ryman team members are expected to read the code of ethics as part of their induction
and keep it at the core of everything they do. It is also accessible to all team members on the
Ryman intranet and the company website.
Financial
product
trading policy
Ryman supports the integrity of New Zealand’s financial markets. This integrity is maintained,
in part, through the insider trading laws that apply in New Zealand. Ryman’s financial product
trading policy outlines how those laws apply as well as the rules that Ryman has put in place
so that those laws are followed.
RYMAN HEALTHCARE
158
Statement of corporate governance (continued)
PRINCIPLE 2 – BOARD COMPOSITION AND PERFORMANCE
“To ensure an effective board, there should be a balance of independence, skills, knowledge,
experience and perspectives.”
The board of
directors
The directors are responsible for the corporate governance practices of the company.
The practices adopted by the board are prescribed in a charter that sets out the protocols
for how the board operates.
The charter complies with the relevant recommendations in the Code and is reviewed annually.
The board’s primary role is to effectively represent and promote the interests of
shareholders with a view to adding long-term value to the company’s shares.
The board carries out its responsibilities according to the following mandate.
• The board should consist of a majority of non-executive directors.
• At least a third of the directors should be independent of management and free from any
business or other relationship or circumstance that could materially interfere with the
exercise of a director’s independent judgement.
• The board’s chair should be a non-executive director (and not the group chief executive).
• Directors should possess a broad range of skills, qualifications and experience and remain
up to date on how best to perform their duties as directors.
• Management must provide information of sufficient content, quality and timeliness as the
board considers necessary to allow the board to effectively discharge its duties.
• The effectiveness and performance of the board and its individual members should be
re-evaluated annually.
The board consists entirely of non-executive directors. The directors of the company at
31 March 2022 are Greg Campbell (chair), Dr David Kerr, Jo Appleyard, Warren Bell,
Claire Higgins, George Savvides, Geoff Cumming, Anthony Leighs and Paula Jeffs.
The board has determined that Greg Campbell, Dr David Kerr, Jo Appleyard, Claire Higgins,
George Savvides, Anthony Leighs and Paula Jeffs are all independent directors for the
purposes of the Listing Rules.
More information on the directors, including their experience, interests, qualifications, length of
service and shareholdings, is provided in the ‘Director's disclosures’ section of this report and
on the company’s website. A summary of the board’s skill set is detailed in the table below.
Day-to-day management of Ryman is delegated to the group chief executive and the senior
executive team. The group chief executive and senior executive team are delegated the
responsibility for implementing the board’s strategy.
Directors, certain employees and their related parties must seek approval from the company to
trade in the company’s quoted financial products (shares and retail bonds). Trading is limited
to two trading windows between the full-year announcement date and 31 August, and between
the half-year announcement date and 31 January each year.
The directors’ shareholdings and all trading of quoted financial products during the year by the
directors is disclosed in the ‘Director's disclosures’ section of this report. A director or senior
manager is obliged to advise the NZX promptly if they trade in the company’s shares or retail bonds.
ANNUAL REPORT 2022
159
Statement of corporate governance (continued)
Governance
Experience of governance through board
appointments at other organisations or
through former CEO experience.
••••••••
Executive leadership
Former CEO or C-suite executive with
excellent track record of growing value,
leading with purpose, strategy, development
and execution, including investing in people,
leadership of culture and effective delegation.
•••••
Finance, accounting and taxation
Finance and accounting experience of
large companies. May hold a recognised
accounting qualification. The skills to chair
the Audit, Finance and Risk Committee.
••••
Risk management
Risk management experience developed
through either leadership or governance
roles at similar-sized organisations.
•••••••••
Property and construction
Experience successfully leading property
and construction companies or performing
governance roles for companies in the sector.
Skills to support and challenge new site
investment decisions and build programme.
•••••
Health and safety
Experience in the development of health,
safety and wellbeing frameworks and risk
management tools at large organisations.
••••••
Health, clinical and aged care
Leadership or governance experience
across the health and aged care sector.
•••••••
Digital and technology
Experience in the implementation of
digital transformation or new digital
product development in the health or
aged care sectors.
••
Human resources
Leadership experience in the development
and implementation of people and culture
programmes at large organisations.
••••••
Strategy
Experience of strategic oversight, including
the development and implementation of
strategic plans for organisations of similar
scale and complexity.
•••••••••
Greg Campbell
Dr David Kerr
Jo Appleyard
Warren Bell
George Savvides
Claire Higgins
Geoff Cumming
Anthony Leighs
Paula Jeffs
RYMAN HEALTHCARE
160
Statement of corporate governance (continued)
The board’s
responsibilities
The primary responsibilities of the board are to:
• ensure the company’s goals are clearly established and that strategies are in place for
achieving them
• establish policies for strengthening the performance of the company and ensure that
management is proactively seeking to build the business
• monitor the performance of management
• appoint the group chief executive and set the terms of the group chief executive’s
employment agreement
• decide on what steps are needed to protect the company’s financial position and its
ability to meet its debts and other obligations when they fall due and ensure that such
steps are taken
• ensure the company’s financial statements are true and fair and conform with the law
• ensure the company adheres to high standards of ethics and corporate behaviour
• ensure the company adheres to its health and safety obligations and commitments
• ensure that the company is adopting policies, practices and procedures that result in
the company meeting or exceeding societal and shareholders’ expectations with respect
to environmental, social and governance standards
• ensure the company has appropriate risk management/regulatory compliance policies
in place.
On appointment to the board by the shareholders, new directors sign a written agreement
that covers the terms of their appointment.
Every year, the board and its committees critically evaluate their own performance and
their own processes and procedures. Through this process, the board identifies any training
opportunities for individual directors to ensure they have relevant and up-to-date skills for
performing their role.
Under the Listing Rules, every director must stand for re-election on the later of 3 years
or the third annual meeting after their appointment. These directors may offer themselves
for re-election.
The Governance, Nominations and Remuneration Committee undertakes the process for
nominating directors on behalf of the board and makes appropriate recommendations to
the board.
Directors appointed by the board must retire at the next annual meeting following their
appointment. These directors may offer themselves for re-election.
ANNUAL REPORT 2022
161
Statement of corporate governance (continued)
Diversity
The board and management ensure that all eligible people get an equal opportunity to
demonstrate that they have the right skills and experience for a particular role, which forms
the basis of our diversity policy.
Ryman embraces the uniqueness in all of our people and welcomes diversity. We encourage all
of our employees to listen to each other and to our residents and their families and to work to
meet the needs of individual people.
Our approach to diversity is to continually develop a work environment that supports equality
and inclusion, regardless of difference.
The board sets measurable objectives for assessing performance against Ryman’s diversity
policy (including achieving gender diversity) and assesses progress annually. The board
ensures Ryman’s objectives are appropriate for promoting diversity and inclusion.
The gender diversity for our leadership roles at 31 March is as follows.
20222021
DirectorsMale66
Female33
99
Senior executive teamMale65
Female32
97
Ryman leadersMale224197
Female3 74349
598546
Independent
professional
advice
With the prior approval of the chair, each director has the right to seek independent legal
and other professional advice at the company’s expense about any aspect of the company’s
operations or undertakings to assist in fulfilling their duties and responsibilities as a director.
RYMAN HEALTHCARE
162
Statement of corporate governance (continued)
PRINCIPLE 3 – BOARD COMMITTEES
“The board should use committees where this will enhance its effectiveness in key areas,
while still retaining board responsibility.”
Board
committees
The board has five standing committees: Audit, Finance and Risk; People and Safety;
Clinical Governance; Development, Design and Construction; and Governance, Nominations
and Remuneration.
A separate Independent Directors’ Committee meets as needed.
Each committee operates under specific terms of reference approved by the board.
Any recommendations a committee makes are recommendations to the board.
The terms of reference for each committee are reviewed annually.
Audit,
Finance
and Risk
Committee
The objective of the Audit, Finance and Risk Committee (AFRC) (previously the Audit and
Financial Risk Committee) is to assist the board in discharging its responsibilities for financial
reporting, enterprise risk management and financial/secretarial compliance.
The committee makes recommendations to the board on appointing external auditors to
ensure that they are independent and to ensure that the company provides for a 5-yearly
rotation of the lead audit partner.
The committee provides a forum for effective communication between the board and
external auditors.
The committee’s responsibilities include to:
• review and oversee enterprise risk management, internal control and compliance systems
• review the appointment of the external auditor, the annual audit plan, audit findings
and address any recommendations from the audit
• review and oversee financial performance, forecasting, treasury management,
capital management and debt structure
• approve the release of all financial information.
The AFRC must consist of at least three directors who must wherever possible be independent
non-executive directors. The board chair must also not be the chair of the AFRC. The
current members are Claire Higgins (chair), Warren Bell, Geoff Cumming, Dr David Kerr,
George Savvides and Greg Campbell. Claire Higgins, Dr David Kerr, George Savvides and
Greg Campbell are all independent non-executive directors. Claire Higgins is a Fellow of CPA
Australia, and Warren Bell is a Fellow of Chartered Accountants Australia and New Zealand.
The committee generally invites the group chief executive, group chief financial officer and
external auditor to attend AFRC meetings as appropriate. The committee also meets and
receives regular reports from the external auditor without management present concerning
any matters that arise in connection with the performance of the auditor’s role.
The committee maintains direct lines of communication with the group chief executive
and group chief financial officer. Any director may attend.
ANNUAL REPORT 2022
163
Statement of corporate governance (continued)
Clinical
Governance
Committee
The Clinical Governance Committee supports and enhances the quality of the company’s
clinical performance and care, and exploration of new service provision.
The committee assists the board in discharging its oversight of clinical reporting and clinical
compliance and is focused on innovation in healthcare and ensuring alignment with emerging
best clinical practice.
The committee consists of three non-executive directors – George Savvides (chair),
Dr David Kerr and Jo Appleyard – as well as Tim Wilkinson, a professor at Otago Medical
School and a consulting geriatrician, and Dr Doug Wilson, an author and biotechnologist.
The committee also invite clinically-trained employees to attend as required.
People
and Safety
Committee
The People and Safety Committee assists the board in discharging its responsibilities
in overseeing and reviewing matters relating to organisational culture, health, safety and
wellbeing management and people and culture strategy and the impact of these activities
on employees, contractors, residents and visitors to Ryman.
The committee recognises the critical role people and safety forms as part of
Ryman’s day-to-day operations and wants to ensure a safety-first culture across
all business operations.
The members of the committee are Paula Jeffs (chair), Claire Higgins, Dr David Kerr,
Jo Appleyard, Geoff Cumming, Greg Campbell, Richard Umbers (Group Chief Executive),
as a director of all Ryman Group subsidiaries and David Bennett (Group Chief Financial Officer)
as a director of all Ryman Group subsidiaries.
The committee’s responsibilities include to:
• review and recommend health, safety and wellbeing strategies and provide oversight
of major projects or improvement plans
• review, monitor and make recommendations to the board on the organisation’s health
and safety risk management framework and policies, including assessments that
systems are fit for purpose and being effectively implemented, regularly reviewed
and continuously improved
• monitor compliance with health, safety and wellbeing policies and relevant applicable
law through oversight of major assurance functions conducted across the business and
ensuring that appropriate resources are available
• review and recommend people and culture strategies and provide oversight of major
projects or improvement plans to drive a positive culture and effective workforce
• review and recommend talent, succession and development plans, diversity and inclusion
plans and metrics, remuneration policy and targets, and employee engagement plans.
The committee maintains direct lines of communication with the chief executive – Australia,
chief operations officer, chief construction officer and chief people and safety officer.
RYMAN HEALTHCARE
164
Statement of corporate governance (continued)
Development,
Design and
Construction
Committee
The Development, Design and Construction Committee (previously the Development and
Construction Committee) reviews and enhances the quality of the company’s performance
in the development of integrated retirement villages. The committee has a focus on capital
management and recycling.
The committee assists the board in discharging its oversight of the company’s development,
design and construction activities and practices.
The committee consists of five non-executive directors: Anthony Leighs (chair), Jo Appleyard,
Warren Bell, Claire Higgins and Greg Campbell.
The committee’s responsibilities include to:
• oversee the company’s portfolio of village developments to ensure the annual and
longer-term business plans can be achieved
• monitor the stage-gate progression of projects from land acquisition recommendation to
construction commencement, including making recommendations to the board throughout
the process
• review risk and mitigation measures relevant to the development, design and construction
functions, including timeliness, quality and compliance issues
• review a range of profitability performance metrics for each development
• investigate innovative construction and design methods to improve resident and employee
experiences, improve efficiency and support the sustainability and climate change strategy
• review systems and procedures supporting the design, consent and building process.
The committee maintains direct lines of communication with the group chief executive,
group chief financial officer, chief construction officer and chief executive – Australia.
The committee’s responsibilities are to:
• ensure appropriate clinical information systems and external controls are in place
to achieve statutory compliance and quality care
• liaise with external clinical auditors, including reviewing the appointment of auditors
and audit findings
• liaise with internal clinical auditors and review audit findings
• review significant changes to clinical policies
• review significant complaints and investigations relating to care of residents
• review changes in clinical practice in aged care
• monitor the quality of care experienced by all Ryman residents.
The committee maintains direct lines of communication with the external clinical auditors,
group chief executive, chief operations officer, chief executive officer – Australia and internal
clinical auditor.
External clinical auditors are invited to attend a meeting each year and report to the
committee, including presenting a review of the internal clinical audit function.
ANNUAL REPORT 2022
165
Statement of corporate governance (continued)
Independent
Directors’
Committee
The Independent Directors’ Committee is convened as needed and consists of independent
non-executive directors who address significant conflicts of interest and any other matters
referred by the board.
Ryman has protocols that set out the procedures to be followed if there is a takeover offer.
These procedures are set out in the takeover response protocols that have been adopted
by the board.
Governance,
Nominations
and
Remuneration
Committee
The Governance, Nominations and Remuneration Committee (previously the Governance,
Remuneration and Nomination Committee) assists the board in establishing remuneration
policies and practices for the company in discharging the board’s responsibilities for
remuneration. The committee also undertakes the process for nominating directors on
behalf of the board and makes appropriate recommendations to the board.
Membership of the committee must comprise non-executive directors, a majority of
whom must be independent. The committee consists of four non-executive directors:
Geoff Cumming (chair), Dr David Kerr, George Savvides and Paula Jeffs.
Management attends committee meetings only at the invitation of the committee.
The committee’s objectives are to:
• assist the board in establishing remuneration policies and practices for the company
• assist in discharging the board’s responsibilities for reviewing the group chief executive’s
and directors’ remuneration
• advise and assist the group chief executive in setting remuneration for the senior
executive team
• regularly review and recommend changes to the composition of the board and identify
and recommend individuals for nomination as members of the board and its committees.
The directors’ remuneration is set out in the ‘Director’s disclosures’ section of this report.
Detail of the group chief executive’s remuneration is set out under Principle 5.
RYMAN HEALTHCARE
166
Statement of corporate governance (continued)
Attendance
at board and
committee
meetings
Director attendance at board and committee meetings is shown in the table below.
The table details the attendance at the meetings outlined in the board and committee
meeting plan for the year ended 31 March 2022 plus additional meetings held during the year.
Board meetings consist of a number of meetings held over multiple days.
Board
Audit,
Finance
and Risk
People and
Safety
Clinical
Governance
Development,
Design and
Construction
Governance,
Nominations and
Remuneration
Number of
meetings held
10345123
Greg Campbell
1
102410
Jo Appleyard104510
Warren Bell10312
Geoff Cumming10343 (chair)
Claire Higgins103 (chair)411
Paula Jeffs104 (chair)3
Dr David Kerr103452
Anthony Leighs1012 (chair)
George Savvides1035 (chair)3
The Independent Directors’ Committee did not meet during the year.
1 Greg Campbell replaced Dr David Kerr as chair of the board in January 2022.
Summary of
committee
memberships
CommitteeMembers at 31 March 2022Members at 31 March 2021
Audit, Finance and Risk
(previously Audit and
Financial Risk)
Claire Higgins (chair), Warren Bell,
Dr David Kerr, George Savvides,
Geoff Cumming, Greg Campbell
Claire Higgins (chair), Warren Bell
(deputy chair), Dr David Kerr,
George Savvides, Geoff Cumming,
Greg Campbell
People and Safety Paula Jeffs (chair), Claire Higgins,
Dr David Kerr, Jo Appleyard,
Geoff Cumming, Greg Campbell,
Richard Umbers (Group Chief
Executive), David Bennett
(Group Chief Financial Officer)
Paula Jeffs (chair), Claire Higgins,
Dr David Kerr, Jo Appleyard,
Geoff Cumming, Greg Campbell,
Gordon MacLeod (Group Chief
Executive), David Bennett
(Chief Financial Officer)
Clinical GovernanceGeorge Savvides (chair),
Dr David Kerr, Jo Appleyard,
Tim Wilkinson (external
consultant), Dr Doug Wilson
(external consultant)
George Savvides (chair),
Dr David Kerr, Jo Appleyard,
Tim Wilkinson (external
consultant), Dr Doug Wilson
(external consultant)
Development, Design and
Construction (previously
Development and
Construction)
Anthony Leighs (chair),
Jo Appleyard, Warren Bell,
Claire Higgins, Greg Campbell
Anthony Leighs (chair),
Jo Appleyard, Warren Bell,
Claire Higgins, Greg Campbell
Governance, Nominations
and Remuneration (previously
Governance, Remuneration
and Nomination)
Geoff Cumming (chair),
Dr David Kerr, George Savvides,
Paula Jeffs
Geoff Cumming (chair),
Dr David Kerr, George Savvides,
Paula Jeffs
ANNUAL REPORT 2022
167
Statement of corporate governance (continued)
PRINCIPLE 4 – REPORTING AND DISCLOSURE
“The board should demand integrity in financial and non-financial reporting, and in the timeliness
and balance of corporate disclosures.”
Reporting and
disclosure
The board focuses on providing accurate, adequate and timely information both to existing
shareholders and to the market generally. This enables all investors to make informed
decisions about the company.
As a company listed on the NZX Main Board, Ryman has an obligation to comply with the
disclosure requirements under the NZX Main Board Listing Rules. Ryman recognises that
these requirements aim to provide equal access for all investors or potential investors to
material price-sensitive information concerning issuers or their financial products. This in
turn promotes confidence in the market.
Ryman’s market disclosure policy outlines the obligations of Ryman and relevant Ryman
personnel in satisfying the disclosure requirements. It also covers other related matters
including external communications by Ryman.
This annual report is produced using the principles of Integrated Reporting <IR>. An integrated
report provides more information on the company’s business model and how we create value
over time. As a result, an annual report produced under the <IR> Framework will have a
broader narrative than an annual report that does not use the framework.
Ryman publishes its key governance and other relevant documents in the investor centre
of the company’s website at rymanhealthcare.co.nz/about-us/investors/governance.
All significant announcements made to the NZX and reports issued are also posted on the
company’s website.
RYMAN HEALTHCARE
168
Statement of corporate governance (continued)
PRINCIPLE 5 – REMUNERATION
“The remuneration of directors and executives should be transparent, fair and reasonable.”
Remuneration
The Governance, Nominations and Remuneration Committee makes recommendations
to the board on remuneration matters in keeping with the committee’s terms of reference.
The committee does not have the authority to make decisions on behalf of the board.
The committee is also responsible for making recommendations to the board on the
remuneration of the group chief executive.
The total director remuneration pool is approved by shareholders at the annual general
meeting (AGM) as required under the Listing Rules.
The board is responsible for the setting of individual directors’ fees in line with the approved
pool and the Listing Rules.
Details of the directors’ remuneration for the year are in the ‘Director’s disclosures’ section
of this report.
Ryman has in place a remuneration policy that outlines the key principles that influence
Ryman’s remuneration practices.
The remuneration of the group chief executive and senior executive team is determined by
the significance of their role and the industry. The total remuneration is made up of fixed
remuneration and short-term and medium-term cash-based incentives. The group chief
executive and senior executive team are also members of the senior leadership share scheme
(see note 26 of the financial statements).
The short-term and medium-term incentives are at-risk payments that reward performance.
They are designed to motivate and incentivise senior employees in the delivery of performance
over a 1-year and 3-year operating cycle. The amount payable is set over the performance
period. The payment of the short-term and medium-term incentive depends on achieving
certain results and outcomes. Performance over the 1-year and 3-year periods is measured
against stretch performance targets. The performance metrics differ with each role.
Every year, the committee reviews the levels and appropriateness of these incentives
and weighting.
There are no long-term incentives for the senior executive team that are subject to
performance risk.
The senior leadership share scheme provides certain employees with limited-recourse loans
on an interest-free basis to support the employees’ participation in the scheme.
For accounting purposes, these shares are treated as treasury stock when purchased on
market, due to the features of the scheme.
Shares subject to this scheme have a restricted period of 3 years from the date of purchase
to appropriately incentivise participants over a longer period. The loan is repayable if the
employee is no longer employed by Ryman.
ANNUAL REPORT 2022
169
Statement of corporate governance (continued)
Employees’
remuneration
The table below details the number of Ryman group employees who have earned over
$100,000 during the year ended 31 March 2022. The remuneration includes salary,
short-term incentives and employer’s contribution to KiwiSaver and superannuation.
Remuneration $Number of employees
2,760,000–2,770,0001
620,000–630,0001
600,000–610,0003
560,000–570,0001
530,000–540,0001
510,000–520,0001
450,000–460,0001
390,000–400,0001
370,000–380,0001
350,000–360,0001
340,000–350,0004
320,000–330,0002
310,000–320,0003
300,000–310,0002
280,000–290,0002
270,000–280,0004
260,000–270,0002
250,000–260,0002
240,000–250,0005
230,000–240,0004
220,000–230,00010
210,000–220,0005
200,000–210,00011
190,000–200,00010
180,000–190,00010
170,000–180,00013
160,000–170,00028
150,000–160,00036
140,000–150,00036
130,000–140,00045
120,000–130,00076
110,000–120,00076
100,000–110,000150
RYMAN HEALTHCARE
170
Statement of corporate governance (continued)
Group chief
executive
remuneration
Richard Umbers was appointed group chief executive effective 25 October 2021.
His remuneration for the period 25 October 2021 to 31 March 2022 is as follows:
20222021
$$
Salary498,462-
KiwiSaver14,954-
Subtotal513,416-
Short-term incentive--
Medium-term incentive --
Total remuneration
1
513,416-
Loan provided under the leadership share scheme
2
--
1 There were no other benefits (including long-term incentives) received in this financial year.
2 Richard Umbers is yet to participate in the leadership share scheme.
Gordon MacLeod was group chief executive until 22 October 2021.
His remuneration was as follows:
20222021
$$
Salary1,668,2161,080,284
KiwiSaver80,45432,408
Subtotal1 ,74 8 ,6 701,112,692
Short-term incentive1,013,583-
Medium-term incentive --
Total remuneration2,762,2531,112,692
Loan provided under the leadership share scheme-1,200,000
The at-risk short-term and medium-term incentives are payable on the achievement of certain
key performance indicators (KPIs). These KPIs are focused on the financial performance of
Ryman, specific operational targets and people-related expectations.
ANNUAL REPORT 2022
171
Statement of corporate governance (continued)
PRINCIPLE 7 – AUDITORS
“The board should ensure the quality and independence of the external audit process.”
PRINCIPLE 6 – RISK MANAGEMENT
“Directors should have a sound understanding of the material risks faced by the issuer and how to
manage them. The board should regularly verify that the issuer has appropriate processes that identify
and manage potential and material risks.”
Management
of risk and
internal
controls
External
auditor
The board is responsible for overseeing the company’s system of internal controls to manage
key risks and have overall responsibility for managing risk.
The company maintains a group risk register to identify and manage risk. Specific people and
safety, and clinical risk registers are separately maintained given the significance of these areas
to the business. The senior executive team is responsible for maintaining the risk registers.
Ryman operates an extensive internal accreditation programme that addresses issues such as
service delivery, health, safety and wellbeing, and administration. Internal audits are undertaken
regularly. The results of these audits and critical indicators are regularly reported to the board.
Through the AFRC, the board considers the recommendations and advice of external auditors
and ensures that those recommendations are investigated and, where considered necessary,
appropriate action is taken.
Through the board committees, health, safety and wellbeing is discussed regularly at board,
senior executive team, construction team and operational team meetings. Regular reporting
of key metrics is prepared to assist these teams in managing health, safety and wellbeing risks.
Ryman has a group tax charter that sets out the group tax strategy of Ryman and its subsidiaries.
The tax charter along with the tax risk management policy and other operational tax policies
form part of the group tax governance framework.
Ryman business activities include the construction and operation of retirement villages. These
activities are subject to the impact of climate change. The board has acknowledged that climate
change is a risk to Ryman activities and has accepted responsibility for managing and assessing
climate-related risks. In response to the recognition of climate change as a risk to the operations
of Ryman and in response to its legal obligations as an NZX issuer, Ryman has developed a
roadmap to support the implementation of climate risk-related processes across governance,
strategy, risk management, targets and metrics. The processes identified are consistent with the
climate-related disclosure (CRD) recommendations articulated by the XRB.
Through consultation with external and internal stakeholders, Ryman has identified key risks and
the impact of these risks. These risks and Ryman’s response are detailed in the materiality matrix
contained in this annual report.
The AFRC makes recommendations to the board on the appointment of the external auditor
as set out in its terms of reference. The committee also monitors the independence and
effectiveness of the external auditor and reviews and approves any non-audit services
performed by the external auditor.
RYMAN HEALTHCARE
172
Statement of corporate governance (continued)
PRINCIPLE 8 – SHAREHOLDER RIGHTS AND RELATIONS
“The board should respect the rights of shareholders and foster constructive relationships with
shareholders that encourage them to engage with the issuer.”
Information
for
shareholders
The company seeks to ensure that investors understand its activities by communicating
effectively with them and providing access to clear and balanced information.
The company website rymanhealthcare.co.nz provides an overview of the business and
information about Ryman. This information includes details of operational sites, latest news,
investor information, key corporate governance information and copies of significant NZX
announcements. The website also provides profiles of the directors and the senior executive team.
Previous annual reports, financial statements and results presentations are available on
the website.
Shareholders have the right to vote on major decisions of the company in line with the
requirements set out in the Companies Act 1993 and the Listing Rules.
Communicating
with
shareholders
Ryman has a dedicated investor relations manager and corporate affairs manager. These two
roles allow us to develop strong relationships and ensure our shareholders and bondholders
are kept informed.
Ryman’s investor centre sets out contact details for the investor relations manager and
corporate affairs manager for communications from shareholders.
We send the notice of the AGM to shareholders and publish it on the company website at least
20 working days before the meeting each year.
Voting by
shareholders
Voting on all resolutions at Ryman’s shareholder meetings is conducted by poll. This means
that Ryman shareholders enjoy one share, one vote (subject to any voting restrictions applying
under the Listing Rules).
The committee regularly meets with the external auditor to approve the terms of engagement,
audit partner rotation (at least every 5 years) and audit fee and to review and provide feedback
on the annual audit plan. Every year, a comprehensive review and formal assessment of the
independence and effectiveness of the external auditor is undertaken. The assessment uses
an external auditor evaluation tool, which is internationally recognised and endorsed by the
Independent Directors Council. The AFRC routinely meets with Ryman’s external auditor
Deloitte without management present.
Deloitte attends the company’s AGM.
The company continually monitors its internal control environment. Clinical auditors and
health, safety and wellbeing officers regularly test and assess controls and report their
findings to the Clinical Governance Committee and the People and Safety Committee.
ANNUAL REPORT 2022
173
General disclosures of interest
FOR THE YEAR ENDED 31 MARCH 2022
JO APPLEYARD
PartnerChapman Tripp
1
MemberUniversity of Canterbury Vice-Chancellor Employment Committee
Board memberCommunity Law Canterbury
TrusteeWai Wanaka
WARREN BELL
ChairHallenstein Glasson Holdings Limited group of companies
ChairSt George’s Hospital Inc.
DirectorMeadow Mushrooms group of companies
DirectorCyprus Enterprises Limited
DirectorSabina Limited
DirectorWarren Bell Limited
DirectorCHC Properties Limited
DirectorGlasson Trustee Limited
Director152 Hereford Limited
DirectorNew North Holdings Limited
DirectorWaiwetu Trustees Limited
DirectorHickman Family Trustees Limited
(part shareholder of Airport Business Park Christchurch Limited)
TrusteeEmerald Trust (part shareholder of Airport Business Park Christchurch Limited)
TrusteeWaiwetu Trust (part shareholder of Airport Business Park Christchurch Limited)
Bare trusteeRyman Healthcare Share Scheme ( jointly with Dr David Kerr)
2
Director/shareholderPoraka Limited
GREG CAMPBELL
DirectorChristchurch City Holdings Limited
3
Director
Terrequipe Limited
Director
Transdiesel Limited
Director/shareholder
Greg Campbell Limited
Director
Calder Stewart Family Holdings Limited and associated entities
Trustee
Maia Health Foundation
Director
Ravensdown Limited group of companies
4
Director
Development Christchurch Limited
4
GEOFFREY CUMMING
Chair/CEO/sole shareholderKarori Capital Limited
Chair/CEO/sole shareholderKarori Capital Canada Limited
Shareholder/lender/
joint manager
Various commercial property investment companies in the Caniwi Capital Partners
Limited group of entities
Advisory board member/
unit holder
Viewpoint Global Fund Trust
Advisory board member/
sponsor
Cumming Medical Research Fund, University of Calgary
DirectorAmira Medical Technologies Inc.
RYMAN HEALTHCARE
1 74
General disclosures of interest (continued)
FOR THE YEAR ENDED 31 MARCH 2022
CLAIRE HIGGINS
ChairREI Superannuation Fund Pty Ltd
ChairGMHBA Limited and subsidiaries
DirectorMargin Clear Pty Ltd
DirectorQE042 Pty Ltd
TrusteeHelen Macpherson Smith Trust
PAULA JEFFS
(None)
DR DAVID KERR
Bare trusteeRyman Healthcare Share Scheme ( jointly with Warren Bell)
2
DirectorForté Health Limited
TrusteeChristchurch City Mission
Director/shareholderD.W. Kerr Limited
ANTHONY LEIGHS
DirectorLeighs Construction Holdings Limited and associated entities
Director/shareholderAlisanca Holdings and associated entities
DirectorPortus Property Limited and associated entities
DirectorStar Scaffolding Limited
DirectorLabour Logistics Auckland Limited
DirectorChrist Church Cathedral Reinstatement Limited
4
GEORGE SAVVIDES
ChairSpecial Broadcasting Service (SBS) Australia
DirectorIAG Insurance Australia Group
Chair/shareholderTeamflow Asset Management Pty Ltd
Chair/shareholderTeamflow Pty Ltd
DirectorBuildXACT Software Limited
Chair/shareholder Lewis Street Nine Pty Ltd
ChairNext Science Limited
4
1 Jo has been a director since 2009, and since that time she has performed no professional services for the company in her
capacity as a partner at Chapman Tripp.
2 Greg Campbell has taken over the role of bare trustee of the Ryman Healthcare Leadership Share Scheme from Warren Bell.
3 Resigned post 31 March 2022.
4 Resigned during the year.
ANNUAL REPORT 2022
175
Directors’ disclosures
FOR THE YEAR ENDED 31 MARCH 2022
DIRECTORS’ REMUNERATION POOL
MEMBERSHIP OF COMMITTEES
Directors’ fees are reviewed every 2 years. Fees currently paid to Ryman directors for their
board and board committee responsibilities are paid out of a pool. The pool was set at the
amount approved by shareholders in 2021 ($1,500,000 based on a board of nine directors).
As permitted by Listing Rule 2.11.3, the pool can be increased by the board to enable any
additional non-executive director to be paid the average amount being paid to the other
non-executive directors (excluding the chair). This was not required in 2021. Australia-based
directors’ fees are paid in Australian dollars.
In 2021, the board adopted a fixed share trading plan so that each director must hold shares to
better align directors’ interests with those of the shareholders of Ryman. Under the plan, each
director will acquire shares in Ryman equivalent to 33.33 percent of their gross directors’ fees.
The shares are acquired by a broker on behalf of the directors through on-market purchases
during two fixed trading windows each year. The shares must be retained by the directors for
the term of their appointment, except in exceptional circumstances.
Shares acquired by directors under the plan are included in the disclosed security holdings
at 31 March 2022.
Director fees were aligned with the 2021 recommendations of Ernst & Young's Non-Executive
Director Fee Practices report commissioned by Ryman Healthcare and recommended to
the board by the Governance, Nominations and Remuneration Committee. Directors receive
fees for committee membership, and additional fees are paid to a director who acts as the
chair of a committee. During the year, George Savvides, Claire Higgins, Anthony Leighs,
Geoff Cumming and Paula Jeffs held committee chair positions. The board chair does not
receive fees for committee membership.
The approved fees are as follows.
Fees (per annum)From 1 August 2021Up to 1 August 2021
Board – chair263,000220,000
Board – deputy chair-18,000
Board – member110,000110,500
Committee – chair20,00018,000
Committee – member (excluding board chair)10,000-
Independent Directors’ Committee--
RYMAN HEALTHCARE
176
Directors’ disclosures (continued)
FOR THE YEAR ENDED 31 MARCH 2022
DIRECTORS’ REMUNERATION FOR THE YEAR ($)
DIRECTORS OF SUBSIDIARY COMPANIES
Greg Campbell, Dr David Kerr, Richard Umbers and David Bennett are directors of all
the company’s New Zealand subsidiaries. Claire Higgins, George Savvides, Paula Jeffs,
Richard Umbers, David Bennett and Cameron Holland are directors of Ryman Healthcare
(Australia) Pty Ltd and its subsidiaries. Martyn Osborn is a director of Ryman Healthcare
(Australia) Pty Ltd and Ryman Construction Pty Ltd. David Swann is a director of Ryman
Construction Pty Ltd. Greg Campbell, Dr David Kerr, Richard Umbers and David Bennett
are trustees of the Ryman Healthcare Charitable Trust. Warren Bell and Gordon MacLeod
resigned from their respective subsidiary directorships during the year. No fees are paid to
individuals in their capacity as directors of the subsidiaries.
SPECIFIC DISCLOSURES
In line with the company’s constitution and the Companies Act 1993, the company has
provided insurance for and indemnities to directors of the company and its subsidiaries.
Director
Board
fees
Audit,
Finance
and Risk
fees
Clinical
Governance
fees
Development,
Design and
Construction
fees
Governance,
Nominations,
and
Renumeration
fees
People
and
Safety
fees
Foreign
exchange
Total
directors’
fees
1
Greg Campbell
2
148,4184,167-4,167-4,167-160,919
Jo Appleyard110,167-6,6676,667-6,667-130,168
Warren Bell116,1676,667-6,667---129,501
Geoffrey Cumming110,1676,667--13,3336,6678,457145,291
Claire Higgins110,16719,333-6,667-6,6678,933151,767
Paula Jeffs110,167---6,66719,3338,980145,147
Dr David Kerr
3
211,0832,5002,500-2,5002,500-221,083
Anthony Leighs110,167--19,333---129,500
George Savvides110,1676,66719,333-6,667-8,934151,768
1,136,67046,00128,50043,5012 9,1 6 746,00135,304
1,365,144
1 Fee structure changed effective 1 August 2021, as noted above.
2 Greg Campbell was appointed chair of the board effective 1 January 2022.
3 Dr David Kerr resigned as chair of the board effective 1 January 2022.
The directors’ remuneration paid in the financial year ended 31 March 2022 is within the approved pool.
ANNUAL REPORT 2022
177
Directors’ disclosures (continued)
FOR THE YEAR ENDED 31 MARCH 2022
SECURITY HOLDINGS AT 31 MARCH 2022
Director
Ordinary
shares
RYM010
retail bonds
Jo Appleyard
1
86,885 -
Warren Bell 2,090 -
Greg Campbell
2
79,335 -
Geoffrey Cumming
3
49,040,716 -
Claire Higgins
4
19,011 -
Paula Jeffs 4,668 -
Dr David Kerr
5
388,193 -
Anthony Leighs
6
20,590 -
George Savvides
7
54,746 -
The table above includes shares acquired under the fixed share trading plan.
1 Held as trustees of The Appleyard and Larkin Family Trust.
2 Shares held by Gregory Shane Campbell and Nicole Anne Campbell.
3 Shares held by Karori Capital Limited.
4 Held as trustees of Adam Higgins Superannuation Fund Pty Ltd.
5 An ongoing disclosure notice was lodged on 25 May 2021 showing the transfer of legal holding of 358,000 shares from
DW & DJ Kerr and The DW Kerr Family Trust No. 2 to David William Kerr and Deborah Jane Floyd Kerr.
6 Shares held by Alisanca Holdings Limited.
7 Shares held by Teamflow Asset Management Pty Ltd.
RYMAN HEALTHCARE
178
SECURITY TRANSACTIONS DURING THE YEAR
DirectorNature of interest
Number of securities
acquired/(disposed of )Consideration ($)Date
Dr David KerrBeneficial (358,000) - 25 May 2021
Dr David KerrBeneficial 358,000 - 25 May 2021
Dr David KerrBeneficial 7,000 97,896 25 May 2021
Anthony LeighsBeneficial 10,000 131,600 26 May 2021
Greg CampbellBeneficial 22,600 297,308 26 May 2021
Claire HigginsBeneficial 2,870 3 7, 2 2 5 26 May 2021
Dr David KerrBeneficial 7,000 92,200 27 May 2021
Geoffrey CummingBeneficial 75,434 991,814 27 May 2021
Geoffrey CummingBeneficial 44,566 584,211 27 May 2021
Geoffrey CummingBeneficial 120,000 1,544,748 27 May 2021
Paula JeffsBeneficial 4,000 52,098 1 June 2021
Geoffrey CummingBeneficial 120,000 1,538,400 2 June 2021
Jo AppleyardBeneficial 7,550 99,487 13 July 2021
Dr David KerrBeneficial 15,000 194,275 23 November 2021
Dr David KerrBeneficial 1,193 14,536 6 December 2021
Greg CampbellBeneficial 635 7,73 7 6 December 2021
Geoffrey CummingBeneficial 716 8,724 6 December 2021
Paula JeffsBeneficial 668 8,139 6 December 2021
Warren Bell Beneficial 590 7,189 6 December 2021
Jo AppleyardBeneficial 635 7,73 7 6 December 2021
George SavvidesBeneficial 716 8,724 6 December 2021
Anthony LeighsBeneficial 590 7,189 6 December 2021
Claire HigginsBeneficial 716 8,724 6 December 2021
Greg CampbellBeneficial 8,100 98,650 10 December 2021
Dr David Kerr and Warren Bell, as joint custodians of the Ryman Healthcare Leadership Share Purchase Scheme,
acquired 1,065,259 shares during the year, disposed of 979,030 shares during the year and held 2,741,246 shares
in total at 31 March 2022 (see note 26 of the financial statements).
Directors’ disclosures (continued)
FOR THE YEAR ENDED 31 MARCH 2022
ANNUAL REPORT 2022
179
Shareholder information
TOP 20 SHAREHOLDERS AT 13 MAY 2022
Rank Investor nameNo. of shares% issued capital
1HSBC Nominees (New Zealand) Limited
1
63,549,761 12.71
2Karori Capital Limited 49,040,716 9.81
3BNP Paribas Nominees NZ Limited
1
44,634,772 8.93
4Hickman Family Trustees Limited
2
33,000,000 6.60
5Custodial Services Limited 30,370,270 6.07
6Citibank Nominees (NZ) Limited
1
27,862,632 5.57
7HSBC Nominees (New Zealand) Limited
1
27,086,065 5.42
8BNP Paribas Nominees NZ Limited
1
19,777,777 3.96
9JPMorgan Chase Bank
1
14,177,447 2.84
10Accident Compensation Corporation
1
11,654,909 2.33
11BNP Paribas Nominees NZ Limited Bpss40
1
10,991,024 2.20
12New Zealand Superannuation Fund Nominees Limited
1
10,446,491 2.09
13Tea Custodians Limited
1
10,327,099 2.07
14New Zealand Depository Nominee 7,001,784 1.40
15Forsyth Barr Custodians Limited 6,824,263 1.36
16National Nominees New Zealand Limited
1
6,385,291 1.28
17Premier Nominees Limited
1
5,654,748 1.13
18FNZ Custodians Limited 4,776,019 0.96
19Private Nominees Limited
1
4,240,992 0.85
20Public Trust
1
3,372,635 0.67
1 Held by New Zealand Central Securities Depository Limited as custodian.
2 Held as trustee of the Hickman Family Trust.
DISTRIBUTION OF SHAREHOLDERS AT 13 MAY 2022
Size of shareholdingNumber of shareholdersShares held
1–1,000 6,988 43.07% 3,453,241 0.69%
1,001–5,000 6,241 38.47% 16,014,192 3.20%
5,001–10,000 1,601 9.87% 12,008,107 2 .41%
10,001–50,000 1,184 7.30% 24,558,961 4.91%
50,001–100,000 116 0.71% 7,866,566 1.57%
Greater than 100,000 94 0.58% 436,098,933 87. 2 2 %
Total 16,224 100.00% 500,000,000 100.00%
RYMAN HEALTHCARE
180
Shareholder information (continued)
DISTRIBUTION OF BONDHOLDERS AT 13 MAY 2022
RYM010
Size of shareholdingNumber of bondholdersBonds held
1–1,000 - 0.00% - 0.00%
1,001–5,000 35 6.33% 175,000 0.12%
5,001–10,000 118 21.34% 1,138,000 0.76%
10,001–50,000 334 60.40% 9,092,000 6.06%
50,001–100,000 28 5.06% 2,261,000 1.51%
Greater than 100,000 38 6.87% 137,334,000 91.55%
Total 553 100.00% 150,000,000 100.00%
SUBSTANTIAL PRODUCT HOLDERS AT 31 MARCH 2022
ShareholderRelevant interest
Karori Capital Limited49,040,716 9.81%
Hickman Family Trustees Limited,
1
Kevin James Hickman and Joanna Hickman,
2
Warren Bell,
3
John Lindsay Holland
3
33,000,000 6.60%
ACATIS Investment KVG mbH on behalf of GANÉ Value Event Fonds
4
25,250,0005.05%
A total of 500,000,000 ordinary Ryman shares were on issue as at 31 March 2022 (the only voting products on issue).
1 Held as trustee of The Hickman Family Trust.
2 Joint holders of 100 percent of the shares in and directors of Hickman Family Trustees Limited and beneficiaries of
The Hickman Family Trust.
3 As independent directors of Hickman Family Trustees Limited and associated voting provisions attached to the shares
(alongside the other directors of Hickman Family Trustees Limited).
4 A substantial product holder notice was lodged on 1 October 2021 from the ACATIS Investment KVG mbH on behalf
of GANÉ Value Event Fonds.
ANNUAL REPORT 2022
181
RYMAN HEALTHCARE
182
We would like to thank
you, our team of
Rymanians. We are
immensely proud and
grateful for your incredible
efforts over the past
year. Your commitment
demonstrates what it
means to be a Rymanian,
and we send our sincere
thanks to each and
every one of you.
183
ANNUAL REPORT 2022
Aaminah Ahmed · Aanchal Bajaj · Aaron Allen · Aaron Brown · Aaron Bui · Aaron Edwards · Aaron
Enriquez · Aaron Essenberg · Aaron Eyles · Aaron Silk · Aaron Wairepo · Aarti Rawat · Aasim Zaveeri
· Abbe King · Abbey Mason · Abbey Bray · Abbey Santos · Abbey Williams · Abby Fernandez · Abby
Power · Abby Skipper · Abhi Abhishek · Abhishek Vashisht · Abigail Gacutan · Abigail Webb · Aby
Jomy · Ace Somosot · Achaal Prakash · Adam Allan · Adam Bird · Adam Harbour · Adam Joyce ·
Adam van Raalte · Adeesha Haljothi · Adele Lings · Adeline Plamenco · Adelle Scott · Adetoun
Oyekunle · Adheesha Perera · Adi Baleisomosomo · Adi Ratusai · Adi Secake · Adi Vakalalabure ·
Adrian Crowe · Adrian Lao · Adrianna Pavlekovic · Adrienne Marsh · Adrienne Sincock · Adrienne
Stewart · Adrienne Todd · Adrienne Wadham · Aez Pega · Afroz Sreekandh · Afsoun Nazari · Ag
Bloxham-Toi · Aga Gonzales · Aggie Butler · Agnes Cuanan · Agnes Lakner · Agnes Wallace ·
Aguinaya Ananayo · Agustine Affandi · Ahmed Naji · Aida Cachuela · Aik Eng · Aila Tan · Ailen Gaw
· Ailen Luste · Ailyn Estopace · Ailyn Muyano · Ailyn Reyes-Esmilio · Aima Polestico · Aimee Bell ·
Aimee Court · Aimee Gregory · Aimee Stratta · Aimee Verran · Aimee Wright · Ainslee Buchanan ·
Airun Kumar · Aiv Bagsican · Ajai Roy · Ajay Gautam · Ajay Philip · Ajdin Fejzic · Ajo Jose · Ajuna
Cherian · Akanisi Matanisiga · Akhil Viswambharan · Aki Yumoto · Akku Thomas · Aklima Akter ·
Akshat Tripathi · Al Lim · Alaenna John · Alan Jackson · Alan Wood · Alana Sanderson · Alana
Wallace · Alana Watson · Alanah Faga · Alastair Joyce · Albie Calope · Aldo Atmadja · Alefina
Baleisuva · Aleja Mendez Arango · Alena McCulloch · Alena McKenzie · Alesgo Ngu · Alesha Clark-
Gilmour · Alex Cagalitan · Alex Carter · Alex Cook · Alex Jackson · Alex Jurczenko · Alex Li · Alex
Lopez · Alex Mathew · Alex McNeillie · Alex Price · Alex Purcell · Alexa Alcantara Claudio · Alexa
Todd · Alexandra Perdrisat · Algine Ingking · Alias Kurian · Alice Gordon · Alice Johnstone · Alice
Jones · Alice McDuff · Alice Morrison · Alice Peram · Alice Vargas · Alicia Lane · Alicia Prima · Alie
Brinded · Alina Pariyar · Alisha Alex · Alisha Aliperio · Alisha Figgess · Alison Love · Alison Naylor ·
Alison Winstanley · Alison Wyllie · Alix Fabi · Aliya Bibi · Alka Thakur · Allan Brown · Allan Dempsey
· Allan Macala · Allana Caldwell · Alleah Munoz · Alleisha Briones · Allen Lee · Allen Zhang · Allison
Doak · Ally Harris · Alma Azarcon · Alma Cagalitan · Alma Ramirez · Alma Sicat · Almira Beniasan ·
Almira Bentadan · Alona Wandas · Alona Mateo · Alpha Atienza · Alpho George · Alphonsa George
· Alphy Thankachan · Alphy Thomas · Althea Santos · Alvin Campbell · Aly Procter · Alyana Delima
· Alysha Russell · Alyssa Budy · Alyssa Baxter · Alyssa Marion · Alyssa Saljay · Amal Sunil · Amali
Amarasinghe · Aman Balassi · Aman Kaur · Aman Kaur · Aman Kaur · Aman Kaur · Aman Kaur ·
Amanda Anastasopoulos · Amanda Brocklebank · Amanda Feltoe · Amanda Gilbert · Amanda
Goudie · Amanda He · Amanda Knight · Amanda Kruse · Amanda Murray · Amanda Whithair ·
Amanda Wootton · Amandeep Aulakh · Amandeep Kaur · Amandeep Kaur · Amandeep Sidhu ·
Amanjot Kaur · Amanpreet Kaur · Amanpreet Kaur · Amanpreet Kaur · Amanpreet Mahal · Amar
Kaur · Amaya Samarasinghe · Amber Aguilar · Amber Bottomley · Amber Lewis · Amber McKenzie-
Takau · Amber Qualischefski · Ambily Abraham · Ameek Singh · Amelia Ong · Amendra
Samantilake · Amika Thapa · Amina Dzakic · Amit Khanchi · Amit Patel · Amit Sapkota · Amita
Joseph · Amita Prasad · Amita Vyas · Amith Sabu · Ammy Kaur · Amol Adhokar · Amrit Kaur · Amrit
Kaur · Amrita Raj · Amrita Rattan · Amrutha Mathew · Amy Amtman · Amy Burgess · Amy Carpenter
· Amy Duncan · Amy Flood · Amy Hii · Amy Irwin · Amy Mian · Amy Morrison · Amy Muru · Amy Shen
· Amy Singleton · Amy Thornton · Amy Ward · Amy Wheeler · Amy Woon · Amy Yin · An Nguyen ·
Ana Catahan · Ana Fangupo · Ana Gluyas · Ana Hintay · Ana Leite · Ana Moala · Ana Padrelanan ·
Ana Savou · Ana Vukovic · Anabel Konigstorfer · Anabel Lindstrom · Anajepia Meimban · Analyn
Irorita · Anan Du · Anchitha George · Andre Battrick · Andre Calustre · Andre Kassal · Andrea
Adams · Andrea Ansell · Andrea Burgos · Andrea Butler · Andrea Caitum · Andrea De Wet · Andrea
Deo · Andrea Gaskell · Andrea Hills · Andrea Latoa · Andrea Manuel · Andrea Neil · Andrea
Ngamokopuna · Andrea Pangan · Andrea Smith · Andrea Tremain · Andrei Pirlea · Andresa Mendes
Teles · Andrew Browne · Andrew Caracoglia · Andrew Crerar · Andrew Gibson · Andrew Goldfinch
· Andrew Hilbert · Andrew Hill · Andrew Inch · Andrew Jones · Andrew McKenzie · Andrew Moulding
· Andrew Otto · Andrew Parker · Andrew Quezon · Andrew Roberts · Andrew Robins · Andrew
Searancke · Andryna Eberle · Andy Battersby · Andy Callaghan · Andy Clarke · Andy Heap · Andy
Martin · Andy Maylock · Andy Osborne · Andy Reid · Ane Pulou · Aneely Bhatt · Aneesh Kattikatt
George · Aneesha Aniyan · Ang Chamberlain · Ange Knibb · Angel Augustine · Angel Jose · Angel
Mendoza · Angel Montanez · Angela Aballog · Angela Barraclough · Angela David · Angela Ferguson
· Angela Fidler · Angela Hawkes · Angela Henry · Angela Johnson · Angela Kueh-Henry · Angela
MacKay · Angela McKenzie · Angela McLeod · Angela McMeekin · Angela O’Connor · Angela
Ravlich · Angela Simpson · Angela Singh · Angeli Suson · Angelica Araiza · Angelica Ona · Angelina
Adams · Angelique Roberts · Angelo Trabado · Anggia Puspa Kirana · Angie Angeles · Angie Cope
· Angus Newell · Ani Tuilau · Anika Smith · Anika Snell · Anish Anto · Anisha Chaudhary · Anisha
Thapa · Anit Dominic · Anita Bhusal Banjade · Anita Binns · Anita Chapman · Anita Dayal · Anita
Devi · Anita Devi · Anita Farmer · Anita Lowther · Anita Pau · Anita Setiaji · Anitha Paul · Aniva Hunkin
· Anja Thorne · Anjali Manoj · Anjali Mitra · Anjana Lama · Anjana Poojary · Anjani Chaudhary ·
Anjani Suresh · Anjelyn Pocession · Anjiline Singh · Anju Abraham · Anju Ashok · Anju Malakunnel
Isac · Anju Sajan · Anju Sebastian · Anjumol Saju · Ankita Joshi · Ann Beom · Ann Brady · Ann
Codina · Ann Fernando · Ann Furlong · Ann Joy · Ann Martin · Ann Mongcal · Ann Moorman · Ann
Nelson · Ann Olbinado · Ann Vo · Ann Wongchan · Anna Ao · Anna Benadie · Anna Binas-Lucinario
· Anna Brayshaw · Anna Casaje · Anna Coppens · Anna Crossan · Anna Curzon-Hobson · Anna
DeLorenzo · Anna Flanagan · Anna Groome · Anna Hendry · Anna Holland · Anna Jim · Anna
Johnson · Anna Lai · Anna Lumanglas · Anna Maharjan · Anna McCorkindale · Anna McLeod · Anna
Ouyang · Anna Pochron · Anna Scott · Anna Sianipar · Anna Smith · Anna Sriwulan · Anna Thomson
· Annabel Arcipe · Annabel Macdonald · Annabel Sharp · Annabelle Diamond · Annabelle Ewart ·
Annabelle March · Anna-lee Lyons · Annamay Toa · Anne Cameron · Anne Cantos · Anne Cooke ·
Anne Flint · Anne Hall · Anne Kenna · Anne Nihotte · Anne Nordstrom · Anne O’Donnell · Anne
Streatfeild · Anne Verano · Anneke Kuiti · Anne-Marie Hartley · Annette Adams · Annette Holdaway
· Annette Jeffares · Annette Lawrence · Annette Molloy · Annette Rains · Annie Dao · Annie
Armstrong · Annie Bright · Annie Eunson · Annie Glossop · Annie Tamang · Annie Walker · Annika
Lindquist · Ann-Marie Innes · Annu Gaur · Anoma Gunaratne · Anoop John · Anran Li · Ansh Prasad
· Anshal Hussain · Anshu Singh · Anshul Jairath · Ansu Anna Varkey · Ansu Babu · Anthea Johnson
· Anthony Baragwanath · Anthony Eaglestone · Anthony Mammone · Anto Sundaram · Antoinette
Morgan · Antonette Asuncion · Antonio Lavin Delgado · Anu Gill · Anu Jacob · Anu Joy · Anu Kumar
· Anu Kuruvilla · Anu Mathews · Anu Paul · Anu Samuel · Anu Sebastian · Anu Xavier · Anuja Kunwar
· Anuja Shrestha · Anuradha Shrestha · Anusha Peddina · Anusha Tamang · Anusha Vikram · Ao
Fuifui · Api Arpanpreet · Api Tuinasau · Apoorva Boora · Apple Uy · April Deraja · April Lacson · April
Ladia · April Mahuika · April Nattrass · April Nino · April Pinza · April Roberts · Arahia Wilson · Arati
Tamrakar · Archa Rajan · Archana Varghese · Archanau Devi · Archie Rawat · Aren Tonganibeia ·
Argay Clarin-Alvis · Arge Colado · Argie Forteza · Aria Wood · Ariana Guerin · Ariana Tarapi-Harris
· Ariane De La Pena · Aribo Timaai · Ariel Kwan · Arieta Faalau · Arishma Arti · Arjun George · Arlen
Evangelista · Arlene Corkin · Arlene Simadari · Arlet Anastasia · Armie Estevez · Armie Magcale ·
Arnel Cabanayan · Aroha Blythe · Aroha Te Huia Ngatuere · Arpana Andrades · Arpana Khadka ·
Arraminda Ariate · Arris Maximo · Arsha Gurung · Arthur Keane · Arthur Labiris · Arti Devi · Arti
Karan · Arti Lata · Arti Patel · Arti Prakash · Artika Lata · Artika Naidu · Aruna Prakash · Aruna Ram
· Aruna Reddy · Arvin Singh · Arvin Treebhowan · Asa Porter · Asfeen Khan · Ash Devi · Ash Kant ·
Ash Waszak · Ash Wensor · Asha Babu · Asha John · Asha Kiran · Asha Mariyarasa · Asha Thomas
· Asharif Rahman · Ashika Chand · Ashika Mandri · Ashika Singh · Ashim Singh · Ashish Mankotia ·
Ashka Patel · Ashleigh Griffiths · Ashleigh Kavanagh · Ashley Campbell · Ashley Dacyon · Ashley
Gray · Ashley Gutsell · Ashley Son · Ashley Willis · Ashmita Adhikari · Ashmita Gurung · Ashmita
Lata · Ashmita Roy · Ashnee Prakash · Ashupreet Kaur · Ashvin Mendonca · Ashween Singh ·
Ashwick Sharma · Ashwina Ashwina · Ashwina Seenevassenpillay · Ashwindar Kaur · Ashwini
Krishna · Ashwini Naicker · Asma Akram · Asmita Bhandari · Asmita Hirachan · Asmita Nepali ·
Asmita Rai · Asset Galeno · Astio Tunggonno · Astoria Litt · Aswathy Krishna · Aswathy
Padmanabhan · Aswathy Sreedas · Aswathy Thulaseedharansheela · Aswin Ajithkumar · Ata
Rerekura · Ateliana Ah Kuoi · Athena Tangonan · Athira Thilak · Athulya Jestin · Athulya Rakesh ·
Athulya Thankappan · Atin Suprihatin · Atish Suresh · Aurora Orogo · Ava Hu · Avhie Kagaoan · Avi
Singh · Avrill Burchell · Avrisha Singh · Awanui Tangiia · Awhina White · Axis Donato · Axl Funtila ·
Ayako Oyama · Ayesha Bashir · Ayesha Saeed · Aysha Ideris · Ayteya Lopez · Ayu Hardy · Ayumi
Maruyama · Ayumi Sato · Ayush Prasad · Ayusha Dheke · Azel Ramos · Azumi Kemmotsu-Watt · Ba
Sigola · Babal Kaur · Babita Baluri · Babita Kashyap · Bailee Jackson · Bailee Payne · Bailey
Anderson · Bailey Coombs · Bailey Trotter · Baisil Isaac · Balbir Ghuman · Baljeet Kaur · Baljinder
Kaur · Baljit Kaur · Balpreet Kaur · Bamber Postance · Bano Tasheem · Banu Banu · Barbara Barker
· Barbara Federico · Barbara Large · Barbara Russell · Barbara Turnbull · Barbie Bickerton · Barkha
Prakash · Barsha Timalsina · Bawan Kaur · Bayden Mellington · Bea Patang · Beata Buchajczyk ·
Beauty Chua · Bebien Montecillo · Beck Little · Beck Wilkins · Becky Gillanders · Becky McClelland
· Becky Moore · Becky Olliff · Bedi Thapa · Bee Weiss · Beena David · Beena Tamang · Belinda Bargh
· Belinda Greenwood · Belinda Hunt · Belinda Madriaga · Belinda Petitto · Bella Gray · Bella Jabat ·
Bella Lovison · Ben Bowles · Ben Chesler · Ben Dass Shrestha · Ben Garner · Ben Gonsalves · Ben
Jordan · Ben May · Ben Munro · Ben Musonye · Ben Sommerville · Ben Walshe · Ben Winters · Benita
Edwards · Benita Jessop · Benita Jonathan · Benita Kirkovits · Benita Prasad · Benjamin Cavanagh
· Benjilen Pablo · Benjula Timsina · Benni Hulme · Benson Mejorada · Bensy Philiph · Benzon De
Castro · Bernadette Forsdyke · Bernadette Lerios · Bernadine Faber · Bernard Cagalawan ·
Bernard Philpott · Bernie Pask · Bert Barola · Beryl Ryan · Beth Aseniero · Beth Capistrano · Beth
Fernandez · Beth Haryett · Beth Minsalan · Beth Po · Beth Reaney · Beth Smillie · Bethany Douglas ·
Bethany Edie · Betty Groves · Betty Lamb · Bev Dela Cruz · Bev Fockenga · Bev Newdick · Bev
Tembo · Bev Todd · Bev Toms · Bev Walker · Bevan Harris · Bex Croft · Bex Dean · Bex Nawalowalo
· Bex Neera · Beza Esclamado · Bharti Bedi · Bhavneet Kaur · Bheng Barrientos · Bhumi Jain · Bianca
de Agrella · Bianca Szabo · Bianca Van Doren · Bibin Christopher · Bibin Philip · Bibin Vijayan ·
Biddhya Gurung · Bidhya Magar · Bijo Mathew · Bikash Pathak · Bill Jin · Bill McCurdy · Billy Vickers
· Bimala Galaju · Bimbika Sirimane · Bina Patel · Bina Prajapati · Bina Pun · Binay Shrestha · Bindu
Paul · Bini Gurung · Binky Marsh · Binter Joseph · Binu Tiwari · Biyanka Maisuria · Blair Cullen · Blaire
Jang · Blake Amtman · Blanch Laroga · Blanche McLean · Blessie Lintag · Blessy Mathew · Blythe
Ward · Bobby Abhilash · Bobby Beck · Bobby Trolove · Bobin Pullikkattil Jose · Boris Barnett ·
Boritta Vorng · Braam Ellis · Brad Adlam · Brad Thomas · Brandi Ireton · Brando Bartolome ·
Brandon Paul · Breanna West · Brechell Dela Vega · Bree Gerritsen · Bree Farrow · Bree Herrick ·
Bree Jones · Bree Rayment · Brenda Dudson · Brenda Ferguson · Brenda Hobbs · Brenda
Schroeder · Brendon Marsh · Brent Lee · Brent Maru · Brent Morfett · Brent Sweeney · Brett
Johnson · Bri Insley · Brian Bark · Brian Irvine · Brian Robinson · Brian Tidey · Brian Ward · Brianna
McDonald · Brice Imanishimwe · Bridget Bocock · Bridget Free · Bridget Lyons · Bridgette des
Landes · Bridie Green · Brie Brian-Lumsden · Brieanna Hobbs · Briee Robinson · Brit Gilmore · Brita
Corbett · Brittany Francis · Brittany Jeffcott-Moore · Brittany Lovejoy · Brittany Wilson · Brodie
Hewitt · Brodie McPhail · Bronnie Carston · Bronte Lamond-Aird · Bronwyn Hancock · Bronwyn
Thomas · Brook Spedding · Brooke Arnold · Brooke Hughes · Brooke Muirsmeath · Brooke Roberts
· Brooke Tainui · Brooke Tyler · Brooke Upjohn · Bruce Andrews · Bruce Court-Patience · Bruce
Dawkins · Bruce Hodge · Bruce Nolan · Bruna Manduci · Bryan Bolong · Bryan Giray · Bryan
Manlangit · Bryant Fernandez · Bryce Rae · Brydie Baxter · Brydie Curtis · Buddhima Arachchige ·
Caelum Ewens · Caitlin Couling · Caitlin Jones · Caitlin Schultz · Caitlin Degering · Caitlin Foster ·
Caitlin McDonnell · Caitlin Taylor · Caitlin Thomas · Caleb Lepper · Caley McNeely · Callum
Chatfield · Callum Morrish · Cam Holland · Cam Palmer · Cam Sidhu Sidhu · Cameron Robertson ·
Cameron Scott · Camila Glaser · Camila Tawse-Smith · Camila West · Camilla Ryzner · Camille
Antonio · Camille Cajoles · Camille Santos · Candice Camingawan · Cara Bennett · Cara Floreza ·
Cardona Castro · Carina Paynter · Carina Toscano · Carl Arnst · Carl Dela Cruz · Carl McCullough ·
Carla Davies · Carla Dela Cruz · Carla Jones · Carla Lofredo · Carla Mantella · Carlo Damiani ·
Carmel Magbojos · Carmel Marino · Caro Swanston · Carol Duke · Carol Kay · Carol Luttrell · Carol
Mathias · Carol Nguyen · Carol Restrepo Ledesma · Carol Simpson · Carol Toohill · Carola Acevedo
· Carole Quickfall · Carolina Russi Serrato · Caroline Hart · Caroline Jones · Caroline Kean · Caroline
Manning · Caroline Martin Salas · Caroline Potgieter · Caroline Reyland · Caroline Senior · Caroline
Shanks · Caroline Skegg · Carolyn Delugar · Carolyn Faloon · Carolyn Greenaway · Carolyn Grogan-
Tinney · Carolyn Khan · Carolyn Lennox · Carolyn MacDonell · Carolynn Aicken · Carolynn Phillips ·
Carrie Duncan · Carroll King · Casey Cowley · Cassandra Osborne · Cassandra Wallis · Cassarndra
McNeil · Cassidy McMillan · Cassidy Woods · Cassie Chen · Cassie Scaife · Cassie Stephens ·
Cassie Ward · Cassim Nawaz · Cat Maessen · Cate Unsworth · Cath Concon · Cath Magbaton · Cath
Seguan · Catherine Bosch · Catherine Bunting · Catherine Cordwell · Catherine Haren · Catherine
Jalbuena · Catherine McKellar · Catherine Ramos · Cathrina Ababat · Cathy Byrne · Cathy
McDermott · Cathy Yang · Cathy Young · Cathy Zhou · Cece Moore · Cecelia Alford · Cecilia
Hansson · Cecilia Herrera · Cecilia Kerekes · Cecille Winspear · Cel Amante · Cel Padayogdog ·
Celeste Boonzaaier · Celeste Payne · Celeste Wallbank · Celia Anderson · Celia Doleman · Celly
Wilson · Celthea Yu · Cha Cabalagnan · Cha Diaz · Cha Juco · Chakri Siluveru · Cham Saragena ·
Chamara Hettiarachchige · Chan Manuel · Chandan Kaur · Chanel Porter-Reidy · Chanette
Teodosio · Chanpreet Kaur · Chantal Atngag · Chantal Guiguit · Chantal Kennedy · Chante Fourie ·
Chantel Pilcher · Chantelle Hand · Chantelle Hocking · Char Spencer · Charan Dhillon · Charie
Paytocan · Charise Meunier · Charisse Spence · Charith Ruwanpathirana · Charla Graham ·
Charlene Javier · Charlene Lardizabal · Charlene Tabigne · Charles Bushell · Charles Hall · Charles
Han · Charles Hannaford · Charles Serino · Charli Bootsma · Charlie Uy · Charlotte Body · Charlotte
Brown · Charlotte Bullock · Charlotte Hughes · Charlotte Key · Charlotte Senining · Charlotte
Turner · Charlyne Casil · Charm Laguardia · Charm Pontillano · Charmae Golosino · Charmagne
Castillo · Charmaine Infante · Charmaine Jeciel · Charmaine Lim-Capendit · Charmaine Smith ·
Charmaine Staines · Charmaine Tan · Charmaine Urbano · Charmaine Volschenk · Charmayne
Clarke · Charu Solanki · Chayle Argallon · Chazz Legaspi · Chee Chang Ho · Cheer Lin · Chelcei
Ninal · Chell Biato · Chelsea Gray · Chelsea Hill · Chelsea Richdale · Chelsea Sleep · Chelsea Woolf
· Chelsea Ziolo · Cherie Belcher · Cherie Brosnan · Cherie Reamico · Cherise Finnie · Cherry
Casama · Cherry Gallego · Cherry Lagare · Cherry Quiros · Cherry Ramel · Cherry Taleno · Cherryl
Bauzon · Cheryl Allan · Cheryl Buchanan · Cheryl Laguit · Cherylynn Stevenson · Chessie Yap ·
Cheyenne Gamblin · Cheyne Chalmers · Chhiring Lama · Chi Zhao · Chiara Mercer · Chikaina
Makatea · Chike Seguban · Chin Tutty · Chinchu Boban · Chinchu Charly · Chiquita Fleming · Chira
Ngamlerd · Chit Escalon · Chitra Devi · Chitt Fajardo · Chizuko Fabrin · Chloe Fitzgibbon · Chloe Gao
· Chloe Miller · Chloe Perez · Chloe Ruffles · Chloe Winn · Chris Ackerman · Chris Allen · Chris
Anderson · Chris Ashton · Chris Baet · Chris Beckett · Chris Busbridge · Chris Camm · Chris
Caselton · Chris Church · Chris Corriea · Chris Dombroski · Chris Downes · Chris Evans · Chris Hall
184
RYMAN HEALTHCARE
· Chris Harwood · Chris Henry · Chris James · Chris Jobe · Chris Keilty · Chris Kirk · Chris Lim · Chris
MacDonell · Chris Mathai · Chris Morell · Chris Owans · Chris Parker · Chris Saxon · Chris Sinclair ·
Chris Storer · Chris Strapp · Chris Sutton · Chris Timoti · Chris Tottenham · Chris Tunbridge · Chris
Tweedie · Chris Wright · Chrissy Atkins · Chrissy Macpherson · Chrissy Mathews · Chrissy Nkya ·
Chrissy Stanton · Chrissy Thompson · Chrissy Toa · Christelle Sazon · Christensen Barcelona ·
Christian Kiley · Christianna Yu · Christina Navarro · Christina Niutao · Christina Potgieter ·
Christina Reed · Christine Buck · Christine Clarke · Christine De Leon · Christine Dhariwal ·
Christine Elizalde · Christine Han · Christine Hawley · Christine Javier · Christine Kwiatkowski ·
Christine Labiton · Christine Langford · Christine Langley · Christine Laurente · Christine McCurdy
· Christine Miller · Christine Pauling · Christine Wang · Christo Paulraj · Christoph Fernandes ·
Christopher Singer · Christy Solina · Chu Kohlman · Chu Templa · Chua Chua · Chummy Madarieta
· Chunmei Li · Chyna Javier · Cici Miao · Cijo Augustine · Cilla T Stevenson · Cindy Cao · Cindy
Evangelista · Cindy Hou · Cindy Velasquez · Cindy Zhang · Citra Praditi · Claire Bate · Claire Burrell
· Claire Daunivavana · Claire Flanagan · Claire Harris · Claire She · Claire Vaughan · Claire Whitfield
· Clara Harrison · Clara Tan · Clarace Codyre · Clare Bower · Clare Burgess · Clare Glasspool · Clare
McKone · Clarissa Alojado · Clark Magtibay · Claudette Ndenzako · Claudia May · Claudia Reed ·
Claudia Rogers · Claudia Rueda De La Serna · Claudita Tayag · Clayton Jones · Cliff Lasmarias ·
Clint Deane · Clint Virgona · Clinton Palmer · Clod Uy · Coco Prak · Colin Alderson · Colin Caldwell ·
Colin Cameron · Colin Vose · Colleen Johnson · Colleen McCann · Colleen Watson · Collette
Backhouse · Collette Gordon · Comaneci Ong · Con Ciobanu · Con Van Niekerk · Conie Tiongson ·
Connell Bergin · Connie Fernandez · Connie Tagle · Connie Waine · Conor Fyall · Cooper Burns ·
Cora Jambalos · Cora Van der Heul · Coralea Potgieter · Coralie Vine · Corien Blom · Cornelia Chin
· Correen Steyn · Corrie Jarme · Corrine Belencion · Corrine Gillan · Corrinne Cooper · Cory Bryan
· Courtney Opie · Courtney Heberley · Courtney Skene · Courtney Trautvetter · Craig Atkinson ·
Craig Gibbons · Craig Hardy · Cree Fulford · Cris Viernes · Criselda Agbayani · Crish Landiza ·
Crishelle Robertson · Cristal Lozada · Cristel Carter · Cristina Alejandro · Cristina Corre · Cristina
Oliquiano · Cristina Plevko · Cristine Penuela · Cristy Carreon · Crystal Payne · Crystal Pomale ·
Crystal Walker · Csilla Feherne Kincses · Cushla Manaia · Cuzzy Iwai · Cym Seguan · Cynthia Bunag
· Cynthia Mercado · Cynthia Soriano · Cyril Balloso · Cyrus Vallecera · Czarina Ederango · Czarina
Pangilinan · Czhanna Dayo · Dae Yude · Dahlia Bontilao · Dailyn Meo · Dainah Magonde · Daisy Duka
· Daisy Lane · Daisy Wang · Dale Basinal · Dale Bell · Dale Donoghue · Dale Sadler · Daman Kaur ·
Daman Kaur · Damani Lata · Damith Amarathunga · Dan Domalanta · Dan Liu · Dan Pega · Dan Reid
· Dan Russo · Dan Vajc · Dana Levy-Sadlier · Danelle Franklin · Dani Bartle · Dani Bonoan · Dani Yu ·
Danica Little · Daniel Bakht-Khosh · Daniel Baldwin · Daniel Franklin · Daniel Halengo · Daniel Hanelt
· Daniel Knell · Daniel Pavletich · Daniela Diederichs · Danielle Jeffery · Danielle Kalkhoven · Danielle
Moran · Danielle Newton · Danielle Numan · Danielle Park · Danielle Steer · Danielle Tweed · Danni
Bond · Danni Wood · Dannie Bajkai · Danny Connery · Danny Roddick · Dara Prak · Darian Norgate
· Darille Huhu · Dario Parolin · Darlene Ross · Darnell Bonita · Darren Hicarte · Darrin Findlay · Darrryl
Neshausen · Darryl Smith · Darsana Ram Bindu · Darshan Patel · Daryl Page · Dashan Kaur · Dave
Clearwater · Dave Cooper · Dave Cronin · Dave Ellis · Dave Monk · Dave Murrell · Dave Pogson ·
Dave Robertson · Dave Sevilleno · Dave So · Dave Syle · Dave Wu · David Bennett · David Boston ·
David Cartwright · David Datoy · David de Veth · David Emblin · David Gibson · David Hall · David
Herrera-Rodriguez · David Kenny · David King · David Laing · David Ma · David Macdonald · David
Mahony · David Mills · David Oldham · David Oliver · David Ravenscroft · David Sepulveda · David
Stevens · David Swann · Davinder Kaur · Davinder Kaur · Davinna McDonald · Davu Deol · Dawn
Hunt · Dawn White · Daylinda Durango · Dayna Mckay · Dean Jackson · Deanna Glasson · Deb
Argent · Deb Butler · Deb Klein · Deb Ray · Deb Richardson · Deb Smith · Debbie Mindoro · Debbie
Ansett · Debbie Bontuyan · Debbie Bridger · Debbie Buchanan · Debbie Chapman · Debbie Dai ·
Debbie Dixon · Debbie Gemmell · Debbie Gray · Debbie Hartley · Debbie Hicks · Debbie Horne ·
Debbie Kennedy · Debbie Kilgour · Debbie Komarkowski · Debbie Lin · Debbie Ogden · Debbie
Quennell · Debbie Shotter · Debbie Wells · Debbie Williams · Debbie Zhou · Deborah Budden ·
Deborah Forde · Debra Berryman · Debra Lamartinie · Debra Stone · Debs Gordon · Declan
Rhodes · Dedeh Karyati · Dee Aery · Dee Broad · Dee Dilhani · Dee Geetanjali · Dee Jones · Dee
Mantell-Harding · Dee Matakece · Dee Nadan · Dee Reddy · Deep Kaur · Deep Kaur · Deepa
Bhandari G C · Deepa Lohala · Deepa Magar · Deepa Sigas · Deepa Sudhakaran · Deepak Chauhan
· Deepani Hewa Batagodage · Deepankshi Deepankshi · Deepi Kaur · Deepika Deepika · Deepika
Deepika · Deepika Wijesekara · Deeviya Patel · Dehan Henning · Deidre Flemming · Deidre
MacGregor · Deirdre Finlayson · Dekodda Tippett · Delia Espenido · Delia Wilkinson · Dell Smythe ·
Denicee Alongo · Denis Goodwin · Denise Carppe · Denise Chandler · Denise Cunniffe · Denise
Greenbank · Denise Higgs · Denise Hutchison · Denise Martin · Denise Payne · Denise Scott ·
Denise Thompson · Denisse Valdrez · Dennis De Leon · Dennis Frazer · Deo Arenajo · Derek Bird ·
Derek Gibbs · Derek Greening · Derek Holland · Derek Rodgers · Des Fielder · Desiree Vermeeren ·
Desirie Diwa · Desley Lawrence · Destinee Duthie · Dev Little · Devanshi Soni · Devi Arifah · Devi
Nagalingam · Devika Reddy · Devon Liddell · Devon Maurice · Dhanju Rana · Dhanya Ciril · Dhanya
Francis · Dhanya Lukose · Dhorey Gabinete · Dhruv Patel · Dhruvi Shah · Di George · Di Lister · Di
Mannix · Di McKenzie · Di Page · Di Sinclair · Di Tahi · Diana Brown · Diana Ettema · Diana Hanafin ·
Diana Keith · Diana Nicolescu · Diana Plesovs · Diana Sian · Diane Anderson · Diane Brown · Diane
Mondero · Diane Smiler · Diane Smith · Diane Taylor · Diane Vergara-Galang · Diane Wood · Dianhui
Huang · Dianna Alexander · Dianne Amolong · Dianne Austin · Dianne Casimiro · Dianne Dona ·
Dianne Durham · Dianne Melhuish · Dianne Rosado · Dianne Thompson · Diedri Bates · Diem Tran ·
Diksha Darlami · Diksha Mainh · Dilani Arachchilage · Dilpreet Kaur · Dilpreet Kaur · Dilshani
Mudiyanselage · Dina Garcia · Dindo Caitum · Dinika Godakumbura · Dinithi Medagedara · Dinna
Ermitano · Dipal Patelia · Disha Gandhi · Disha Kaur · Dishna Karunarathna · Divya Sebastian · Divya
Velunny · Dolly Alekar · Dolor Raposas · Don MacKay · Don Mathew · Dona Abeywickrama · Donah
Cagalawan · Donald Ferguson · Donald Pool · Donna Barnes · Donna Bradford · Donna Campbell ·
Donna Dael · Donna Dungey · Donna Flaws · Donna Garcia · Donna Gonzales · Donna Lepardo ·
Donna Lewis · Donna Munoz · Donna Rose · Donna Summerfield · Donna Tercenio · Donnelle Dean
· Dora Martinez-Velandia · Doreen Dacanay · Doreen Kumar · Doreen Lata · Doreen Narayan · Doris
Genovese · Dorji Yangzom · Dorothy Harris · Dorothy Kudinha · Dorothy Tavinor · Dot Luna · Dottie
Abuyabor · Doug Holt · Douglas Zhang · Dovie Villalobos · Dragan Mitrevski · Duncan Phillips ·
Duncan Underhill · Dustin Dominic · Dustin Tran · Dvenn Loibl · Dwi Wangsawidjaja · Dyan Rosquita
· Dylan Geldard · Dylan Sharma · Dylan Turner · Dylann Sweeney · Earl Te · Eda Galias · Eddie Deo ·
Eddie Kemp · Eddie Parker · Eddie Tandy · Eden Chapman · Eden Marshall · Edgar Condino · Edgar
Mamaril · Edgardo Blaya · Edi Igot · Edward Marshall · Edwina Hutchings · Edy Sayson · Effie
Emmanouel · Egho Lozada · Eileen Kielty · Eileen Welford · Eileen Wu · Eina Campos · Ekta Kaur ·
Ekta Sharma · Elaine Galbraith · Elaine Luay · Elaine Marsh · Ele Bibby · Eleanor Gaffley · Eleanor
Lee · Eleanor Santos · Eleen Kee · Elena Delector · Elena Kubesh · Elena Turnley · Eleni Heaven ·
Eleni Meimaris · Eleonor Moral · Eliana Kerrigan · Eliane Machado · Elina Rajie · Elina Yang · Elise
Clark · Elisel Valoria · Eliseo Lapus · Elishwa Toma · Eliza Smith · Elizabeth Bethell · Elizabeth
Caboverde · Elizabeth Davie · Elizabeth Dibanadane · Elizabeth Hunter · Elizabeth Mans · Elizabeth
Okanga · Elizabeth Peters · Elizabeth Ruffles · Elizabeth Waghorn · Elka Drozdowski · Ella Griffin ·
Ella Mravicich · Ella-Rose Henderson · Ellen Anastacio · Ellen Baguio · Ellen Cribb · Ellen
Encarnacion · Ellen Ganzon · Ellen Giles · Ellie Bovey-Brown · Ellie Siu · Ellie Welch · Ellie Wilson ·
Ellora Santos · Elly Nash · Elma Reoma · Elmer Carreon · Elodie Jullien · Eloisa Obnial · Eloise Baker
· Eloise Viscarra · Elona Walker · Elsie Pablo · Elsie Warriner · Elva Latonio · Elvia Fitriany · Elvira
Tangonan · Ely Masil · Emalyn Prosia · Emelie Taposok · Emelita Cagas · Emilia Ackerman · Emily
Andersen · Emily Burgess · Emily Chen · Emily Cruz · Emily Curd · Emily Dunbar · Emily Hayward ·
Emily Jepson · Emily Langdon · Emily Maoe · Emily Matthews · Emily Price · Emily Truong · Emily
Underwood · Emily White · Emily Xi · Emma Baker · Emma Begg · Emma Burnett · Emma Clark ·
Emma Coles · Emma Eason · Emma Ford · Emma Harper · Emma Hogan · Emma Holder · Emma
Jamie de Laborde · Emma Kielty · Emma Knott · Emma Lim-Yip · Emma McLeod · Emma Ngoc ·
Emma Nolan · Emma Raho · Emma Rankin · Emma Reardon · Emma Reece · Emma Ritchie · Emma
Saquiban · Emma Singh · Emma Tarunge-Wasi · Emma Tuipulotu · Emma Webb · Emman Galve ·
Emmy Dolotina · Entani Naidu · Eric Demo · Eric van Diggele · Eric Yu · Erica Bacasen · Erica
Butcher · Erick Abille · Ericka Sauquillo Adoyo · Erik Homena · Erin Lesley · Erin Munisamy · Erin
Pole · Erin Woodcraft · Erll Hulleza · Ernesto Espiritu · Eru Raroa · Erwin Blacer · Esau Knowles ·
Esmie Gonzaga · Este Barnard · Estela Garcia · Estela Guiao · Estella Jin · Estelle O’Neil · Estelle
Ramtano · Ester Da Rosa · Esther Cole · Esther Curtis · Esther Gupana · Esther Hukui · Esther Kingi
· Esther Lawangen · Esther Lin · Esther Simpson · Esther Zvenyika · Ethan McCarthy · Ethan
Prentice · Ethan Turner · Ethel Mondarte · Eti Aunese · Eugene Ortile · Eugenie May · Eunice Parreno
· Eunice Salenga · Eurita Balazo · Eva De Jong · Eva Mago · Eva Pan · Eva Rotich · Eva Xu · Eve
Espanta · Eve Lock · Eve Ojales · Evelinda Elan · Evelyn Liu · Evelyn Booth · Evelyn Cadzow · Evelyn
Calaunan · Evelyn Espina · Ezra Erueti · Fadhel Al Halwachi · Faeona Wallace · Fair Rupal · Faith
Sakalia · Fallon Eynon · Fana Raveora · Fang Zhou · Fara Naicake · Farah Abuyabor · Farida Shilpi ·
Fariha Nowshin · Farisha Begum · Farishta Samadi · Farry Hardianto · Farzana Begum · Farzana Bi ·
Faseela Thodi · Fatima Hima · Fay Furness · Fay Lilley · Fay Ramirez-de Jong · Fe Asinas · Fe Cuevas
· Fe Taganas · Fefiloi Tausi · Felicity King · Felis Pael · Felix Lacerna · Felmi Thomas · Fely Magpantay
· Fenton Prickett · Ferdi Roncal · Fermina Pasiona · Fern Elias · Feroza Bano · Figen Tunc · Fin Martin
· Finau Kafoa · Finbarr Doherty · Fincy Francis · Fiona Chen · Fiona Douglas · Fiona Dube · Fiona
Justine · Fiona Kingi · Fiona Le Gros · Fiona Noonan · Fiona Quinn · Fiona Rolland · Fiona Scotland ·
Fipe Lama · Fletcher Clarke · Fleur Smith · Flo Schrimpf · Flor Anasarias · Flora Torres · Florance
Nikeeta · Floren Guira · Florence Collis · Florence Esteban · Florence Mallari · Fonda Burt · Fortune
Onwukwe · Fraan Quirk · Fran Inoue · Fran Parkinson · Fran Spitzer · Fran Troncoso · Frances Bola ·
Frances Brown · Frances Haworth · Frances Le Grice · Frances Palmer · Frances Twaalfhoven ·
Frances West · Francesca Dela Cruz · Francesca Lockyer · Francie Cappleman · Francine
Palendeng · Francis Deferia · Francisca Soto · Frank Ryan · Frank Wang · Franz Sale · Fraser Hendry
· Fraser Mander · Fraser Sheat · Freda Chase · Freda Raptopoulos · Freda Van Schouten · Freddy
Akkara · Frelyn Acuzar · Fritha Ellis · Fritz Lozano · Frozan Azizi · Gabby Da Rosa · Gabby Hermen-
Free · Gabby Nunn · Gabriel D’Alberto · Gabriel Gimena · Gabrielle Lewis · Gabrielle Raife · Gaby
Maniloff · Gagan Dhaliwal · Gagan Hothi · Gagan Kaur · Gagan Kaur · Gagan Kaur · Gagan Kharoud
· Gagandeep Kaur · Gaganpreet Kaur · Gagneet Kaur · Gail Brown · Gail Calicdan · Gail Castro · Gail
Miller · Gail Te Au · Galina Shipina · Gamage Priyangika Sandamali · Garlett Ceniza · Garry Bott ·
Garry Dentice · Garry Singh · Gary Body · Gary Cox · Gary Robinson · Gary Sutcliffe · Gavin Lucas ·
Gay Benabaye · Gay Libatog · Gay Ordonio · Gayathri Kumar · Gaye Duff-Laing · Gayle Watt ·
Gayleen Watkins · Gaylene Downs · Gaylene Graham · Gaylene Hutcheson · Gedy Belicario · Geet
Sidhu · Geeta Mongam · Geetha Marupati · Gellie Dela Cruz · Gelyn Dalusag · Gem Evans · Gemeda
Wesho · Gemma Fernandez Duck · Gemma Hindley · Gemma Raumati · Gemma Tattley · Gen
Bautista · Gen Cabarles · Gen McEwan · Genalyn Arca · Gene Sanchez · Genelil Gonzales ·
Generose Jocson · Geneveve Van Dooren · Genevieve Schrijvers · Gennelle Davies · George
Crawford · George Mathew · George Sebastian · Georgekutty Joseph · Georgia Berry · Georgia
Butler · Georgia Kendall · Georgia Kirk · Georgia Ritchie · Georgia Sherlock · Georgia Smaill ·
Georgia Smith · Georgia Taylor · Georgie O’Dea · Georgina Spiers · Geraldine Kevill · Gerlie Navaja
· Ghela Domalanta · Gifty Anthrayose · Gihani Chathurika · Gil Fielding · Gil Ona · Gilbert Romero ·
Gilly Noon · Gilu Johnson · Gina Parkinson · Gina Salt · Gina Schenkel · Gina Villanueva · Gina Yan ·
Ginnie Ravell · Gino Magsino · Giovanna Falchi · Girley Pingol · Girlie Stevens · Giroma Labradores ·
Gisha Chandy · Glady Davis · Gladys Muwunganirwa · Gladys Datugan · Gladys Dayrit · Gladys
Gaspar · Glaiza Alwit · Glaiza Bernardo · Glaiza Saul · Glen Thomson · Glenda Aggarao · Glenn
Lubguban · Glenn McNickle · Glenn Scott · Glenn Taylor · Glenys Percy · Glenys Popenhagen ·
Glenys Stewart · Gloria Kavanagh · Gloria Kawadza · Gloria Wardle · Glyn Jenkins · Glynis Brenner
· Glynn Pegarro · Glynnis Mackay · Gogi Mudhar · Golda Ceniza · Gong Padayogdog · Gordon
Lambagan · Gorica Brasic · Govind Ghemre · GR Taala · Grace Aldridge · Grace Anacleto · Grace
Arbitrario · Grace Armstrong · Grace Blake · Grace Boyle · Grace Brunke · Grace Buchanan · Grace
Castro · Grace Fleming · Grace Gubatan · Grace Justus · Grace Kamuhangire · Grace Lubos ·
Grace MacIntyre · Grace Martinez · Grace Nathan · Grace Nieto · Grace Nochefranca · Grace
Samuel · Grace Tabut · Grace Tavara · Grace Tubo · Grace Wang · Grace Wei · Grace Wilson ·
Gracely Miyake · Gracie McLeod · Graeme Marriott · Graeme Thomson · Graeme Wilson · Grant
Costello · Grant King · Greece Tade · Greema Paul · Greeshma Kallanakkara Rajan · Greeshma
Susham · Greg Barclay · Greg Conquest · Greg Giles · Greg Pearce · Greg Small · Greg Whithair ·
Greta Kennedy · Gretch Tacuyan · Guilherme Reis · Gul Kaur · Guncha Maggu · Gunpreet Tiwana ·
Guri Mahel · Guri Singh · Gurjeet Kaur · Gurjit Kaur · Gurjit Kaur · Gurki Sandhu · Gurleen Kaur ·
Gurmeet Kaur · Gurmeet Kaur · Gurneet Kaur · Gurpreet Bhullar · Gurpreet Dhillon · Gurpreet Kaur
· Gurpreet Kaur · Gurpreet Kaur · Gurpreet Kaur-Gill · Gursharan Kaur · Gursharan Kaur · Gurwinder
Kaur · Guy Dryden · Guy Warburton · Gween Balistoy · Gwen Cajigas · Gwen Ward · Habiba Neniel ·
Hadrian Sultan · Hafsah Loukili · Haley Tran · Hamida Khan · Hamish Kennedy · Hamish Smith ·
Hanan Alshbrawi · Haneen Bsaiso · Hanh Pham · Hani Fatu · Hanna Huang · Hannah Angelucci ·
Hannah Apurillo · Hannah Barlow · Hannah Byas · Hannah Cantrick · Hannah Carter · Hannah
Casia · Hannah Diaz · Hannah Espanola · Hannah Garcia · Hannah Hamilton · Hannah MacLean ·
Hannah Manalaysay · Hannah Mercado · Hannah Oldroyd · Hannah Riches · Hannah Smith ·
Hannah Taylor · Hannes Cronje · Hans Joy Albano · Hans Koman · Hans Mohd Kassim · Happy
Nijjar · Hardeep Kaur · Harendra Sajwan · Harianne Canoy · Hariharan Ramakrishnan · Harish
Purohit · Harjeet Kaur · Harjinder Kaur · Harka Neopaney · Harkamal Minhas · Harleen Johal ·
Harman Kaur · Harman Kaur · Harmanpreet Deol · Harmonee Scott · Harmony Clark · Harneet
Kaur · Harparveen Kaur · Harper Connolly · Harpinder Kaur · Harpreet Kaur · Harpreet Kaur ·
Harpreet Kaur · Harpreet Kaur · Harpreet Kaur · Harpreet Kaur · Harpreet Kaur · Harpreet Kaur ·
Harpreet Khokhar · Harpreet Pabla · Harriet Hawksworth · Harriet Miller · Harry Capacite · Harry
Hemus · Harry Huynh · Harry Makhloga · Harry Snell · Harsh Kaur · Harshani Jayasinghe · Harveer
Kaur · Harwinder Kaur · Harylle Canoy · Hashini Ekanayake · Havana A’aifou · Haycie Orina · Haydee
Anson · Hayden Beaton · Hayden De Cleene · Hayley Behrns · Hayley Berriman · Hayley Gillespie ·
Hayley Hemsley · Hayley Kluytmans-Smith · Hayley Mackintosh · Hayley Milne · Hayley Mustapha ·
Hayley Sharp · Hazel Dodunski · Hazel Gonzales · Hazel Guillen · Hazel Magar · Heather Barnett ·
Heather Baron · Heather Jury · Heather Maynard · Heather Sharp · Heather Snodgrass · Heather
Turney · Heather Wallace · Heather Wilson · Heather Wooles · Hebbe Xia · Hedda Viray · Heena
Arora · Heena Kapoor · Heena Pardeshi · Heide Barkman · Heidi Atkins · Heidi Holm · Heidi O’Reilly
· Heila Louw · Helen Bailey · Helen Burnley · Helen Danielsen · Helen Edwards · Helen Farrell · Helen
Hall-King · Helen Hayes · Helen Higgins · Helen Highcazony · Helen Liu · Helen Maxwell · Helen
McKinnel · Helen Page · Helen Timra · Helen Van Der Meys · Helen Wehipeihana · Helen Weston ·
185
ANNUAL REPORT 2022
Helen Xu · Helena Barriga · Helena Dawson · Helena Van Zoggel · Hellen Grenfell · Hema Baldania ·
Hemal Patel · Henny Villaverde · Henry Arunjaroen · Henry Davis · Henry Stuart · Hepi Matapa ·
Herbert Zielinski · Hermie Nuqui · Hiep Do · Hieu Lam · Hilary Freeth · Hilary Van Zoelen · Hilary
Westley · Hilda Dimalibot · Hildah Muthui · Himanshu Juneja · Himshikha Paneri · Hina Veituna ·
Hine Kameta · Hinewa Mahanga · Hiromi Mizushima · Hit Patel · Hitesh Vaza · Hoana Brown · Hoani
Brown · Hollee McKay · Hollie Ruddick · Hollie Thomlinson · Holly Baxter · Holly Binnie · Holly Briggs
- Lyne · Holly Duff · Holly French · Holly Gillett · Holly Pham · Holly Pihema · Holly Ryan · Holly
Whitaker · Honey Arceo · Honey Duque · Honey Gill · Honey Honey · Honey John · Honey Neilson ·
Honey Pagtanac · Honeylane Bautista · Honor Braid · Hope McKelvey · Hope Robyns-Mackay ·
House Yuan · Hua Chen · Hubert Gacera · Hugo Gonzalez · Hui Ju Oh · Huiling Lu · Hulen Ke · Hunter
Lee · HyeJu Jeon · Hyma Gantyada · Iain Doody · Iain Jagger · Ian Bell · Ian Bezzubov · Ian Corry · Ian
Lee · Ian Mackay · Ian Whyte · Icon Dales-Lequido · Ida Waiwiri · Ili Lase · Iliui Filipo · Ilthon Tomo · Im
Konsila-Henderson · IndiaRose Cunningham · Indika Abeykoon · Indra Devi · Indra Senevirathne ·
Indu Baiju · Indu Gounder · Indy Farmer · Ine Wheeler · Inge Rickards · Ingrid Cagalawan · Ingrid
Hurst · Ingrid Ludovice · Ingrida Jones · Inigo Holmes · Inoka Jayaweera · Inosha Hettiarachchi ·
Iosefo Bahn · Irene Burt · Irene Celino · Irene Lee · Irene Li · Irene Morgan · Irene Rapa · Irene Yang ·
Iresha Perera · Iresha Jahinge · Irina Davis · Irish Pelegren · Iritana Tua · Isaac Bright · Isaac
Kavanagh-Stewart · Isabel Jimenez · Isabel Seville · Isabelita Ceniza · Isabelle Purdy · Ishan
Kolothodi · Ishara Subedi · Ishina Adhikari · Ishu Koirala · Isi Uata · Iskima Bhandari · Isla Gillies · Isla
Jean Tregonning · Isy Cassidy · Italia Taka · Ivan Nugraha · Ivane Parba · Ivy Carino · Ivy Chatterjee ·
Ivy Han · Ivy Liza · Izak Luther · Izel Martinez · Izzy Getty · Izzy Partridge · Jaala Attewel · Jabeline
Obra · Jac George · Jacinta Afamasaga · Jacinta Field · Jacinta Neilson · Jack Markham · Jackie
Diago · Jackie Hotter · Jackie Jenkins · Jackie Miller · Jackie O’Fee · Jackie Scanlon-James ·
Jackson Sumich · Jacky Adam · Jacky Basongit · Jaclyn Aitken · Jacob Cherian · Jacoeb
Uprichard · Jacque Manzano Leadbetter · Jacquelyn Cottam · Jacqui Clarke · Jacqui Forde ·
Jacqui Gillard · Jacqui Hurley · Jacquie Rui · Jade Bedel · Jade Dix · Jade Hemi · Jade Magno · Jade
Morrice · Jade Te Awhe · Jade Washbourn · Jaden Kim · Jadi Cubita · Jagath Esposo · Jagath
Wijetilleke · Jahleel Espineda · Jahn Katene · Jaime Awab · Jaime Clews · Jaime Redmond · Jaine
Hidalgo-Plaza · Jaison Johny · Jake Clansey · Jam Collado · Jam Rivera · Jamaika Mejorada ·
James Aoys · James Earls · James Inobaya · James Marshall · James Simpson · James Ward-
Johnson · James Webb · James Zeng · Jamie Murray-Macgregor · Jamie Quigg · Jamie Roberts ·
Jamie Rumbold · Jamie Sheary · Jamie Ung · Jamila Khaled · Jan Corbett · Jan Farac · Jan
Goodwin · Jan McKee · Jan Reyes · Jan Smith · Jan Strickland · Jan Thomson · Jan Tuuta · Jan
Villacorta · Jana Dinusova · Janaki Shrestha G. · Jane Baker · Jane Cribb · Jane Duncan · Jane Elle
· Jane Escalera · Jane Gordon · Jane Hickman · Jane Hockey · Jane Jordan · Jane Magan · Jane
Matorino · Jane McNeill · Jane O’Connell · Jane Paredes · Jane Patrick · Jane Pow · Jane Ram ·
Jane Smith · Jane Sun · Jane Tattley · Janeil Tan · Janel Castillano · Janelle Broughton · Janes
Castro · Janess Estillore · Janet Bucag · Janet Jesen · Janet Ngamaru · Janet Spaabaek · Janet
Stacey · Janeth Pascual · Janette Boyd · Janette Llesis · Janica Villaver · Janice Baker · Janice Liu
· Janice Munro · Janice Peralta · Janice Rodriguez · Janice Rothwell · Janice Ruste · Janice Stent ·
Janice Walsh · Janice Wright · Janine Aitken · Janine Amacio · Janine Lipsys · Janine Nathan ·
Janine Snape · Janine Waugh · Janine Wilde · Janis Bredenbeck · Jan-Marie Houliston · Jann
Heasley · Jann Tarrant · Janna Bowman · Jannel Escueta · Jannet Joseph · Janrell Relucio · Jared
Kemsley · Jas Bhotea · Jas Kaur · Jas Kaur · Jas Kaur · Jas Maxwell · Jas Taala · Jasleen Kaur ·
Jaslove Singh · Jasmeen Kaur · Jasmeet Kaur · Jasmeet Virk · Jasmin Cataquiz · Jasmin Raju ·
Jasmine Aulakh · Jasmine Evans · Jasmine Huang · Jasmine Kim · Jasmine Lee · Jasmine Mcilraith
· Jasmine Parker · Jasmine Shahbaz · Jasmine Song · Jasmine Ting · Jasmit Kaur · Jason Adam ·
Jason Browne · Jason Davey · Jason Higgins · Jason Kenna · Jason Mack · Jason Zhao · Jason
Zhao · Jasond Jamboy · Jaspal Singh · Jasper Ducusin · Jasper Wilson · Jaspinder Kaur · Jaspreet
Gill · Jaspreet Kaur · Jaspreet Kaur · Jaspreet Kaur · Jaspreet Kaur · Jaspreet Kaur · Jaspreet Singh
· Jasprit Kaur · Jass Kaur · Jass Kaur · Jass Kaur · Jass Kaur · Jass Kaur · Jass Reddy · Jasveer
Sidhu · Jasvir Kaur · Jaswinder Kaur · Jasz Kaur · Jay Kang · Jay Kirk · Jay Moore · Jay Pascua · Jay
Payot · Jay Saclo · Jay Sukhdarshan Singh · Jaya Mohan · Jaya Vandhana · Jayde Brown · Jayde
Kumsawng · Jayjay Jung · Jayn Baker · Jayne McIlroy · Jayne Money · Jaypee De Peralta · Jayson
Ehn · Jaz Fox · Jaz Sigley-Millar · Jaz Spicer · Jazz Harris-Urlich · Jazz Phillips · Jazz Rabbett · Jean
Cleaver-Paris · Jean Farrell · Jean Raga · Jean Ramos · Jean Rigor · Jean Villarin · Jeanafe
Abelarde · Jeanel Gutong · Jeanet Bagares · Jeanette Erestingcol · Jeanette Tebbutt · Jeanette
Wensor · Jeanie Gradwell · Jeanie Gamboa · Jeanie Salcedo · Jeanne Paterson · Jeannette
Subritzky · Jeannie Bautista · Jeannie Sales · Jeannie Wang · Jee Manipis · Jeema Lijo · Jeena Jose
· Jeena Oshana · Jeeva Vakkachan · Jeff De Los Reyes · Jeff Parkins · Jeff Ragragio · Jeff Salas ·
Jeff Suana · Jejay Sen · Jele Papellero · Jeli Howes · Jelica Ceballos · Jemma Lewin · Jen Asuncion
· Jen Ethugala · Jen Garcia · Jen Lemery · Jen Magrath · Jen McLean · Jen Nuevo · Jen Penfold · Jen
Rea · Jen Tufuga · Jenelyn Ragadi · Jenette Fursdon · Jenn Valavala · Jenna Aspeling · Jenna
Lester · Jenna Maire · Jenna Moore · Jenni Berkers · Jenni Harris · Jenni Simpson · Jenni Stevenson
· Jenni Thompson · Jennie Choi · Jennie South · Jennie Teodoro · Jennifer Ferrier · Jennifer
Gonzalo · Jennifer Grover · Jennifer Roberts · Jennifer Rodriguez · Jennifer Storer · Jennifer Wong
· Jenny Abalos · Jenny Achilles · Jenny Bongcog · Jenny Bower · Jenny Buhat · Jenny Campbell ·
Jenny Chen · Jenny Christmas · Jenny Cobden-Cox · Jenny Coleman · Jenny Cuffe · Jenny de
Peralta · Jenny Dominguez · Jenny Griffiths · Jenny Guanco · Jenny Halliday · Jenny Jackson ·
Jenny Kaur · Jenny Lane · Jenny Leader · Jenny Lopez · Jenny Magsilang · Jenny Parker · Jenny
Pasiol · Jenny Reyes · Jenny Ruttar · Jenny Thiele · Jenny Wilson · Jenny Zhang · Jens Kuriakose ·
Jerald Isleta · Jerald Sunto · Jeremy Alvez · Jeremy Moore · Jeremy Munday · Jeremy Wood · Jerin
Joy · Jerlene Cruz · Jermae Aguilon · Jermaine Masangkay · Jerome Wong Yit · Jerrom Lomocso ·
Jerry Barclay · Jervilou Santiago · Jesica Escueta · Jesilyn Delgado · Jesna Jose · Jess Anderson ·
Jess Benfell · Jess Bonustro · Jess Crook · Jess Dawes · Jess Hatfield · Jess Jewell · Jess Kim · Jess
Lewis · Jess Matthews · Jess Morris · Jess Nathan · Jess Snowball · Jess Steele · Jess Webb · Jessa
Dela Cruz · Jesse Grove-Gowans · Jesse Varney · Jessica Angelia · Jessica Csengo · Jessica
Gerken · Jessica Lewis · Jessica Martin · Jessica McArley · Jessica Rice · Jessica Taningco ·
Jessica Tonacao · Jessica Tran · Jessica Zhang · Jessica Zhou · Jessie Chu · Jessie McKay · Jessie
Tang · Jessy Arthur-Worsop · Jestin Johny · Jesty Nelson · Jeuenesse Martinez · Jewel Galang ·
Jewel Novera · Jharmane Catolico · Jhiede Tormis · Jhoanna Maithani · Jhonaliza Detera · Jhong
Solen · Jhuls Ocho · Jhunnelle Tabay · Jia Li · Jiaqi Zhao · Jiaying Yang · Jibin John · Jibita Maharjan
· Jie Yu Zeng · Jie Zhang · Jigisha Baraiya · Jiji Sevilla · Jijo Laurence · Jijo Paul · Jijo Varghese · Jiju
Joy · Jil Chua · Jill Clark · Jill Gregson · Jill Job · Jill Patel · Jill Turner · Jill White-Northcroft · Jillian
Cole · Jilsy Joy · Jim Beban · Jim David · Jim Frost · Jim Jose Vellakada · Jim Otimi · Jim Qian ·
Jimaima Naikatini · Jimmy Clemente · Jimmy Franks · Jimmy Sihombing · Jincy Thambi · Jing Cui
· Jing Estrella · Jing Fu · Jing Hu · Jing Meipieza · Jinghua Zhang · Jingjing Hou · Jini Joy · Jinit
Bhavsar · Jinky Munoz · Jinky Romero · Jinsa Joseph · Jinson Abraham · Jiny Johny · Jiratha
Khamsungnoen · Jisbin Siby · Jit Chhetri · Jiwon Park · Jiyeon Kim · Jo Anam · Jo Baker · Jo Bando
· Jo Base · Jo Bindon · Jo Blyth · Jo Cant · Jo Clare · Jo Dickson · Jo Dorado · Jo Duncan · Jo Franklin
· Jo Goode · Jo Hermogenes · Jo Hunt · Jo McKay · Jo Mooney · Jo Nelson · Jo Ratapu · Jo Rojo · Jo
Seed · Jo Turner · Jo Ward · Jo Willis · Joan Aguillo · Joan Lagman · Joan Lastimosa · Joan Rubio ·
Joan Wang · Joana Caramoan · Joanna Forbes · Joanna Gumangan · Joanna Little · Joanna
Symons · Joanna Taylor-Spedding · Joanne Bass · Jo-anne Buhler · Joanne Eaton · Joanne Ga-as
· Joanne Hart · Joanne McConchie · Joanne Robinson · Joanne Satchwell · Joanne Snalam ·
Joanne Steele · Joanne Wang · Joanne Wong · Joaquin Barillas · Joash Felipe · Joban Singh · Jobcy
John · Jobi Paul · Jocasta Jowett · Jocelyn Davidson · Jocelyn Hansen · Jocelyn Infante · Jocelyn
Lines · Jocelyn Prospero · Jodie Jenkins · Jodie Parker · Jodie Perocho · Jodie Robb · Jody
Brennan · Jody Coverdale · Jody Keating-Gorton · Jody Rerekura · Joe Manaena · Joe
Muttumpurath · Joe Nio-Aporo · Joe Rooney · Joe Sturrock · Joe Suedad · Joe Tierney · Joe Vas ·
Joe Won · Joeben Roxas · Joena Baculio · Joey Weaver · Johann Mabao · Johannes Bronkhorst ·
John Bernardo · John Beuth · John Buyung · John De Leon · John Entice · John Gavin · John
Graham · John Jenkins · John Jeong · John Katiyo · John Keighron · John Koen · John Maddaluno ·
John Malonzo · John Nayga · John Outten · John Reihana · John Reyes · John Taylor · John Uy ·
John Van Turnhout · John Viscovini · John Walker · John Waller · John Young · Johnny Seque ·
Johnny Zhu · Johno Robins · Johnson Alex · Johny Jory · Jojo Archer · Jojo Diquit · Jolden
Fernandes · Jolenie Zomil · Jolie Thuy · Jomith Jose · Jona Arganda · Jona Osmena · Jonah Lawry
· Jonald Laurico · Jonathan Ball · Jonathan Barber · Jonathan Barrett · Jonathan Cruz · Jonathan
Stewart · Jonathon Hean · Jone Seniceva · Jonelyn Valeroso · Joni-Lou Arcelo · Jonna Mangahas ·
Jonnel Tan · Jono Barnes · Jordan Braid-Eley · Jordan Dobson · Jordan Elvy · Jordan Mealings ·
Jordyn Keys · Joreena Mabini · Jorja Antunes · Jose Palathunkal · Jose Sebastian · Josep Marin
Lumbreras · Josephine Cunado · Josephine Slater · Josh Fitzsimmons · Josh Goodfellow · Josh
John · Josh Jones · Josh Meehan · Josh Orchard · Josh Rasolo · Josh Smith · Joshua Cole · Joshua
Elan · Joshua Smith · Josiane Bizoza · Josie McCrone · Josie Placino · Josmi Joseph · Josmin Jose
· Josna Joseph · Joti Chand · Joti Kumari · Joti Reena · Jouanna Tristeza · Jova Marquez · Jovana
Brasic · Jove Alocelja · Jovelyn Sison · Joy Abella · Joy Abellar-Sinha · Joy Ador · Joy Breward · Joy
Dolozon · Joy Gautam · Joy Mason · Joy Sy · Joy Tan · Joy Yang · Joyce Kydd · Joyce Roa · Joyce
Wang · Juanito Alforque · Juann Fabia · Jubin Sabu · Jude Fegi · Jude Guild · Jude Kerr · Jude Liddle
· Judette Froilan-Algodon · Judit Lukacsa · Judith Fernando · Judith Bell · Judith Ditablan · Judith
Rutledge · Judith Sturzaker · Judy Barron · Judy Binarao · Judy Campbell · Judy Christie · Judy
Lobb · Judy Lubanga · Judy McAuley · Judy Miguel · Judy Montero · Judy Patterson · Judy Petersen
· Juffin Koshy · Juhee An · Julia Charteris · Julia Evans · Julia Main · Julia Murphy · Juliana Serafim
da Silva Ribeiro · Juliana Stone · Julie Akinyele · Julie Camay · Julie Carlson · Julie Collings · Julie
Corkill · Julie Crayford · Julie Crofts · Julie Dehar · Julie Deticio · Julie East · Julie Gumban · Julie
Hoskin · Julie Leilua · Julie Madden · Julie Madden · Julie Mallia · Julie McGhie · Julie Morrish · Julie
Nelson · Julie Parker · Julie Rice-Gray · Julie Rodwell · Julie Rose Guinyang · Julie Russ · Julie Ryan
· Julie Schaab · Julie Seymour · Julie Simpron · Julie Sleep · Julie Thompson · Julie Toevai · Julie-
ann Beattie · Juliet Dixon · Juliet Findlay · Juliet Smith · Julio Rezende · Julius Macaraeg · Jully Cui ·
July Pili · Julyn Cancino · Jum George · Jun Lam · June Marshall · June Savage · Junior Tai · Junn
Alminaza · Juselle Dangate · Jussell Benedicto · Justin Reinecke · Justin Thankachan · Justine
Hilado · Justine Michel · Justine Taylor · Jylyn Javier · Jyoti Jyoti · Jyoti Bhanot · Jyoti Gurung · Jyoti
K C · Jyoti Kunwar · Jyoti Phuyal · Jyoti Shahi · Jyoti Sharma · Kabita Acharya · Kade O’Meara ·
Kaden Ko · Kae Tayong · Kael Fallu · Kaelan Healy · Kaitlin Ruscoe · Kaitlyn Do · Kaitlyn Rosevear ·
Kaito Hayashi · Kal Sherchan · Kalaivani Logeswaran · Kaleb Dunstan · Kaleshni Devi · Kali Nottle ·
Kalisi Savu · Kalpa Kumarasinghe · Kalpana Negi · Kalvi Selvaraj · Kam Kaur · Kamal Dhaliwal ·
Kamal Jajoria · Kamal Kaur · Kamal Pandher · Kamal Pathak · Kamala Phuyel · Kamalpreet Kaur ·
Kamalpreet Kaur · Kamini Prasad · Kanchan Dangol · Kanchi Peiris · Kane Harper · Kani Davis ·
Kaniata Halanukonuka · Kanika Arora · Kanta Mani · Kanti Karan · Kanwal Kaur · Kanwal Sandhu ·
Kanwal Singh · Kaori Matsunobu · Kara Montilla · Karamjeet Kaur · Karan Kaur · Kareen Galang ·
Karel Atilano · Karen Andrews · Karen Anne Strachan · Karen Bensemann · Karen Bloxham · Karen
Bolton · Karen Borland · Karen Castel · Karen Gage · Karen Ikimata · Karen Jackson · Karen
Jellyman · Karen Jenkins · Karen Kaefer · Karen Kelly · Karen Lake · Karen Layman · Karen Mabao ·
Karen Marquina · Karen McGinty · Karen Mecca · Karen Melo · Karen Merrilees · Karen O’Driscoll ·
Karen Rodger · Karen Sears · Karen Shaw · Karen Wellard · Karen Wellington · Karen Williams ·
Karen Young · Karena Miller · Karin McDonald · Karin Smits · Karina Landero · Karina Misterio ·
Karishma Naidu · Karl Drent · Karl Holloway · Karl Rosales · Karla Marrs · Karla Naude · Karm Kaur ·
Karm Kaur · Karuna Katwal · Karuna Maharaj · Karuna Singh · Karyl Saavedra · Karylle Dacanay ·
Karyn Marshall · Karyn Nobilo · Karyn Porter · Kase Woolley · Kasun Silva · Kat Hanson · Kat Porter
· Kata Samuelu · Katalina Aitaua · Katarina Biaukula · Katarina Cox-Winiata · Kate Anderson · Kate
Bowden · Kate Bruce · Kate Carr · Kate Cheng · Kate De Los Santos · Kate Ensor · Kate Lim · Kate
Milne · Kate Morgan · Kate O’Neill · Kate Ren · Kate Sharples · Kate Tran · Kate Whatford · Kate
Wood · Katelyn Stuart · Kath Abelligos · Kath Collett · Kath Daveis · Kath Dwyer · Kath Morgan · Kath
Owen · Kath Pegalan-Bataanon · Kath Simpson · Katherine Cade · Katherine Chen · Katherine
Olivar · Katherine Smith · Kathie Dimock · Kathleen Corcuera · Kathleen de Gracia · Kathlen
Gingoyon · Kathrin Schott · Kathrine Tan · Kathryn Francis · Kathryn Geopano · Kathryn Van de
Westerlo · Kathy Petersen · Katie Benson · Katie Greig · Katie Hutchinson · Katie Japor · Katie
Longden · Katie-Jane Knight · Katrin Marundan · Katrina Armstrong · Katrina Boyd · Katrina
Copland · Katrina Ede · Katrina Mann · Katrina McLean · Katrina Stevens · Katty Maya · Katy Fryer ·
Katy Hodder · Katy Van Nieuwenhuizen · Katz Melebo · Kavitha Sukumar · Kawther Kadhom · Kay
Fabrin · Kay Katene · Kay McKirdy · Kay Merekula · Kay Murdoch · Kaycee Borja · Kaycee Salmasan
· Kayden Clarke · Kaye Clyne · Kaye Francisco · Kaye Kaur · Kaye Stoddart · Kaye Wesley · Kayla
Gee · Kayla Myles · Kayla Richmond · Kaylee Du Preez · Kaylee Hird · Kaylee Stevenson · Kaylee
Tonga · Kaylene Brock · Kaylene Tipene · Kaylyn Merrall · Keefe Martinez · Keira McEwan · Keisi
Puafuti · Kellie Hura · Kelly Amemita · Kelly Barnes · Kelly Cooke · Kelly Findlay · Kelly Hatherell ·
Kelly Jansen · Kelly Jones · Kelly McDonald · Kelly Turner · Kelsey Griffin · Kelsey Wilson · Kelsie
Grantham · Kelvin Weston · Kemmarin Atkinson · Ken McKay · Ken Wongsomboon · Kendall James
· Kendall Johnson · Kendall Stobart · Kendra Parker · Kendyl Hudson - McDonald · Kennely Atilano
· Kenneth Alo · Kenneth Baldivinos · Kenneth Coade · Kenneth Penolbo · Kenny MacAskill · Kent
Chavez · Kenzie Genet · Keran Taylor · Keri Brickmann · Keri Ladbrook · Kerri Martin · Kerri Roberts
· Kerri Shirley · Kerri Smith · Kerry Gall · Kerry Hawkins · Kerstine Egot · Keryn Johnston-Dixon ·
Keryn Norris · Kev Moore · Kevin Selner Maniego · Kevin Bautista · Kevin Bowgett · Kevin Dela Cruz
· Kevin Durkin · Kevin Grimwood · Kevin Taylor · Kevin Tsai · Kharina Milan · Khaylen Schaup · Khina
Neupane · Khusbu Patel · Khush Arora · Khushboo Dhiman · Khushi Kiran · Kidst Mekonnen · Kie
Kassal · Kiely Buttell · Kiem Bayona · Kiera Bradford · Kiera Follows · Kieran Cox · Kieran Simpson ·
Kieti Kalava · Kika Fosita · Kim Baker · Kim Braniff · Kim Brougham · Kim Buere · Kim Chayag · Kim
Cunard · Kim Dawson · Kim Fisher · Kim Grundmann · Kim Hammersley · Kim Henry · Kim Housiaux
· Kim Hua · Kim Kavanagh · Kim Leighton · Kim Manansala · Kim Nanscawen · Kim Rivett · Kim Son ·
Kim Tran · Kim White · Kim Zipagan · Kimi Donaldson (Naruse) · Kin Wan · Kinley Wangdi · Kira
Wetere · Kiran Dhillon · Kiran Gudopp · Kiran Jawandha · Kiran Kaur · Kiran Kaur · Kiran Kiran · Kiran
Lata · Kiran Singh · Kirandeep Kaur · Kirandeep Kaur · Kirby Chunaco · Kiri Walsh · Kirk Lubos · Kirn
Brar · Kirsten Liggett · Kirsten Merrett · Kirsten Schubert · Kirstin Murdoch · Kirsty Newton · Kirsty
Winter · Kisa Faauli · Kisa Tanuvasa · Kishore Kurian · Klarissa Dacyon · Klarizza Piquero · Kolotita
Makalio · Komal Goundar · Komal Kaur · Komal Komal · Komal Patel · Koppel Sorono · Korinna Dela
Cruz · Koshala Waduwatta · Kreeti Kumar · Kripa Garad · Kris Perkins · Krishma Singh · Krishna
Krishna · Krishna Malcampo · Krishna Rajput · Kriss Apad · Krissy Hohepa · Krissy Talavera · Krista
Lee · Kristen Dela Cruz · Kristin Cadavis-Khiathani · Kristina Benkova · Kristine Baring · Kristine
186
RYMAN HEALTHCARE
Bello · Kristine Borres · Kristine Dalauidao · Kristine Fegi · Kristine House · Kristine Llave · Kristine
Pancho · Kristine Payot · Kristine Singh · Kristofer Toledo · Kristoff Bawayan · Krystal Manson ·
Krystyna Bostrovas · Kuart Jamero · Kuldeep Chauhan · Kuldeep Singh · Kuldip Singh · Kuljeet Kaur
· Kurt Hiller · Kurt Mepana · Kushma Gurung · Kusum Gurung · Kyamala Magar · Kyan Rumbold · Kyla
Ellis · Kyla Jeanjaquet · Kyle McIntyre · Kyle Thomson · Kylie Campbell · Kylie Dearing · Kylie Martin
· Kylie Maxwell · Kylie Thomas · Kym Le Riche · Kyoungmi Kim · Kyrene O’Donnell · Lacey Savage ·
Lachlan McIntosh · Lachmi Kanta · Ladine Hobson · Ladonna De Asis · Lady Canda · Lagi Fogavaa
· Laikha Mohamoud · Lailega Iosefa · Laiza Peters · Lal Sangi · Lami Taua · Lana Bogacheva · Lana
Boynton · Lana Fraser · Lana Tuipulotu · Lance Clendon · Lance Fletcher · Lance Gabionza · Lanei
Dimaano · Laney Brown · Laney Tomkins · Lanie Mabale · Lanna Schnetler · Lara Durand · Lara
Formentera · Lara Giles · Lara Nielson · Larissa Sedouch · Larry Montoya · Latchmi Murti · Lateesha
Douglas · Laura Attwood · Laura Blunsdon · Laura Carleton · Laura Carrington · Laura Clarke ·
Laura Jones · Laura Luague · Laura Manalaysay · Laura Menzies · Laura Moffett · Laura Mouat ·
Laura Reynolds · Laura Richmond · Laura Taylor · Laura Taylor · Laura Whicker · Laurel Gaskin ·
Laurellea Holmes · Lauren Baldock · Lauren Beaumont · Lauren Hubert · Lauren Marshall · Lauren
Odgers · Lauren Trowsdale · Lauren Wells · Laurence Alojado · Laurence Llenes · Laurindo De
Sousa · Lavanya Perumandi · Lavanya Shetty · Lavinia Kelly · Lavpreet Kaur · Lawale Baigern ·
Lawrence Manohara-Seelan · Lawrence Parina · Laya Mary Veliyil Shaji · Lazel Nieto Baungally · Le
Minh Bach · Le Phan · Lea Sullivan · Lea Valdez · Leah Bryan · Leah Evans · Leah Hill · Leah Mapa ·
Leah Ouano · Leah Soliva · Leah White · Leanda Bekker · Leanna Harding · Leanne Booth · Leanne
Des Landes · Leanne Fabish · Leanne King · Leanne Madsen · Leanne McFarlane · Leanne
Nukunuku · Leanne O’Meara · Leanne Paekau · Leanne Stewart · Leanne Watson · Leaoa Tolo ·
Leba Leqakowailutu · Lebron Suedad · Lee Evans Tadeo · Lee Gao · Lee Rodgers · Lee Wilson ·
LeeAnne Mahadeo · Leeba Babu · Leela Pathirannahelage · Leen Porathur · Leena Kumar ·
Lehanna Pio · Leigh Kench · Leigh Greyling · Leigh Kennedy · Leilane Alforo · Leis de Vernon · Leisa
Brown · Lekdhen Tshogyal · Len Diga · Len Ferrer · Len Medalla · Lena Gawler · Lena Te Miha · Lenin
Moncy · Leo Cochrane · Leo Dumagan · Leo Hahn · Leon Hewitt · Leon Joy · Leon van den Berg ·
Leonie Kebbell · Leonie Taylor · Lerio Corum · Leshani Gunawardana · Leshika Arachchige · Lesley
Crampton · Lesley Parfett · Lesley Pells · Leslie Ortega · Lester Salvosa · Lester Toms · Letitia
Corcoran · Leva Latu · Levi Roberts · Lewis Bradford · Lex More · Lexie Lei · Lez Pencz · Li Hayman
· Li Ma · Lia Pou · Liam Blackett · Lianne Woolford · Lianne Yoo · Libby Esguerra · Liby Joseph · Lidiya
Joseph · Lie Fiu · Ligaya Cobile · Ligi Johnson · Ligy John · Liji Jose · Lijo Ittoop · Likhwa Sigola · Lila
Patel · Lili Dong · Lili Talega · Lili Volpicelli · Lilian Ferreira · Liliana Romero · Lill Wawatai · Lilli Regan
· Lillian Lian · Lillie Harris · Lilly Va’a · Lilly-Belle James · Lily Aitken · Lily Elliott · Lily Forcadilla · Lily
Graciano · Lily Isleta · Lily Joyce · Lily McGivern · Lily Murphy · Lily Nicolescu · Lily Woodbury · Lily
Xiao Ying · Lima Ugapo · Lin Lim · Lin Tian · Lina Benedetti · Lina Tuimana · Lincy Cheriyan · Linda
Bridge · Linda Burnside · Linda Chungath Willys · Linda Churchill · Linda Gribben · Linda Havinga ·
Linda Hobrough · Linda Lockington · Linda Maharjan · Linda McGill · Linda Morey · Linda Odhiambo
· Linda Pettigrew · Linda Reid · Linda Richards · Linda Skelton · Linda Soloman · Linda Tyler · Linda
Vescherre · Linda Warren · Linda Yu · Lindsay Harrison · Lindsay Lewis · Lindsey O’Connor · Ling
Cheah · Lionel Kho · Lionel Pillay · Lisa Breeden · Lisa Cooper · Lisa Cowens · Lisa Crichton · Lisa
Gilligan · Lisa Grantham · Lisa Healey · Lisa Hinton · Lisa Humphrey · Lisa Laforgia · Lisa Marr · Lisa
Mazey · Lisa More · Lisa Neiman · Lisa Petana · Lisa Philps · Lisa Puklowski · Lisa Raika · Lisa
Robinson · Lisa Ross · Lisa Walton · Lisa Wang · Lisa Whitcombe · Lisa Wiltshire · Lisa Xu · Lisette
Mann · Lisi Fifita · Lita Naude · Litel Lacerna · Liting Hsu · Livi Ketewai · Liyana Bandara · Liyi Zhu ·
Liz Andoy · Liz Beresford · Liz Bradford · Liz Close · Liz Davidson · Liz De Villiers · Liz Dilger · Liz
Hampton · Liz Hickling · Liz Kwaimani · Liz Loughlin · Liz McRobbie · Liz Nancollis · Liz Penman · Liz
Schofield · Liz Thrush · Liz Wells · Liza Mierzejewski · Liza Siano · Liza Tso · Lize Blay · Lizell Umayam
· Lizeth Monzalo · Lizzie Pasa · Lizzie Tennent · Lizzie Viljoen · Lizzy McKenzie · Loa Tuiolemotu ·
Lochlan Wilson · Logan Fairbairn · Loida Malanyaon · Loida Zarandona · Lois Battersby · Lois
McKenzie · Lois Tooley · Loranne Bayford · Lordei Ledesma · Lorelle Cole · Loren De Chavia ·
Lorenza Macayba · Lorie Anderson · Lorie Bantugan · Lormie Talape · Lorna Alcasabas · Lorna
Carter · Lorna Dolores · Lorna Jenkin · Lorraine Barcibal · Lorraine Benjamin · Lorraine Dawson ·
Lorraine Fuller · Lorraine Hulse · Lorraine Knight · Lorraine Price · Lorraine Tippett · Lorraine White
· Lotis Baldozano · Lotis Caranguian · Loto Foaese-Aiolupo · Lou Anisy · Lou Cabuyadao · Lou
Camargo · Lou Moyle · Louis Matakino · Louis Wolmarans · Louisa Liang · Louisa Bradburg · Louisa
Morton · Louise Addis · Louise Brown · Louise Carr · Louise Challis · Louise Dawson · Louise James
· Louise Jean Bajao · Louise Nicholas · Lourde Riotoc · Lovaine Glariada · Love Singh · Lovely
Chauhan · Lovepreet Kaur · Lovepreet Kaur · Lovey Lovey · Loyda Miranda · Lua Tauaneai · Luca
Chiavola · Luca Fanti · Lucia Meyer · Lucie Chambers · Lucie Harrison · Lucille Catchete · Lucky
Schuster · Lucky Shakya · Lucresia Caitor · Lucretia Del Mundo · Lucy Ayers · Lucy Banaba · Lucy
Caldwell · Lucy Crawford · Lucy Fan · Lucy Kim · Lucy Lu · Lucy Mataki · Lucy McWilliams · Lucy
Nordstrom · Lucy Ryan · Lucy Uro · Lucy van Deursen · Lucy Ward-Johnson · Lucy Zengeni · Luis
De Los Santos · Luis Leh · Luis Lencioni · Luisa Feisst · Luisa Filimoehala · Luke Flynn-Mackenzie ·
Luke Hutchinson · Luke Patience · Luke Tapsell · Luna Touzel · Luna Wang · Lupe Finau · Lusia
Makihele · Lusiana Khan · Lusila Perez · Lydia Burgess · Lydia Gordon · Lydia Morintat · Lydia Renu
· Lydia Zheng · Lyds Nutter · Lyka Liban · Lylene Nuguid · Lyn Aso · Lyn Brown · Lyn Caylan · Lyn
Elton · Lyn Felizarta-Lee · Lyn King · Lyn Metran · Lyn Nguyen · Lyn Nickel · Lyn Zalavarria · Lynda
Dean · Lynda Ellington · Lynda Goston · Lynda Green · Lynda Hill · Lynda Petrie · Lynda Schuler ·
Lyndon Harper · Lyndsay Richards · Lyndy Direen · Lynette Darling · Lynette Neale · Lynette Pido ·
Lynette Polley · Lynley Ballantine · Lynley Gillies · Lynn Buist · Lynn Charlton · Lynn Feng · Lynn
Garner · Lynn Matthews · Lynn Rollo · Lynne Bretherton · Lynne Domigan · Lynne Egging · Lynne
Kane · Lynne Lepoidevin · Lynton Parkinson · Lynz Efalaimo · Lyree Sayers · Lyric Hoani · Lyssa
Foreman · Ma Kriezl Ramos · Ma Ley Diaz · Maaimoa Latu · Maan Singh · Mabel Mathews · Mable
Stewert · Mackenzie Jones · Mackenzie Wilson · Macy Moradei · Maddie Anthony · Maddie Layupan
· Maddy Huckel · Madeleine Dela Rosa · Madelyn Premacio · Madelynne Casison · Madhu Singh ·
Madi Rahman · Madison Wright · Mae Flores · Mae Resos · Mae Toreja · Maffy Coates · Maggie
Cornelio · Maggie Kam · Maggie Ma · Maggie Malone · Maggie Roberts · Maha Ramachandran ·
Mahal Gabionza · Mahi Rani · Mahija Jayasundara · Mai Nguyen · Maia Clare · Maia Scott-Wheeler ·
Maia Tagod · Maica Velasco · Maisy Hallet · Maitha Tan · Maitree Patel · Maitri Parikh · Mak Eketi ·
Makayla Ward · Makelesi Vula · Malav Patel · Malcolm Tolman · Malcolm Wilson · Maleesa Daniel ·
Malia Savelio · Malki Ruppage · Mallory Currier · Malo Tauaneai · Mamta Gusain · Mamta Kumar ·
Man Wai Fung · Manasa Mohan · Mandeep Gill · Mandeep Kaur · Mandi Ceelen · Mandi Smith ·
Mandy Clutterbuck · Mandy Errington · Mandy Grewal · Mandy Hemmingsen · Mandy Jiang ·
Mandy Parker · Mandy Tarquinio · Mandy Tipoki · Mandy Uren · Mangere Mairaro · Mani Mani ·
Manilyn Calda · Maninder Kaur · Manisha Rawat · Manisha Baniya · Manisha Gurung · Manisha Majhi
· Manisha Mane · Manisha Tiwari · Manjinder Kaur · Manju Benoy · Manju Bothara · Manju Shrestha
· Manjula Devi · Manmeet Kaur · Manni Singh · Manny Recamadas · Manny Tanzuaco · Manohari
Mendis · Manpreet Gill · Manpreet Kaur · Manpreet Kaur · Manpreet Kaur · Manpreet Kaur ·
Manpreet Kaur · Manpreet Kaur · Manpreet Kaur · Manpreet Kaur · Manpreet Sekhon · Mantha
Thou · Manu Jimmy · Manu Sharma · Manu Sherchan · Manuela Jaramillo Gonzalez · Manwinder
Sangha · Mara Hernando · Marama Lomia · Marc Archbold · Marc Lyle · Marc Ytom · Marcela
Salazar · Marcelle Sherwood-Whall · Marcia Bernardo · Marcia Hawe-Akinwumi · Marcus Cullen ·
Marcy Dolar · Marecel Stevens · Maree Crozier · Maree Hughes · Maree Ockwell · Maree
Washbourne · Maree Whiting · Mareike Bohte · Mareli Carter · Marg Machee · Marg Vicente · Marg
Vince · Margaret Lethbridge · Margaret Osage · Margaret Rakai · Margarette Pepito · Margeaux
Harris · Margie Bell · Margie Mould · Margo Beale · Margot Boock · Margot Taylor · Mari Gomes-
Bradford · Mari Isnit · Mari Menchavez · Mari Piamonte · Mari Takahashi · Maria Abilay · Maria Achari
· Maria Aguilos · Maria Bautista · Maria Catu · Maria Cavan · Maria Cawdron · Maria Cuizon · Maria
Escandor · Maria Fe Pacible · Maria Flores · Maria Fodel · Maria Francisco · Maria Fuga · Maria
Gutierrez · Maria Inocencio · Maria Isnit · Maria James · Maria Jenkins · Maria Jordan · Maria Kurian
· Maria Lee · Maria Martinez · Maria Mathieson · Maria McNeilly · Maria Neill · Maria Nuval · Maria
Ralawa · Maria Ramos · Maria Reid · Maria Restrepo · Maria Rivera · Maria Salva · Maria Soares ·
Maria Torralba · Maria Viernes · Maria Walker · Maria Warriner · Marian De La Cruz · Mariane
Vicente · Marianel Miralles · Marianita Pelaez · Marianne Cobeldick · Marianne Hernandez ·
Marianne Vakalalabure · Marianne Ventura · Marianne White · Maricar Aquino · Maricar Blancaflor
· Maricar Santos · Maricel Angeles · Maricel Atienza · Marichille Bandales · Marichu Calpo · Marichu
Siao · Maricor Suarez · Maridel Balingit · Marie Aki · Marie Chandra · Marie Darling · Marie Domingue
· Marie Hodges · Marie Jenkins · Marie Molina · Marie Percy · Marie Rutherford · Mariel Marcos ·
Mariel Simblante · Marielle Daligdig · Marielle Palabasan · Marien Fabillar · Marievan Tan · Marife
Galvez · Marife Patterson · Marika Laflamme · Marilou Callo · Marina John · Marina Wildbore · Mario
Algodon · Mario Figura · Marion Paquit · Marion Ver Esguerra · Maris Taueki · Marisa Newman ·
Mariss Yamson · Marissa Hirawani · Marites Suaring · Marivic Sinio · Mariya Antony · Marizz Maneng
· Marj Diciano · Marj Guillemer · Marjan Aghakarimi · Marjo Engel · Marjorie Decena · Marjorie
Gomez · Marjorie Sojor · Mark Adams · Mark Attard · Mark Barber · Mark Bravo · Mark Buada · Mark
Cooley · Mark Dimaano · Mark Florendo · Mark Gela · Mark Gribble · Mark Harper · Mark Lacy · Mark
Nunn · Mark Padlan · Mark Rees · Mark Taylor · Mark Turton · Marlene Barbosa Da Silva · Marlys
Gollop · Marmyl Robson · Marnie Higgins · Marry Pareja · Marsha Cadman · Marta Manicia · Martha
Diprose · Martha Peka · Martin Angeles · Martin Greenfield · Martin Lau · Martin Westley · Martina
Himme · Martine Darrou · Martine Mathews · Martley Mitikulena · Martyn Osborn · Marvie Francisco
· Mary Aparicio · Mary Ann Domingo · Mary Ann Noquilla · Mary Ann Velarde · Mary Bayona · Mary
Boyce · Mary Camboliza · Mary Cho Aung · Mary Clare Craigen · Mary Compoc-Canoy · Mary
Cyriac · Mary Freeman · Mary Gipsy · Mary Gonzales · Mary Jacob · Mary Jean Basilio · Mary Jo
Giray · Mary Jo Matullano · Mary MacLeod · Mary Nicy · Mary Petersen · Mary Rayos · Mary Rongo
· Mary Shiju · Mary Sindhumary · Mary Vasaya · Mary Wagwag · Maryam Hosseini · Maryanne
Chester · Maryanne Gilmore · Mary-Anne Stone · Maryknoll Tacayan · Marylyn Narayan · Maryrose
Carina · Maryvonne Gray · Mason Ock · Matakeu Timms · Mathew Josipovic · Mathias Sackey · Mati
Mati · Matt Aldridge · Matt Bell · Matt Dowling · Matt Heys · Matt Hutchinson · Matt Orr · Matt Poskitt
· Matt Reddock · Matt Sheehan · Matt Southwick · Matthew Brown · Matthew Coates · Matthew
Gowdy · Matthew Leadbeater · Matthew Somosot · Matthew Todd · Mattie Rowlands · Maui Padilla
· Maumi Lavakeiaho · Mauree Parker · Maureen Geeves · Maureen Glentworth · Maureen Johnson ·
Maureen Pacilan · Maureen Puno · Maurice de Jesus · Maurice Schroeder · Max Bellamy · Max
Forthun · Max Wallace · Maxine Gordon · Maxine Gray · Maxine Hansen · May Bilalat · May Bonicatto
· May Carinan · May Checa · May De Los Santos · May Duong · May French · May Hemtanont · May
Magsino · May Raquepo · May Sino-Ag Sargento · May Techa · Maya Daniel · Maya Prasad · Maybel
Bumanglag · Maychelle Bechayda · Mayda Bromley · Maye Agdigos · Mayumi Kobayashi · Mayumi
Shinzaki · McKenzie Watson · Meagan Leqakowailutu · Meagan Spicer · Mealofa Faimalo · Meegan
Duncan · Meehee Kim · Meena Meenakshi · Meena Nathan · Meenu Bandara · Meenu Devasia ·
Meenu Mathew · Meenu Sheeja · Meg Atas · Meg Fraser · Megan Allen · Megan Coffey · Megan
Dempsey · Megan Green · Megan Grey · Megan Knight · Megan Rose · Megan Slater · Megha Pal ·
Meghan Blackwell-Hart · Meghana Thakkar · Mei Bitanga · Mei Yu · Meidy Maza · Meise Misa · Mejie
Macatimpag · Meke Unasa · Mel Allan · Mel Cousins · Mel Hart · Mel Mitchell · Mel Morgan · Mel
Redshaw · Mel Tolete · Mela Moceiwai · Melanie Reyes-Tagle · Melanie Asuncion · Melannie
Marasigan · Melchor Velandria · Mele Ekenasio · Mele Palelei · Mele Vaka · Mele Vi · Meleane Tauveli
· Meliame Nimmo · Melina Vasu · Melinda Opray · Melinda Reside · Melis Casimiro · Melissa Allan ·
Melissa Bell · Melissa Brewster · Melissa Caldwell · Melissa Clark · Melissa Cross · Melissa Downs ·
Melissa Escretor · Melissa Fluit · Melissa Gomintong · Melissa Kim · Melissa Knight · Melissa
Wayland · Melita Tivalu · Melkame Kebede · Mellissa Page · Melody Cajigas · Melvin Manglicmot ·
Melvyn Khatri · Mely Cruz · Memoree Wishart · Menaka Silva · Mengyao Luo · Menik De Silva ·
Menno Blom · Mercy Olores · Mere Caginiveisaqa · Mere Korotuku · Mere Mana · Mere Ravoka ·
Mere Tabataba · Meredith Fricker · Merewalesi Rogasagasa · Meri Janevska · Merin Babu · Merin
Sabu · Merin Thomas · Merina Pradhan · Merlin Daniel · Merlin Varghese · Merlyn Clarke · Merree
Harris · Merrin Jack · Merrit Shaju · Merryl Espanol · Meryll Totanes · Merz Maximo · Meserat
Mulegata Cherente · Mezzy Bi · Mhel Agpaoa · Mhel Bautista · Mi Chaw · Mi Mi Antonio · Mia Azogue
· Mia Bernard · Mia Gallao · Mia Herring · Mia Joseph · Mia Kang · Mia Maranan · Mia McKinley · Mia
Mihaila · Mia Sherwood-King · Mia Wallabh · Mia Wong Yit · Miao Tian · Michael Ablan · Michael
Aninon · Michael Apat · Michael Balazo · Michael Borostyan · Michael Cummings · Michael Esguerra
· Michael Lieu · Michael Malicse · Michael Mcdonald · Michael Mitchelson · Michael Morley · Michael
Sanders · Michael Spahn · Michael Stanton · Michael Turner · Michael VanDerZyden · Michaela
Benkova · Michaela Claridge · Michaela Forgus · Michaela Manu-Adams · Michaela Reyes · Michele
Borrack · Michelle Attard · Michelle Barnard · Michelle Bell · Michelle Berridge · Michelle Blanchard
· Michelle Canning · Michelle Cosslett · Michelle Cowan · Michelle Dew · Michelle Dewent · Michelle
Durrant · Michelle Forgus · Michelle Forman · Michelle Garland · Michelle Greig · Michelle Guthrie ·
Michelle Hetaraka · Michelle Houston · Michelle Howell · Michelle Legaspi · Michelle Lewis · Michelle
Lord-Roper · Michelle Mordaunt · Michelle Paco · Michelle Perkins · Michelle Pickworth · Michelle
Priest · Michelle Reponte · Michelle Robinson · Michelle Shaw · Michelle Sims · Michelle Smith ·
Michelle Sutherland · Michelle Tan · Michelle Tan · Michelle Ung · Michelle Vermeer · Michelle
Wright · Michelle Yang · Michy Mostoles · Mick Boyd · Midas Hill · Mifwany Freeman · Miho Tomoike
· Miita Kourabi · Mika Kato · Mika Nacionales · Mikaela Abraas · Mikaela Cunningham · Mikayla
Watson · Mikayla Miller · Mike Adair · Mike Arsenio · Mike Brophy · Mike Davidson · Mike Gebbie ·
Mike Munslow · Mike Narido · Mike Timajo · Mike Waldman · Mikey Payumo · Mikey Villafuerte · Miki
Nojima-Wylie · Mikie Bausin · Mila Biaukula · Mila Slavinskaya · Milan Rana · Mildred Gaspar · Mile
Grkoski · Milla Ymker-Williamson · Millie Edwards · Millie Fraser · Millie Shanahan · Millie Stratta ·
Milly Bergshoeff · Milly Oldfield · Milu Mathew · Mimi Mendoza · Min Cho · Min Huang · Min Kim · Min
Lee · Min Lee Phang · Min Wang · Mindy Duggan · Mini Poulose · Mint Antapanya · Minty Walia · Minu
George · Miracle Vave · Miranda Barnes · Miranda Bull · Mirasol Beattie · Miruna Karki · Misa
Patterson · Mitali Patel · Mitchell McCutcheon · Mitz Abucejo · Miyoung Kim · Miyuki Ferry · Mlete
Asfaw · Moana Fifita · Moana Martin · Moana Whakaruru · Mohini Nand · Mohini Narayan · Mohini
Olds · Molly Dunbar · Molly Elliott · Molly Steel · Molly Timmins · Momena Begum · Mona Mikhaeil ·
Mona Singh · Mona Zeng · Monette Angadol · Moni Choudhury · Monica Aringoy · Monica Cho ·
Monica Crossan · Monica Manao · Monica Monica · Monica Relucio · Monika Prasad · Monika Rani ·
Monika Yadav · Monima Thapa · Monique Awab · Monique Bahizi · Monique Kelly · Monique Leeson
· Monique Villalobos · Monique Voermanek · Monita Mala · Monty Singh · Monu Pradhan · Moon
Young Kim · Morag Davidson · Moreen Kaur · Morgan Barnes · Morgan Devere Beets · Morgan
Owen · Morgan Wood · Mouli Liyanaarachchi · Mounata Shrestha · Mounika Bathula · Mufida Nisha
· Munah Miller · Munaza Azmie · Murray Bain · Murray Mackessack · Murray Parkes · Murray West ·
187
ANNUAL REPORT 2022
Mykie Scott · Mylen Lingaolingao · Mylene Bugo · Mylene Riotoc · Myra Attwood · Myra Gotz · Myra
Tonks · Myrna Tulloch · Myrtle Brown · Myungju Chung · Nadee Talagala · Nadia Heggland · Nadia
Kuruvila · Nadia Te Awa · Nadia Warburton · Nadine Diack · Nadine Williams · Nafeeza Manga · Nafis
Monazam · Naincy Rastogi · Naini Babu · Naise Palusa · Naj Nahar · Najad Ali · Najete Labbouz ·
Najmoon Noorani · Nalanie Munasinghe · Nalukandathil Anilkumar · Nami Zaman · Namiko Uehara
· Namita Puri · Namita Shyam · Nancy Hayden · Nancy Kumaradhas · Nancy Strapp · Nancy Wilson
· Nandie Maung · Nandika Silva · Nandini Joshi · Nandini Ram · Nani Rokotuisuva · Nanise Bulicakau
· Nao Osato · Naoko Matsuo · Naomi Brady · Naomi Kaba · Naomi Silva · Naomi Tulaga · Naomi Vaea
· Narissa Dayap · Narmadha Dissanayake · Narumon Murray · Nashvin Natke · Nasriin Hagi
Mohamed · Natalei Down · Natalie Curtis · Natalie Finn · Natalie Kearns · Natalie Marya · Natalie
Randall · Nataliya Tretyakova · Natalya Latoa · Natalya Medlock · Natana Gisma · Natasha Carson
· Natasha Henderson · Natasha Rattray · Natasha Sydorenko · Nathalie Palad · Nathan Bremner ·
Nathan McPherson · Nathan Salanoa · Nathan Tahi · Nav Hehar · Nav Kaur · Nav Singh · Nav Singh ·
Navdeep Kaur · Navdeep Kaur · Navdeep Sooch · Naveen Allam · Naveen Pasunooti · Navjeet
Multani · Navjot Brar · Navjot Kaur · Navjot Kaur · Navneet Kaur · Navneet Navneet · Navneet Sidhu
· Navpreet Kaur · Naz McNaught · Neekayla McGimpsey · Neema Benny · Neeru Barot · Neethu
Maxin · Neethu Ramachandran Pillai · Neethu Xavier · Neha Malhotra · Neha Neha · Neha Sharma ·
Nehal Patel · Neil Blunden · Neil Davies · Neil Grinter · Neil Natarajan · Neil Sears · Neil Sunil · Neil
Swift · Neil Villaluz · Neil Watson · Nela Sepuloni · Nell Wineti · Nelson George · Nelson Pajarillage ·
Nemo Arriola · Nena Aglosolos · Nena Balbis · Neneth Alicamen · Neri Macolbacol · Nericha Van
Wyk · Nessa Ojales · Nessy Valoria · Nesum Selliah · Nett Taghoy · Nette Gabriel · Neville Dobson ·
Neville Parkinson · Ngaire Moreton · Niamh McGuigan · Nibin Antony · Nic Knight · Nicci Moeloa ·
Nick Bond · Nick Frische · Nick Hibberd · Nick Male · Nick McGarry-Burford · Nick Pearce · Nick
Wilson · Nicki Brown · Nicki Collingwood · Nicki Hawker · Nicki McLaren · Nicki Wilson · Nickie Tani ·
Nicky Anderson · Nicky Bercich · Nicky Crawford · Nicky Smith · Nicola Bowick · Nicola Fagan ·
Nicola Mitchell · Nicola Steel · Nicola Tarleton · Nicole Carroll · Nicole Chen · Nicole Currie · Nicole
Forster · Nicole Hurford · Nicole Toomey · Nicole Tretyakova · Nicole Yeatman · Nicy Abraham ·
Nidhi Patel · Nidhi Patel · Nidhi Patel · Nigel Bannan · Nigel Geonanga · Nigel Jallorina · Nigel Luff ·
Nigel Megaw · Nigel Orr · Nik Ekdahl · Nik Green · Nika Lafaele · Nikhil Arora · Nikhil Thilakan · Niki
Patel · Niki Rogerson · Niki Veeran · Nikita McIntosh-Zuppicich · Nikita Van Niekerk · Nikitha Madola
· Nikka Bermejo · Nikki Kaur · Nikki Bautista · Nikki Careford · Nikki Edwards · Nikki Flett · Nikki
Francisco · Nikki Hill · Nikki Johns · Nikki Kirner · Nikki Prado · Nikola Karlikova · Nikolai Balanski ·
Nila Boocock · Nila Jayasuriya · Nilda Pagba · Nileshni Devi · Nili Gyawali · Nilma Pettagam · Nilukshi
Perera · Nima Zangmo · Nimalka Rathnayaka · Nimi Jacob · Nimisha Bulsara · Nimisha Maharjan ·
Nimisha Shah · Nimmy Thomas · Nina Bulgakova · Nina Kluge · Nina Melocotones · Nina Reyes ·
Ninja Chahal · Nino De-Jesus · Ninu Augusthy · Nipu Malawalarachchi · Nira Gifkins · Nirali Patel ·
Nirmala Sharma · Niru Chouhan · Niru Wijesundara · Nisah Ismail · Nisha Ghimire Bashel · Nisha
Kaur · Nisha Maharjan · Nisha Mathew · Nisha Mohammed · Nisha Thapa · Nishal Narayan · Nita
Rataro · Nita Yu · Nithara Jose · Nithin Cheriyan · Nitish Thaman · Nittu Mathew · Nizar Virani · Noah
Valois · Nochelle Visitacion · Noel de los Reyes · Noel Giddens · Noeline Plowman · Noeline Watson
· Noema Leota · Noemie Flores · Nonie Alicamen · Nora Arango Bedoya · Nora Esplago · Nora
Tjandrawidjaja · Noreen Zamora · Norly Penalber · Norman Beattie · Nova Santiago · Nu Smith ·
Nuwan Rathanyake · Nye Vyas · Oakley Miller · Oceania Roberts · Odessa Abellana · Odette
Whitter · Ofa Lolohea · Ofa Vaipulu · Oksana Kotlyar · Olga Lorton · Olga Ross · Olive Balli · Oliver
Donaldson · Oliver Konigstorfer · Oliver Lanorio · Olivia Antonievich · Olivia Clover · Olivia Ferrer ·
Olivia Gilmore · Olivia Moorman · Olivia Pulley · Olivia Shin · Olivia Stacy · Olivia Tustin · Olivia Van
de Klundert · Ollie Parvin · Olwyn McGee · Om Prasad · Orada Wisatwongsa · Osien Andaya · Otep
Sacristan · Ovini Hewage · Owen Duncan · Oyahida Tumpa · Paban Karki · Paewai Tume · Paige Cull
· Paige Powell · Paige Tholen · Paki Fihaki · Palack Sharma · Palwinder Kaur · Pam Harliwich · Pam
Haskins · Pam Kaur · Pam Malang · Pam McCreedy · Pam Mino · Pam Mirk · Pamela Ginders ·
Pamela Gonzales · Pami Kariyapperuma · Panchami Thapa Koirala · Pandya Pandya · Pankti Modh
· Paolo Robles · Par Magar · Parampreet Kaur · Paras Kundra · Pardeep Brar · Pardeep Kaur · Parm
Kaur · Parminder Kaur · Parmjeet Kaur · Parmjit Kaur · Parmjit Kaur · Parth Patel · Parvathy Nair ·
Parvati Gandhi · Parveen Brar · Parveena Naicker · Parvinder Kaur · Parvinder Kaur · Parwati
Kriletich · Parwinder Kaur · Pascal Martinez · Pasepa Veilofia · Pat Belcher · Pat Mabunga · Pat
McKee · Pat More · Pat Patterson · Pat Sleeman · Pat Turner · Patch Perry · Patricia Dela Cruz ·
Patricia Hewitt · Patricia Nand · Patrick Fitzgerald · Patrick Ng · Patrick Recio · Patty Khunkaew ·
Paul Blackler · Paul Cameron · Paul Child · Paul Farrar · Paul Francis · Paul Korunic · Paul Lenette ·
Paul Maessen · Paul McGill · Paul McLeod · Paul Minards · Paul O’Carroll · Paul Ponce · Paul Ryan ·
Paul Scrimshaw · Paul Sutcliffe · Paul Sutton · Paul Sutton · Paul Tan · Paul To · Paul Tsang · Paul
Viernes · Paula Fa’aoso · Paula Kennard · Paula Moyles · Paula Tuimasi · Paulette Sheehan · Paulina
Woch · Pauline Liao · Pauline Linton · Pauline Moody · Pauline Murray · Pauline Nickson · Pauline
O’Brien · Pauline Robinson · Pauline Rousseaux · Pauline Waby · Paulini Singh · Pavithra Gunarathna
· Pawan Chand · Pawan Ghimire · Pawandeep Sandhu · Pawani Somarathna · Paz Chan · Paz
Checchecan · Peachy Wee · Pedro del Estal · Peggy Chao · Peggy Tonta · Pele Vaaga · Pelise Muiaa
· Peni Raroa · Penny Forrester · Penny Gallear · Penny Honey · Penny Oakes · Pepa Memea · Pepe
Toe · Percy Abian · Persis Chavan · Pete Allport · Pete Dayo · Peter Alloway · Peter Bellam · Peter
Erian · Peter Gertos · Peter Hollins · Peter Jonson · Peter Macintosh · Peter Shen · Peter Smith ·
Peter Swain · Peter Ware · Peter Whelan · Peti Griffiths · Petra Klingbeil · Petta Danny · Pha Taylor ·
Phil Haynes · Phil Price · Phil Quartly · Phil Yarrall · Philip Jackson-Cox · Philip Mealings · Philip
Spinks · Philippa White · Phill Larner · Phill Page · Phillipa A’Court · Phoebe Laureano · Phoebe Neho
· Phoebe Orola · Phoebe Premacio · Phoebe Tumata · Phoebie Wesche · Phoenix Ryan · Pieta
Valentine · Pieter Kruger · Pilar Merino Neyra · Pinal Parmar · Pine Konelio · Pinkal Patel · Pinki
Thapa · Pinky Ariar · Pip Nolan · Pip Smith · Pip Wayne · Piper Charteris · Pita Bhattarai · Piumi
Gallanga · Polly Hooper · Polly Matheson · Polly Maxwell · Poly Judicpa · Pooja Bist · Pooja Karan ·
Pooja Khaire · Pooja Trehan · Poojan Patel · Poonam Kumari · Poonam B K · Poonam Chauhan ·
Poonam Kumar · Poppy Griffin-King · Portia Chatadza · Prabath Meegoda Gamage · Prabh
Cheema · Prabh Kaur · Prabh Kaur · Prabhjot Sodhi · Pradip Khadka · Pragi Nithyananthan ·
Pragnesh Patel · Prakash Singh · Pramila Putuwar · Praneel Singh · Pranisha Shrestha · Prashant
Khaire · Prasita Prasannan · Pratiksha Wagle · Pratima Ghimire Adhikari · Pratima Singh · Prativa
Singh · Praveen Chirakkunnel · Pravin Singh · Precy Bond · Preema Jose · Preet Kaur · Preet Kaur ·
Preet Kaur · Preet Singh Bedi · Preet Thind · Preethi Meares · Preeti Nair · Preeti Preeti · Preferred
Names Last NamePrema Gavarriah · Premitha Silva · Premlata Shah · Pri Sharma · Pria Escalera ·
Prince Pagtanac · Princess Catostos · Princess Tabay · Priscilla Eru · Priscilla Francis · Priscilla
Mihaere · Pritee Gurung Lama Lopchan · Priti Devi · Priti Tayade · Pritika Devi · Priya Chand · Priya
Chellem · Priya Drummond · Priya Goundar · Priya Gurung · Priya Prakash · Priya Priya · Priya Raj ·
Priya Reddy · Priya Sharma · Priya Sharma · Priya Suresh · Priyanka Tandon · Priyanthi Perera ·
Priyashna Nand · Prox Tiwari · Prudy Macdonald · Puja Malla · Pujan Magar · Punam Kafle · Puneet
Bhardwaj · Pusham Pusham · Pushpa Balodi · Qin Xueqin · Qiong Bi · Quan Tran · Queen Samosa ·
Queenie Cabatingan · Queenie Liu · Queenie Ly · Quentin Howell · Quinn van Vierzen · Rabina Silwal
· Rabyn Reveche · Rach Wates · Rachael Boyd · Rachael Crow · Rachael Hearn · Rachael Mason ·
Rachael Pates · Rachael Seyb · Rachael Shaw · Rachael Tuhi · Rachael Van Aalst · Rachael Walker
· Racheal Trinidad · Rachel Alford · Rachel Andrews · Rachel Bakker · Rachel Borthwick · Rachel
Cadzow · Rachel Clark · Rachel Garrard · Rachel Lalor · Rachel Lim · Rachel Llido · Rachel Pointon
· Rachel Ratcliffe · Rachel Seumanutafa · Rachel Simons · Rachel Wangui · Rachel Williams ·
Rachelle Javier · Rachelle Jones · Rachelle Summerfield · Radhika Lingam · Radhika Reddy ·
Radika Sami · Raewyn Bishop · Raewyn Oppert · Raewyn Redfern · Raewyn Sides · Raewyn Slade ·
Raewyn Taylor · Raewyn Wright · Raf Lachica · Rafelle Tantia · Rafi Arrafi · Raghad Asmaro ·
Raghani Chandra · Rahul Choudhary · Rahul Parel · Rahul Rahul · Rahul Suresh · Raissa Manicad ·
Raissa Morales · Raj Grewal · Raj Kaur · Raj Kaur · Raj Kaur · Raj Kumar · Raj Lata · Raj Radhakrishnan
· Raja Lakshmy Antonrefod · Raja Thirumugam · Rajan Kumar · Rajani Acharya · Rajbeer Kaur ·
Rajbir Kaur · Rajee Srikanthan · Raji Naguleswaran · Rajiv Patel · Rajneel Shankar · Rajni Punia · Raju
Lama · Raju Pudasaini · Rajveer Brar · Rajwinder Kaur · Raken Abiteti · Rakesh Patel · Ralph Molina
· Ralph Wang · Ram Amancio · Ram Martir · Rama Niroula · Raman Gill · Raman Kaur · Raman Kaur
· Raman Kumar · Ramandeep Kaur · Ramandeep Kaur · Ramandeep Kaur · Ramandeep Kaur ·
Ramandeep Kaur · Ramandeep Kour · Ramanpreet Syal · Ramhari Basnet · Rami Kamel · Ramil
Francisco · Ramon Supit · Ramya Bellam · Randeep Kaur Parihar · Randy Wineti · Rane Largo ·
Rangi Hill · Rani Devanand · Ranjana GC · Ranjana Gurung · Ranjit Kaur · Ranshan Nanayakkara ·
Raoul Bravo · Raphael Rausch · Raquel Bibal · Raquel Rapp · Rasanjana Kumarasinghe · Rashmi
Gurung · Rashmika Senevirathne · Rasleen Sidhu · Ravandeep Dhaliwal · Ravanjit Sidhu · Raveena
Sharma · Raveesha Suriyapperuma · Raven Bitancor · Raven McMillan · Ravi Singh · Ravs Kaur ·
Rawinia Renata · Ray Fairbairn · Ray Guiao · Raya Aganon · Raylene Rangi · Raziya Nisha · Razyl
Canlas · Rea Pagkaliwangan · Rebecca Bullock · Rebecca Burgess · Rebecca Croudace · Rebecca
Denmark · Rebecca Fielding · Rebecca Keen · Rebecca Kenny · Rebecca Little · Rebecca Lomax ·
Rebecca Marquis · Rebecca McKinstry · Rebecca McMillan · Rebecca Mushet · Rebecca Sabu ·
Rebecca Schumacher · Rebecca Tuipala · Rebecca Waine · Rechelle Gonzales · Red Mati · Reema
Devi · Reema Kaur · Reema Mathew · Reena Abaya · Reena Chandar · Reena Kumar · Reena Waiba
· Reet Gumber · Reet Mann · Reet Ritu · Reeta Singh · Regina Gounder · Regine Macarubbo ·
Rehana Sharif · Rei Paranihi · Reina Saludares · Reis Lectura · Rejena Galimba · Rejena Lazar ·
Rejina Khadka · Rekha Ramanath · Rekha Rekha · Remya Rajagopal · Remya Sudeep · Rena Allen ·
Rene Knight · Renee Green · Renee Green · Renee Hanmore · Renee Hayes · Renee Julian · Renee
Lowe · Renee Mahe · Renee Perreau · Renee Peters · Renee Ring · Renee Schreuder · Renee
Tauwhare · Renee Young · Renei Thaggard · Renish Raju · Renisha Senchyury · Renuka Gounder ·
Renuka Kant · Reshma John · Reshma Mala · Reshma Mathew · Reshma Vandhana · Reshmi Lata ·
Reshmi Narayan · Reshmi Rao · Rester Delarmente · Revlin Ratishma · Reydun Kihi · Reyn Dilag ·
Reys Gengoyon · Rezina Pradhan · Rhea Mesia · Rhianna Litherland · Rhianne Overell · Rhoi Maza ·
Rhona Licanda · Rhona Miranda · Rhonda Colvin · Rhondda Carter · Rhyarna Batchelor · Rhys
Hodgins · Ria Jamin · Ria Verma · Riana van Niekerk · Riarawa Tematau · Ric Bonacua · Ric Diaz ·
Ricardo Onate · Ricardo Pureza · Richa Ale · Richa Kumar · Richard Chisholm · Richard Crump ·
Richard Dackers · Richard Greathead · Richard Rivera · Richard Sherrell · Richard Stoop · Richard
Umbers · Riche Campaniel · Richell Sabsal · Richelle Villanueva · Rick Davies · Rick Moller · Ricky
Bruining · Ricky Ciobanu · Ricky Wang · Riddhi Chaudhary · Rie Moulton · Riffy Jahan-Khan · Riji
Johny · Riju Rajnashi · Rika Kawakami · Riki Dobbs · Rikita Kunwar · Riley Acutt · Rimmi Kaur · Rina
Maharjan · Rindi Harmse · Rino Selvaraja · Rinu Mathew · Rio Lagahit · Risa Ellis · Rishad Hussain ·
Rishi Mangalat Kokkodan · Rita Antonisamy · Rita Chand · Rita Connolly · Rita Duffy · Ritchell Kho ·
Ritchie Ponce · Riya Darshani Ram · Riya George · Riya Mahna · Rizwana Batool · Rizza Moron · Rob
Carter · Rob Madden · Rob Maier · Rob Miller · Rob Shone · Rob Tanner · Rob Treanor · Robbie
Muller · Robby Mendoza · Robert Cradock · Roberta Baxendale · Robyn Elder · Robyn Kerr · Robyn
McCracken · Robyn McNeil · Robyn Nicholson-Pepe · Robyn Sullivan · Robyn Thompson · Robyn
Tutton · Rochelle Chau-Lacerna · Rochelle Apps · Rochelle Bibal · Rochelle Cohen · Rochelle
Concha · Rochelle Cooper · Rochelle McIntyre · Rocky Atendido · Rod Quan · Rodela Caldea ·
Rodney Lewis · Roger Cabuquin · Roger Nuttall · Rohan Sharma · Rohina Nick · Rohini Devi · Rohini
Gurung · Rohini Lal · Rohini Lata · Rohini Lata · Roj Diola · Roji Maharjan · Roji Timilsina · Roma
Tarranza · Romina Carangalan-Rosales · Romisha Timsina · Romy Wimalaratne · Ron Anand · Ron
Emilio · Ron Ente · Ron Lim · Ronald Babe · Ronald De Jesus · Ronaliza Labang · Ronalyn Alolor ·
Ronalyn Corpuz · Ronan Payinda · Roni Lamsen-Castillano · Roni Mathew · Roni Mathew · Ronita
Devi · Ronita Prakash · Ronita Prasad · Ronna Torregosa · Ronny Liew · Roop Bhullar · Roopa Roopa
· Roopa Shetty · Roopal Patel · Rory Harris · Rory Edwards · Ros Glennie · Ros Hayhoe · Rosa
Dalgleish · Rosa Hye-Won · Rosa Pendijito · Rosa Tipa · Rosanna Beveridge · Rosanne Gee · Rosaria
Manjala · Rose Antioquia · Rose Avery · Rose Baby · Rose Coulson · Rose Jenkins · Rose Kaur · Rose
Lawlor · Rose Noval · Rose Tabasan · Rose Taylor · Rose Tom · Roseanne Crockett · Rosebelle
Presilda · Rosecilla Saulon · Roselee Mudalige · Roseleen Khan · Roseline Sharma · Roselle Camatis
· Roselle Plata · Roselle Rensulat · Rosemary Deane · Roshan Punnose · Roshan Sharma · Roshila
Cherman · Roshini De Silva · Roshmen Ali · Roshni Hicks · Roshni Lata · Roshni Raja · Roshni Reddy
· Rosie Butler · Rosie Malone · Rosie Williams · Rosina Bano · Roslyn Prentice · Ross Bulling · Ross
Howes · Ross Sutherland · Rosy Khokhar · Roula Yianakis · Rowan Moustaid · Rowena Battad ·
Rowena Corpuz · Rowena Daan · Rowena McClutchie · Rowena Newport · Rowena Wood · Rowie
Jabiguero · Roxanne Balidio · Roxanne Gapuzan · Roxanne Mores · Roxanne Rosquita · Roxanne
Shaw · Roy Staite · Rozmin Rasheed · Rubbi Kaur · Ruben Kumar · Rubie Banas · Rubina Jamal ·
Ruby Galviz · Ruby Johny · Ruby Kanwar · Ruby Kaur · Ruby Natt · Ruby Shrestha · Ruchi Thakur ·
Ruel Infante · Ruel Alcaria · Rufaida Khaled · Rufaro Ndoro · Rui Liu · Rukshan Gopallawa · Ruling
Huang · Rupa Sherma · Rupi Kaur · Rupinder Kaur · Rupinder Kaur · Rupinder Kaur · Russell Keast ·
Russell Reazon · Ruth Makin · Ruth Murray · Ruth Waterhouse · Ruthy Rabo · Ruthy Van Heerden ·
Rutvik Patel · Ruwan Colombage · Ry Llanes · Ryan Bensberg · Ryan Evans · Ryan Jarvis · Ryan
Junaid · Ryan Knofflock · Ryan McLaren · Ryan Patron · Ryan Tri Duc · Ryan Verbo · Ryan Winks ·
Rylee Trembeth · Rylee Wagteveld · Rymel Polittude · Saakshi Sunnaina · Saane Toniafa · Sabarine
Asif · Sabby Barara · Sabita Bhattarai · Sabitri Gajurel · Sabrina Cheema · Sabrina De Souza ·
Sachin Parmar · Sade Scott · Sadhana Devi · Sadhana Wati · Sadika Shrestha · Sageera Rawat ·
Saggita Devi · Saifun Nisha · Saijy Lijo · Saj Karki · Sajana Khadka · Sajana Shabin · Sajeeve
Rajasuriya · Sajid SK · Sake Kovuri · Sakul Viliyatharayil · Sala Tagata · Sala Waqanituinayau · Salani
Penisula · Sale Guranjit · Saleem Richards · Salie Alcartado · Sally Crawford · Sally Haslam · Sally
Hayashi · Sally Sampson · Sally Thornton · Sally Uolo · Sally Veng · Sally Waldek · Sallyann
Galodamu · Salochana Naidu · Saloma Faaaoga · Salote Mocevakaca · Salote Tuivakano · Sam
Adhikari · Sam Bagrie · Sam Case · Sam Cassidy · Sam Dove · Sam Gardner · Sam Greaves · Sam
Harvey · Sam Hay · Sam Hibbs · Sam Huang · Sam Huang · Sam Hudson · Sam Kingsbury · Sam
Leahy · Sam Magno · Sam Mahapure · Sam Manson · Sam Nelson · Sam Nicholls · Sam Pewhairangi-
Stok · Sam Powell · Sam Price · Sam Rakai · Sam Rintoul · Sam Rusden · Sam Shirkey · Sam Singh ·
Sam Singh · Sam Thomlinson · Sam Tobias · Sam Twyman · Sam van den Heever · Sam Weston ·
Sam Woolford · Samantha McPherson · Samantha Morris · Sami Gulliver · Sami Maharjan ·
Samikshya Dhakal · Samira Khan · Samista Subedi · Samita Magar · Samjhana Rocka · Sammi
Zhang · Samuel Julian · Sanam Adhikari · Sandeep Johal · Sandeep Kaur · Sandeep Kaur · Sandeep
Kaur · Sandeep Kaur · Sandeep Kaur · Sandeep Kaur · Sandeep Kumar · Sandeep Sidhu · Sandeep
Waraich · Sandi Keen · Sandie Campbell · Sandie Eddy · Sandika Ghimire Gautam · Sandra Batten
· Sandra Berridge · Sandra Champion · Sandra Chapman · Sandra Duckworth · Sandra Hartley ·
Sandra Hendriks · Sandra McGlade · Sandra Officer · Sandra Rogers · Sandra Siakifilo · Sandra
Stacey · Sandy Kaur · Sandy Kaur · Sandy Kaur · Sandy Kurukularatne · Sandy Paterson · Sandy
188
RYMAN HEALTHCARE
Patterson · Sandy Pihema · Sandy Wilde · Sangeeta Lata · Sangya Thapa · Sanita Kumar Bai ·
Sanjay Rivera · Sanjay Ruke · Sanjita Gurung · Sanjita Ratnam · Sanjita Rayamajhi Karki · Sanju
Skaria · Sanjuni Thapa · Sanna McGavin · Sanumol Antony · Sanura Kuruwita · Sany Sany
Kalappurakkal · Sapana Bayambu · Sapana KC · Sapna Mer · Sapna Walia · Sara Bray · Sara Croul ·
Sara Fearnley · Sara Ghale · Sara Hodgson · Sara Kuruvila · Sara Lukic · Sara McCunnie · Sara Rosa
· Sara Vahua · Sarah McCardle · Sarah Andrews · Sarah Arps · Sarah Direen · Sarah Emett · Sarah
Greig · Sarah Guo · Sarah Henderson · Sarah Higgins · Sarah Jamieson · Sarah Keane · Sarah Laiz ·
Sarah Lomax · Sarah Lovelady · Sarah Maxwell · Sarah McKeon · Sarah Meakin · Sarah Motion ·
Sarah Munoz · Sarah Owen · Sarah Reat · Sarah Reid · Sarah Taylor · Sarah Tomas · Sarah Vivian ·
Sarah Walsh · Sarah-Jane Hamblin · Saras Govender · Sarath Kundathil · Saravjeet Kaur · Sarda
Gounder · Sarika Prasad · Sarina Hubber · Sarina Shrestha · Sarit Devi Lal · Sarit Epshteyn · Sarita
Kumar · Sarita Prasad · Saritha Kaithavalappil · Saritha Mathew · Saroj Chauhan · Sarojni Kumar ·
Sarojni Sarojni · Sarpreet Kaur · Sasha Laiz · Sasha Nefiodov · Sashi Hutchins · Sashi Lata · Sashi
Prasad · Sasi Chakrapani · Saskia Hannink · Satbir Kaur · Sathya Shanmugasundaram · Savannah
Agnew · Savannah Kemp · Savannah Lu · Savi Kumar · Savita Kumari · Savita Reddy · Savitri Naidu
· Savitri Naidu · Scott Bremner · Scott Crawford · Scott Duckford · Scott Lewis · Scott Newey · Scott
Perry · Scott Schofield · Scott Thompson · Sean Crosby · Sean De Guzman · Sean Jenkins · Sean
Morgan · Sean Ortuoste · Sechelle Smith · Seekku Silva · Seema Parmar · Seena Sudharman ·
Seena Varghese · Seetha Mwashomah · Seirosa Fakaofo · Sejalben Patani · Selina Philibossian ·
Selly Tumigolung · Senijiale Fuakilau · Seniya Sebastian · Senolita Vea · Sequoia Aitken · Sereana
White · Serena Young · Serene Liutogia · Serene Ng Brown · Sergio Cordeiro Junior · Sha Sun ·
Shabana Jawaid · Shabnam Ali · Shaira Canete · Shairin Begum · Shaleeni Goundan · Shalesni
Kumari · Shalika Wijethilaka · Shalini Shah · Shaly Lazer · Shameena Abdurahiman · Shamini
Priyatharsan · Shamshad Begum · Shamsun Partap · Shanaye Anderson · Shane Fairbairn · Shane
Gumley · Shane Ormshaw · Shane Rawlins · Shane Vargas · Shanelle Pretorius · Shanjita Chand ·
Shanlee Barnes-Webber · Shanna Li’o · Shanno Chand · Shannon McClutchie · Shannon Walsh ·
Shannon Whitmore · Shantam Lone · Shanthi Fernando · Shanthy Gopal · Shanti Prasad ·
Shaqueena Kerr · Sharalyn Pomare · Sharan Brar · Sharandeep Kaur · Sharanjit Kaur · Shareen Devi
· Sharifa Hamidu · Sharil Narayan · Sharl Absin · Sharleen Gounder · Sharleen Warren · Sharlene
Garcia · Sharmila Lal · Sharmila Sharma · Sharni Mitchell · Sharol Sunny · Sharon An · Sharon
Armstrong · Sharon Balsom · Sharon Chapman · Sharon Denniston · Sharon Grogan · Sharon
Hamlyn · Sharon Henderson · Sharon Maich · Sharon Mathew · Sharon McDonald · Sharon Ritchie ·
Sharon Saju · Sharon Tainui · Sharon Wilton · Sharon Wu · Sharron Neale · Sharyn Elliott · Sharyn
Basham · Sharyn Hunt · Sharyn Kennedy · Sharyn Pisani · Sharyn Ward · Sharyn Weightman · Shaun
Steele · Shaveen Fernando · Shay Singh · Shay Spark · Shayal Lata · Shayal Naidu · Shayal Raju ·
Shayal Shiwani · Shayna Begum · Shazneen Bi · She Briones · Shee Hawe · Sheema Bhujel ·
Sheemal Shiwani · Sheena Benitez · Sheena David · Sheena Theobald · Sheena Villa · Sheethal
Joseph · Sheevey Quezon · Sheffy Jose · Sheila Bascara · Sheila Gamboa · Sheila Nelgas · Sheila
Opena · Shekhar Katwal · Shelby Bercich · Shell Child · Shellden Kruyff · Shelley Austin · Shelley
Ferguson · Shelley Harris · Shelly Carroll · Shelly Castillo · Shelly Kaur · Shelly Mani · Shelly
Snodgrass · Shelomy Dollaga · Shemery Sevilleno · Shenal Shivasani · Sheng Puguon · Shequille
Stewart · Sheral Dayal · Sherine Megula · Sherlyn Alquetra · Sheron Kaur · Sheron Perera · Sherree
Wilson · Sherry Cruz · Sherry Janagal · Sherry Verma · Sherryl Sy · Sherwin Li · Shery Mercado ·
Sheryl Aguarilles · Sheryl Cosep · Sheryl Keen · Sheryl Madlangbayan · Sheryl Morris · Sheryl
Soriano · Shey Landiza · Shiela Abiada · Shiela Cabauatan · Shiela Llameg · Shiela Nebalga · Shija
Koirala · Shikha Shikha · Shikha Singh · Shikha Vala · Shikha Verma · Shilpa Mathew · Shinaai
Schroeder · Shiny Varghese · Shirjana Neupane · Shirley Bakulich · Shirley Bucua · Shirley Goodall
· Shirley Jiang · Shirley Krishna · Shirley Lagavakatini · Shirley Pan · Shirline Lubanga · Shivam
Awasthi · Shivangika Ashok · Shivani Gounder · Shivani Patel · Shivani Puri · Shivani Shivani ·
Shiwani Acharya Tiwari · Shobna Kumar · Shom Lata · Shon Frater · Shona Bayliss · Shona Newman
· Shoncey O’Brien · Shraddha Maharjan · Shreta Chand · Shrijana Dahal · Shuba Selvaraj · Shubham
Rana · Shukri Mohamed · Shun Lu · Shunyi Zhang · Shuvayi Mbewe · Shweta Bawlekar · Shweta
Devi · Shweta Nand · Shweta Raheja · Shy Thomas · Shyani Weerawansa · Shyji Sebastian · Shyna
Boock · Shyrene Bechoo · Sia Anand · Sia Palusa · Siam Siam · Sianne Pinto · Sibi Antony · Siby
Mathew · Sidharth Saini · Sieska Verdonk · Siga Parker · Sigas Bose · Sigfred Lagajino · Sigin
Pullemkunnel · Sikva Javaid · Siliva Samuelu · Silvana Marascia · Silvy Thomas · Simeon Brink ·
Simerjit Kaur · Simi John · Simin Alipour · Simoa Ale · Simon Mitchell · Simon Emett · Simon Hooker
· Simon Jantke · Simon Judd · Simon Judge · Simon Lee · Simon Morley-John · Simon Richards ·
Simona Cernic · Simone Blandford · Simone Taylor · Simone Venanzi · Simran Kaur · Simran Kaur ·
Simran Kaur Sra · Simran Singh · Simran Verma · Sina Afamasaga · Sini Gibu Joseph · Sini Jose ·
Sioban Gray · Siobhan O’Connor · Sione Tonga · Sipa Kiko · Sirisuda Charoensak · Sisi Tawake · Sisy
Tamala · Sita Mainali · Siteri Kama · Siteri Nava · Siu Tapaevalu · Skye Davis · Snap Venturanza ·
Snezhana Bubnova · Snower Singh · Sobin Stephen · Sofia Ditta · Sofia Ryan (Faagutu) · Sofia
Sartori · Sofin Mohammed · Sohaib Kabir · Somkhit Lightbourne · Sona Basnet · Sona Varghese ·
Sonam Dhir · Sonia Bonaobra · Sonia Cuasito · Sonia Joseph · Sonia McMartin · Sonia Peter · Sonia
Sharma · Sonia Vincent · Sonika Kissun · Sonika Sharma · Sonika Singh · Soniya Alex · Soniya Magar
· Sonya Brown · Sonya Dunlop · Sonya Overy · Sookie Magallones · Sophia Jarvis · Sophia Kevill ·
Sophia Le Grice · Sophia Niblock · Sophia Schaumkel · Sophia Shan · Sophia Zhang · Sophie
Barnes · Sophie Bates · Sophie Beechey · Sophie Campbell-Patston · Sophie Devi · Sophie Gillham
· Sophie Griffths · Sophie Harvey · Sophie Howell · Sophie Iceton · Sophie Koroniadis · Sosma
Adhikari · Soumia Jose · Soumya Antony · Soumya Charlie · Sova Nairoroi · Sowmya
Balasubramanian · Sree Somasekharan · Sreypov Ing · Srishti Yelagani · Sriyani Sriyani · Stacey
Hancock · Stacey Magee · Stan Bickerton · Starra Wood · Steen Neal · Stef Monje · Steffen Muir ·
Stella Boyte · Stella Wong Mok · Steph Cawte · Steph Croy · Steph Griffin · Steph Villarin · Steph
Young · Stephanie Hore · Stephanie Broadhurst · Stephanie Chen · Stephanie Song · Stephen Best
· Stephen Browning · Stephen Cartwright · Stephen Denvers · Stephen Dickson · Stephen Fitchett
· Stephen Hammond · Stephen Thompson · Stephen Wordsworth · Stephy Jose · Stephy Joy ·
Steve Burns · Steve Clark · Steve Cotter · Steve Hayes · Steve Herries · Steve Jennings · Steve
Kleehammer · Steve Lewthwaite · Steve Porter · Steve Wakeman · Steve West · Steven Maxwell ·
Stevie Gideon-Scurrah · Stevie Johnson-Roberts · Stevie Taiwhati · Stewart Connolly · Stu
Oostdam · Stuart McPherson · Stuart Williams · Su Kyong Kim · Su Rai · Subhnam Khan · Suchada
Jarupongpimarn · Sue Adamson · Sue Banks · Sue Claxton · Sue Duckworth · Sue Fox · Sue Frew ·
Sue Gemmell · Sue Hammond · Sue Horan · Sue Hurcomb · Sue Kaur · Sue Kim · Sue Knight · Sue
Lee · Sue Liang · Sue Massie · Sue Miller · Sue O’Brien · Sue O’Malley · Sue Serau · Sue Stace · Sue
Stalls · Sue Su · Sue Su · Sue Tan · Sue Taylor · Sue Wells · Sue Wickham · Sugith Lonappan · Sujana
John · Sujata Patel · Sujee Shrestha · Suji Subash · Sujitha Pallissery · Sukh Rai · Sukhbir Kaur ·
Sukhleen Kaur · Sukhmani Khatri · Sukhmeet Kaur · Sukriti Jain · Sulfiya Abdulrahiman · Su-Lize
Page · Sultan Salauddin · Suman Lata · Sumi Gurung · Sumi Neupane · Sumitha Raju Pottayil ·
Sumitra Shrestha · Sumnima Poudel · Sun Bhandari · Suna Rijal · Sunil Magar · Sunita Ghimire ·
Sunita Nepali · Sunita Sami · Sunny Choi · Sunny Sandeep · Sunny Singh · Sunny Singh · Sunshine
Ramirez · Supriya Shrestha · Suren Deshar · Suresh Fernando · Susan Cristina · Susan Bacod ·
Susan Baird · Susan Braybrook · Susan Brister · Susan Crarer · Susan Crozier · Susan Hughes ·
Susan Jane · Susan MacLean · Susan Rae · Susan Sainsbury · Susan Somerfield · Susan Spittal ·
Susanne Boehm · Sushila Devi · Sushma Bajracharya · Susi Alefosio · Susie Alayne · Susie
Magalhaes · Susie Thomas · Susinder Rajendran · Susmita Chhetri · Susmita GC · Suzan Dougherty
· Suzanna Allan · Suzanne Austen · Suzanne Cook · Suzanne Elliott · Suzanne Gain · Suzanne Mason
· Suzanne Wells · Suzette Nuyda · Suzette Otacan · Suzleen Lata · Suzy Gibbs · Svetlana Ivanova ·
Swastika Kumar · Swathy Dev · Swati Prakash · Sweta Borkar · Sydney Burchell · Sylvia Consadine
· Syvelle Baricuatro · Tabby Foster · Tae Tekarawa · Tagi Yabakirua · Taha Al-Zaher · Tahmina
Rahman · Taina Tuipulotu · Takumi Obara · Tala Taulupoo · Tala Vea · Talai Ati · Tali Ruatu ·
Talwinder Kaur · Tam Gurung · Tamara Bradford · Tamara Nkhuwa · Tamara Price · Tami Trow ·
Tamsin Eldridge · Tanae Jansen · Tangi Ohuka · Tania Boyd · Tania Carlson · Tania Hapi · Tania
Johnston · Tania Lilley · Tania Lister · Tania Palomino Vargas · Tania Richards · Tania Walker ·
Taniko Rangihau · Tanja Kroch · Tannia Tannia · Tanu Kaur · Tanya Dwimarsita · Tanya Grieve ·
Tanya Lombardi · Tanya Mandeya · Tanya McGurk · Tanya Swart · Tanya Waters · Tara Berkett ·
Tara Budhathoki · Tara Jacobsen - Kedzlie · Tarn Gardner · Tarn Ketpichai · Tarnz Jordan · Tarnz
Morrison · Tarnz Nuku · Tarryn Carson · Tarun Kumar · Taryn Eagle · Taryn Jonasen · Tash
Richardson · Tatenda Jack · Tatto Amran · Tau Faatoto Malaga · Tau Kalepo · Tayla Ball · Tayla Beck
· Tayla Markwick · Tayla Penfold · Taylor Allison · Taylor Lawson-Smith · Taylor Murphy-Peters ·
Tayyaba Latif · Tazia Nisha · Tazmin Houghton · Te Kopa Reedy · Te Manuka · Te Rangi White ·
Teeau Kabiri · Teenu Skaria · Tehanie Azcona · Tehsin Mansuri · Tejal Patel · Tek Namoori · Telma
Tom · Tenia Kapera · Tenille Pickett · Teota Aiwa · Tererei Koura · Teresa Churchill · Teresa
Jurkiewicz · Teresa Mazzola · Teressa Matthews · Terri McKenzie · Terri Taylor · Terry Bacon · Terry
Daniels · Terry Geoghegan · Tesa Leano · Teshi Khatiwoda · Tesma Chittettu Tom · Tess Canoy ·
Tess Danganan · Tess Desai · Tess Mallari · Tessa Burry · Tessa Edwards · Thalia Taurere · Thamara
Fernando · Thanz Lachica · Tharaka Premachandra · Tharuksha Soysa · Thavy Mey · Thea Dickson
· Thea Robiso · Theja Kudahetti · Thejani Sasanthika · Thelma Escobar · Thelma Littlejohn · Theo
van de Klundert · Theodore Hernandez · Theresa Zamora-Coates · Theresa Ada · Theresa
Hattingh · Theresa Hooper · Theresa Maniulit · Theresa Rayner · Theresa Robiso · Theresa Te
Whata · Theresa Tuilata · Theresa Turner · Thesa Dizon · Thomas Picard · Thomas Wanke · Thu
Nguyen · Thushari Withanage · Tiau Itaaka · Tiegan Maru · Tiffa Jumao-As · Tiffanie Chen · Tiffany
Grant · Tim Goodwin · Tim Lewis · Tim Reihana · Tim Saubuli · Tim Vaughan · Tin Liclican-Coloma ·
Tin Novilla · Tin Tagle · Tina Aston · Tina Belsham · Tina Cundy · Tina Fenton · Tina Healy · Tina
Mateo · Tina McNally · Tina Schwenke · Tina Strahl · Tina Thomson · Ting Chen · Tintin Naharoh ·
Tin-Tin Ladisla · Tintu Thomas · Tisa Gopal · Tish Prosser · Tita Diamante · Tittu Thomas · Tiyanie
Arachchige · Toa Sa Utaiaana · Toby Cartwright · Toby Cooke · Todd Clayton · Todd Parker · Tofi
Lefeau · Toji Nihinsa · Toka Toawea · Tom Bright · Tom Brownrigg · Tom Farrell · Tom Goldsmith ·
Tom Karamalis · Tom Mantle- Chadfield · Tom Necklen · Tom Sun · Tom Zaugg · Tomi Bidois ·
Tomirose Dela Cruz · Tong Go · Toni Acciarito · Toni Cochrane · Toni Pasco · Toni Rankin · Toni Ryan
· Toni Snell · Tonia Shakhova · Tony Burke · Tony Cassidy · Tony Clyne · Tony Killip · Tony Santiago ·
Tony Thomas · Tony Villanueva · Tony Weber · Tony Zinsli · Tori Miles · Tory Lennon Hamilton · Toto
Ajawas · Toyomi Furuta · Tracey Burtenshaw · Tracey Campen · Tracey Clapp · Tracey Doody ·
Tracey Dunn · Tracey Herron · Tracey Irvine · Tracey Leuty · Tracey Lord · Tracey McCauley ·
Tracey McCullough · Tracey Moncur · Tracey Vertigan · Tracey Voumard · Tracey Williams · Tracy
Blackadder · Tracy Elliott · Tracy Kemp · Tracy Lui · Tracy Mahoney · Tracy McCartney · Tracy
McLeod · Tracy Munford · Tracy Quill · Tracy Thomson · Tracy Webster · Tracy Wickman · Tram
Lam · Trang Le · Trav Maaka · Travis Cocks · Trent Keen · Tressa Thomas · Trevor Davies · Tricia
Ditablan · Trini Humphrey · Trippee Velasco · Trish Coker · Trish De Jong · Trish Malone · Trish
Murray · Trish Reid · Trish Tallott · Trish W Warren · Trisha Valdrez · Tristan Rodway · Tristan
Youngblood · Troy Le Comte · Troy Mason · Troy Noronha · Troy Pedder · Trudi Martin · Trudi
McNamara · Trudy Royfee · Trudy Shepard · Trudy Stark · Trystan Su · Tsitsi Marimi · Tua Brown ·
Tua’a Simone · Tui Duffull · Tulip Atinae · Ubbie Kooma · Udara Wickramaratne · Ula Taufao · Ulric
Bawayan · Ultric Du Plooy · Ulysses Estrellada · Uma Chinnaiyan · Uma Kumar · Uma Tamang ·
Umang Baldaniya · Una Liavaa · Unnti Madaan · Upekha Fernando · Upul Welgama · Urvashi Joshi ·
Urvashi Puri · Usha Pratheepan · Uwe Braun · Uzma Zaveeri · Vaisakh Bijukumar · Val Abarquez · Val
Calvert · Val Spalding · Vandan Rishi · Vandana Kazal · Vandana Narayan · Vandana Pillay · Vanessa
Camba · Vanessa Capistrano · Vanessa Claridge · Vanessa Hallett-Free · Vanessa Jeng · Vanessa
Jinayon · Vanessa Maher · Vanessa Manihera · Vanessa Manozo · Vanessa Ranger · Vanessa Welch
· Vaneza Narsico · Vannida Kheng · Vara Nailawe · Varice Mangente · Varns Tuapawa · Varun Dayal
· Varun Surendranath · Vasga Naidu · Vash Ella · Vasu Sharma · Veda Kantayapalam · Vee Morris ·
Veena Prabha · Veer Kaur · Veerpal Kaur · Venice Sayson · Venus Conag-Ochea · Vera Butler · Vera
Go · Vera Karauia · Vera Tia · Verna Jacobs Douglas · Verna Mepana · Veronica Basinang · Veronica
Freire · Veronica Tellis · Vick Zhou · Vicki Engu · Vicki Leggett · Vicki McLennan · Vicki Minehan ·
Vicki Mokalei · Vicki Payne · Vicki Taylor · Vicki Webb · Vicky Boswell · Vicky Lilley · Vicky Padillo ·
Vicky Sel-Ayen · Vicky Tunnell · Vicky Veeran · Vicky Weekley · Vicky Zhang · Victor Tan · Victoria
Brevoort · Victoria Dalpatan · Victoria De Luna · Victoria Nand · Victoria Nuzzi · Victoria Oun ·
Viduni Gunarathne · Vidya Ashok · Vidya Wati · Vijay Gounder · Vijay Khadka · Vijay Lachmi · Vijaya
Sathasivam · Vikas Sharma · Vikashni Prasad · Vikki Searle · Vilma Cahis · Vilma Valerio · Vimal
Kaur · Vimesha Ramanayake · Vimla Wati · Vincent Ngawini · Vincy Varkey · Vinil Wilson · Vinita
Nand · Vinita Vishalni · Vinny Naikau · Vintika Vinashni · Vipi Vasu · Vir Villacorta Jr. · Virginia
Makore · Vishal Modi · Vishal Kishor · Vishal Patel · Vishal Vaghela · Vishnu Somasundranpillai ·
Vitash Sharma · Viv Nixon-Mead · Viv Sayson · Vivian Phillips · Vivian Du · Wallace Chen · Walter
Aban · Wan Yaemkul · Wanfei Cao · Wani Lalwani · Wanida Boonyarak · Wara Prakobtiang · Watinee
Srathongboon · Wayne Blazey · Wayne Booth · Wayne Lockhart · Wayne Murray · Wayne Turnbull ·
Weena Aglugub · Weena Evora · Wemerson Barbosa Nunes · Wen Wang · Wendy Arluck · Wendy
Bourke · Wendy Burns · Wendy Chinh · Wendy Gacayan · Wendy Gordon · Wendy Hamilton · Wendy
Harris · Wendy Hern · Wendy Jiang · Wendy Johnstone · Wendy Kaka · Wendy Kappler · Wendy
Kennedy · Wendy Laurie · Wendy MacDonald · Wendy Miller · Wendy Stanton · Wendy Turton ·
Wendy Wei · Wenna Barrido · Wesi Singh · Whela King · Whetu Haua-Bartlett · Whitney Howman ·
Wiian Bundalian · Wil Borres · Wilhelmina Bloem · Will Craine · Will Drennan · Will Locking · William
Geck · William See · Wilna Junio · Wilsy Wilson · Win Win Kyi · Won Hills · Wrizu Shakya · Wyndham
Tapsell · Xavier Loretz · Xylia Arnel · Yamuna De Silva · Yan Luo · Yan Zhang · Yancey Valoria · Yani
Encarnacion · Yanjana Limbu · Yanne Vicente · Yanti Forsyth · Yanti Sriyanti · Yaowapa Somjitsakul
· Yasasmi Basnayake · Yash Maduwanthi · Yashna Prasad · Yashni Gounder · Yasmin Hughes ·
Yasoda Dewan · Yemo Ghale · Yeshi Khatiwoda · Yeshia Govender · Yeshni Rai · Yhan Borja · Yin
Huang · Yin Yin Huang · Ying Chen · Ying Jiao · Ying Lam · Ynys Cadogan · Yok Wongsa · Yolanda
Acebedo · Yolanda Grobler · Yoli Zabala · Yordanka Kirkova · Youmi Lee · YounJung Jeong · Yra
Diez · Yuka Minai · Yuki Kanno · Yuki Maeda · Yukie Nakano · Yulia Lucas · Yunisha Nakarmi · Yvanne
Evangelista · Yvette Liu · Yvette Pearl · Yvonne Bourassa · Yvonne Bresser · Yvonne Carter · Yvonne
Go · Yvonne Jiang · Yvonne Manson · Yvonne Murray · Yvonne Na · Yvonne Robinson · Zahra Salot
· Zai Gonzales · Zakk Haddon · Zamira Ensor · Zara Nichol · Zarah Masote · Zarah Villanueva ·
Zayyan Jahan · Zed Tahirovic · Zee Khan · Zehavit Darlington · Zhiella Venezuela · Zhu Zhu · Zingara
McDougall · Zoe Attrill-Palmer · Zoe Canete · Zoe Hunter · Zoe King · Zoe Noble · Zoe Stephens ·
Zoe Zhang · Zoreen Nisha · Zubaida Khan · Zuzka Erdossyova · Zyra Casul
189
ANNUAL REPORT 2022
Village locations
WHANGĀREI
•
Jane Mander
AUCKLAND
Tāmaki-makau-rau
•
Bert Sutcliffe
•
Bruce McLaren
•
Edmund Hillary
•
Evelyn Page
•
Grace Joel
•
Karaka
•
Keith Park
•
Kohimarama
•
Logan Campbell
•
Miriam Corban
•
Murray Halberg
•
Possum Bourne
•
Takapuna
•
William Sanders
WELLINGTON
2
WAIKANAE
PALMERSTON NORTH
WHANGANUI
NEW PLYMOUTH
HAVELOCK
NORTH
NAPIER
GISBORNE
TAURANGA
HAMILTON
CAMBRIDGE
WHANGĀREI
AUCKLAND
111
2
11
4
1
HAMILTON
Kirikiriroa
•
Hilda Ross
•
Linda Jones
CAMBRIDGE
Kemureti
•
Cambridge
TAURANGA
•
Bob Owens
GISBORNE
Tūranga-nui-a-Kiwa
•
Kiri Te Kanawa
NEW PLYMOUTH
Ngāmotu
•
Jean Sandel
NAPIER
Ahuriri
•
Princess Alexandra
HAVELOCK NORTH
Karanema
•
James Wattie
WHANGANUI
•
Jane Winstone
PALMERSTON NORTH
Te Papaioea
•
Julia Wallace
WAIKANAE
•
Charles Fleming
WELLINGTON
Te Whanganui a-Tara
•
Bob Scott
•
Karori
•
Malvina Major
•
Newtown
•
Rita Angus
•
Shona McFarlane
NEW ZEALAND NORTH ISLAND
Aotearoa Te Ika-a-māui
1
1
1
1
1
1
1
1
1
RYMAN HEALTHCARE
190
INVERCARGILL
DUNEDIN
RANGIORA
CHRISTCHURCH
NELSON
2
1
1
7
1
NELSON
Whakatū
•
Ernest Rutherford
RANGIORA
•
Charles Upham
CHRISTCHURCH
Ōtautahi
•
Anthony Wilding
•
Diana Isaac
•
Essie Summers
•
Kevin Hickman
•
Margaret Stoddart
•
Ngaio Marsh
•
Northwood
•
Park Terrace
•
Woodcote
RYMAN VILLAGE
UNDER CONSTRUCTION
COUNCIL APPROVAL
PROPOSED VILLAGE
ROLLESTON
Tauwharekākaho
•
Rolleston
DUNEDIN
Ōtepoti
•
Frances Hodgkins
•
Yvette Williams
INVERCARGILL
Waihōpai
•
Rowena Jackson
NEW ZEALAND SOUTH ISLAND
Aotearoa Te Waipounamu
ROLLESTON
1
11
191
AUSTRALIA VICTORIA
MELBOURNE
•
Coburg North
•
Essendon
•
Highett
•
John Flynn
•
Kealba
•
Mulgrave
•
Nellie Melba
•
Raelene Boyle
•
Ringwood East
•
Weary Dunlop
BELLARINE PENINSULA
•
Charles Brownlow
•
Deborah Cheetham
MORNINGTON PENINSULA
•
Mt Eliza
•
Mt Martha
RYMAN VILLAGE
UNDER CONSTRUCTION
COUNCIL APPROVAL
PROPOSED VILLAGE
In the spirit of reconciliation Ryman Healthcare acknowledges the
Traditional Custodians of country throughout Australia and their
connections to land, sea and community. We pay our respect to their
Elders past and present and extend that respect to all Aboriginal and
Torres Strait Islander peoples today.
CHARLES
BROWNLOW
MT MARTHA
RAELENE BOYLE
KEALBA
1
DEBORAH
CHEETHAM
WEARY DUNLOP
NELLIE MELBA
COBURG NORTHJOHN FLYNN
ESSENDON
MULGRAVE
1
1
1
1
11
1
HIGHETT
1
RINGWOOD EAST
1
1
1
1
MT ELIZA
1
RYMAN HEALTHCARE
192
Directory
REGISTERED OFFICE
Airport Business Park
92 Russley Road, Christchurch
PO Box 771, Christchurch 8042
New Zealand
SHARE REGISTRAR
Link Market Services
PO Box 91976, Auckland 1142
New Zealand
P: +64 9 375 5998
E: enquiries@linkmarketservices.co.nz
MELBOURNE OFFICE
Suite 10.03, Level 10
420 St Kilda Road
Melbourne
PO Box 33119
Melbourne VIC 3004
Australia
New Zealand
0800 588 222
rymanhealthcare.co.nz
Australia
1800 922 988
rymanhealthcare.com.au
For more information on any of Ryman Healthcare’s retirement villages:
AUCKLAND OFFICE
93 Ascot Avenue, Remuera
Auckland 1050
New Zealand
WELLINGTON OFFICE
10B Waterloo Quay
Wellington 6011
New Zealand
ANNUAL REPORT 2022
193
rymanhealthcare.co.nz
rymanhealthcare.com.au
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.